paper_id,entity,relation
e866cadc660cb4ba98d03a363b99523923fb149b,coefficient,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,determination,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,SMAPE,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,MAE,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,MSE,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,regression,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,analysis,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,evaluation,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,coefficient of,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,informative,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,regression analysis,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,Davide Chicco,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,Matthijs Warrens,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,Giuseppe Jurman,has_title
e866cadc660cb4ba98d03a363b99523923fb149b,gentleman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,squares,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,classification,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mining,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,percentage,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ridder,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mathematical definition,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,assume,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Y916187555618064095118577309390584192548727568,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,explanation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,category,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,statistics,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,N ig collecting,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,design,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,magnifies,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,tree,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,away,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,outperformed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,scientific area,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,chunk,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mathematical properties,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,errors,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,executions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Nevitt,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Maiseli,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Forests,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constraint fits,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,definition,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mice,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,weak,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,experience,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,robustness,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,low R CrossValidateda SMAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Hoffmann,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,robust,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnSMAPE give,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,linear regression model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,background,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,monotonic,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,natural,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ran,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,NObeyesdad,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,behavior,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,noise N,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,method model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,UC5 use,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,formulas X,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,branch,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,comparative analysis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Conclusions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,meaning,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,went,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,minus,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,absolute,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,normal weight,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared Random Forests,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,deviations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,machine learning,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jjy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,analysis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,execution,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,resulted being,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,imputation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,perturbations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ad-hoc variations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MSE Sammut,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,global R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,flores,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Results,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Symmetric mean,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,effectiveness,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,UC3 use case,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,derivation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,issues,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,property,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Multiple,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,horizontal line,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,parts,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jacj,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Huber metric H  Huber  LogCosh loss Wang,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sensitive,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MSE RMSE MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,interpreted,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Quantile Q  ,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mental health study,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,root,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,scientific literature,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,comparison,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,to1,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Irvine Machine,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,collopy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression task,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,informative use,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Hepatitis dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fact,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,vanishes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,outcome,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Table,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MSE value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE worst value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,unreliability,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,datasets,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jurman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,forcing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Eq,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE best value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rankings,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,modulo,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,relationship,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,unit interval,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,task,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,space,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,proceeds,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,proposal,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE metric,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Radecka,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,members,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,relevant,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,range,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rue,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,imposed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Decision Tree R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,data elements,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,symmetry,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,plot Fig,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sample,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,language,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression fails,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R 8,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,renaud,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,restriction,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,aspect,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,symmetric,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,gilroy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,quadratic L,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,passing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Jaqaman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,lost,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,prediction vector,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,square,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Fig,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,disastrous,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,webba,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,children,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Palechor dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,collecting,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,showing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,training points,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,article,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,obesity,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,real line,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,plot,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mst,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnSMAPE is9,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,effect,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,relation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,define,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Mean square,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,conclusions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,informative rate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cohn,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regressions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared shehe,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,imbens,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,UC1,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,complementary,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Breiman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,smooths,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,health,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,menard,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,positive,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,T,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,young,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,consists,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,divergent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,prediction,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,version,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,victoriafeser,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnSMAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Cases,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,applicative aspects,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,training,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression line,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predicting,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression scores,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE Mean absolute error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Young Renaud,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,applegate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,absolute values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,general performance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sum,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Allen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Kksoy Sarbishei,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Diversely,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression algorithm,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hand R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,depression scale,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,matsuura,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,detected,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hepatitis dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,formulas,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,catastrophic regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,university,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fjabj,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,know,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regularization,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,respect,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth training points,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,bestfit,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,forests,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hirsch,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,class,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,observable,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,california,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,output value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Minitab Blog Editor,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Decision Trees,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,solutions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Reeves,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,miles,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,went1,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sequence,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,formula defines,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Linear Regression MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,equations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,science,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,curators,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,degree,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,PRED,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE select,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,level,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,vector,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,principal,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,non-negative,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,selection,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,authors,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,machine learning regression methods,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression rate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE Root mean square error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hepatitis C liver fibrosis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,kelley,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,readers,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,community,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fig,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,output,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,confirm,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,negative space,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,goodwin,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,true values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,depression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression analysis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,response,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,scenarios,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mediocre Mean absolute,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,distributions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,outcomes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,set,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ranking,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,scale,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,weights,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,local models,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,verify,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,description,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,distribution,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,nevitt,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,process,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,K,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,employment,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hancock,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rule,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hepatitis C,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,optimal,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,forth element,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R programming language Ihaka,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,limitation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,runner-up,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,interval,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,addition,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,axes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,synthetically,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared worst value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,expression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,continuous,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,evaluation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,test,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,equivalent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,concordant,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,learning,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Ni,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,consequence,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predicted,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,healthy controls,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,metrics,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,expressed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,training set,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Buuren,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fact swaps,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,chen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,data,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,point,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,amend,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,standard deviations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,University,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,concept,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,truth,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,partial,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,yields,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,part,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,use,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,generic,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hibon,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Faced with,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,structure,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,independent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,theth,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,positions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ebe,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constraint,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,actual values R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,crossvalidateda,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,polynomial,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,negative,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,machine,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,method,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,analyzed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,example,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,crossvalidatedb,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ihaka,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predictions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,lichtinghagen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,components,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Linear Regression R 535,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,considerations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sukhatme,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constant,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,correlation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reasons,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,statistical measure,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,starovoitov,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,vice,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rates,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poor results,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,average line nothing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,medical,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,determination,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,huber,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,quadratic equation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,worst value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,call,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth elements,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,coordinates,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,impact,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,methods,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poor,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,elements,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jajjbj,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,matches,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,runnerup,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,drawbacks,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,test set,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,points,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,manuscript,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,shehe,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,measures,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mutually,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,possibility,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,upper bound,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,twycross,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,best-fit line,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,repository,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rational function,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,worst,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,distributions A,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Random,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predictive model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,truthful,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,overweight level II,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predictive,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,coefficient of,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,position,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,chicco,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,prediction model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,applicative,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,classify,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,integer,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,correctness,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,evaluating,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,smape,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,key-message,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,case,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,decreases,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,element,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,lies,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,missing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fit,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,results,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,performances,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,spans,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,suppose,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,changed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,nobeyesdad,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,advantage,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,relative error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,training outliers,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,table,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Chained,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,study,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,result,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ones,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,complete regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,worked,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,advantages,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poor regression model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,behaviour,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,outliers,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,relative distance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,less,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,slope,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,analyse,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,applications,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,instance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,experiments,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,predictive models,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,manner,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,informative,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fits,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Medical Scenarios,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,intrinsic metrics,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,data mining,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,myttenaere,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,amount,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,group,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,developments,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,norm,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reverse,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variables,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,majority,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression analyses,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Obesity,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,infinite,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,California,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,family,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rmse,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rao,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,difference,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ouncharoen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,coincides,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,employed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R  MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,consider,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Gilroy Hirsch  Cohn Imbens Newey,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,type,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,individuals,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cirrhosis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poorly,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,comparing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,models,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,corresponds,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,outputs,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,scenario,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,trivial,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,identical,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,measured,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,implemented,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,equation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,bounded performance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,squares Coefficient of,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,elective,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Linear Regression SMAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,invariant,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,negative value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,editor,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sammut,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,studies,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,draxler,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,binary classification Chicco,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sets,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,positive values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mathematical expression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,medical dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reeves,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression experiments,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,note,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,misled,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Imputation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,singular values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hyperplane,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,glasure,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mathematical background,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,positive value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,linearity,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Lichtinghagen dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,quality,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,researchers,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,numerical,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,overview,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnsmape,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,follow,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poor quality,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,none,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,armstrong,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reaching,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,liver,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R   MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,investigated,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,arctangent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,best-fit model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Schielzeth,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,something,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,trees,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,units,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,end,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,analyses,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,minitab,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,breiman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,multiple correlation coefficient R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,digging,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,palechor,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,side,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,concentrate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnSMAPE Table,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,consensus,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,keymessage,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,example33648161906544529437192687036909977097425010971166,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cnSMAPE scale,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,correct,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Mathematical Background,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hand,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,prediction set,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,bad regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,aspects,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,interpretation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,conceptual level Regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,irvine,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,others,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,tasks,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,general,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,introduction,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mape,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,plan,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,information,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,low forecasts,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,communicates,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Sukhatme,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,zeroed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Linear Regression Montgomery,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,negative values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constrained,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,liver fibrosis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,method R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Hyndman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,records,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reduced,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression line hyperplane,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,whole machine,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE MSE MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Hereafter,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression results,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,nonlinear regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,congruent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE best,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Introduction,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,biomedical applications,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,buuren,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,biomedical scenario,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,delahozcorrea,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MSE best,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,notice,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,quantities,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,trustworthy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,patient,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,transformations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fail,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,magnitude,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,linear model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,warrens,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R-squared Random,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mean,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,properties,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,line,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,solution,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,target,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,adhoc,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,order,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,unknowns,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,SMAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,quadratic,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fails,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variants,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,momentum,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Predictive Mean Matching,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mae,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,wright,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,unit,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,dependent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,standing,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,left room,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,feasibility,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,CrossValidatedb,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Lichtinghagen hepatitis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,swaps,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MCC,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,standardize,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression fitting model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,overweight level I,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,controls,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,david,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,score,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,compare,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,section,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,electronic health records,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,obesity type III 1535,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Miles,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,maximum,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ordering,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,herhis regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,freeman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,REAL,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,analyze,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,happens,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,L,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,as80,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression method,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Methods section,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,discussion,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,area,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,data science,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,brand,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sign,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,patients,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,percentage error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth set,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,terms,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,informativeness,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,machine learning studies,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,decision,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Linear Regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,between6,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,programming,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,informative outcome,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,solve,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,chai,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,list,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regressor,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth set REAL,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,coefficient,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,detect,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,real values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,inequality,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,data structure,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cases,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,extent,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,organization,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MST,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,montgomery,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,obesity type II,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,actual values,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,pmm,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression rates,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,journals,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,theoretical David,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,middle,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,detail,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,newey,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,formula,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,diagnosis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,pervasive,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,references,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,linear transformations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,RMSE MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,trained model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,implication,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,performance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,th value,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,intercept,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,dataset,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,number,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,matthews,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,kksoy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,next section,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Decision Tree SMAPE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,obesity type I 1663,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,numerical variable,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,thanks,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,versions,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,changes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,linear regression,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,passages,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,widespread,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,decrease,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,triangle,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,standings,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,report,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rest,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Table hepatitis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,literature,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,compute,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,yue,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,investigate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,statistical rates,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mse,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mean square error,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,minimum,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,inconsistency,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,mediocre,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,features,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,actual,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,horizontal,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variability,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,low,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ranges,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,noise,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,room,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAE best,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,makridakis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,to9,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,danuser,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,metric,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,classes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jabj,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Decision Tree,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,matching,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,examples,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,nonmatching,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,transformation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,evaluate,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,signs,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,discrimination,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,algorithm,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,computational statistics,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,to7,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,considers,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jjY,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Nguyen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,implies,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Decision Tree Random,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,agreement,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,calculations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,insufficient,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,practitioner,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,cited metrics,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ren,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,experimental part,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,beginning,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,test set R,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,poor performance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,non-matching points,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,interpretability,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,flaw,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,blog,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,distance,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,sarbishei,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,role,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,lai,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constraints,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,assigns,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,introduce,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,forecasts,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,thumb,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Wright,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Matthews correlation coefficient,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Menard,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,constants,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hepatitis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,ground truth points,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,reliable,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,biomedical,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,regression models,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,situation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,purposes,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,inexperienced,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Random Forests,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,loss,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,diagnosed,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,function,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,worst model,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,check,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,rank,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,variable,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,chosen equation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Lu,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,weight,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Kreinovich,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,PMM,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,healthy,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hoffmann,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,take,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,measure,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,proportion,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,numeric calculations,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,manuscript organization,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,subject,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,jaqaman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,limit,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Lichtinghagen dataset Lichtinghagen,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,hyndman,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,fibrosis,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,average,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Discussion,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,Matthews,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,value2,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,koehler,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,model explanation,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAPE MAE MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,applicative aspects allen farebrother gilroy hirsch cohn imbens newey ridder kksoy sarbishei radecka,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,widely adopted nevitt hancock hancock freeman applegate et al kelley lai,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,expected armstrong collopy symmetric mean absolute percentage error smape best value worst value initially defined,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,optimal mathematical expression makridakis hibon hyndman koehler hyndman chen twycross garibaldi smape,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAE MAPE MSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,binary classification chicco jurman chicco ttsch jurman ttsch hoffmann chicco starovoitov jurman chicco warrens jurman r,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,SMAPE MAPE MAE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,MAE MSE RMSE,has_body
e866cadc660cb4ba98d03a363b99523923fb149b,assess,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,classification,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,percentage,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,interpretability,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,values,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,group,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,score,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,mse,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,variables,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,learning,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,analysis,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,error,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,majority,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,domain,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,rates,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,ground,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,rmse,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,difference,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,determination,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,smape,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,predictor,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,value,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,range,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,respect,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,results,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,performance,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,drawback,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,scenarios,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,usage,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,number,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,study,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,evaluate,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,truth,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,set,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,consensus,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,properties,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,target,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,part,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,elements,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,use,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,distribution,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,prediction,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,limitations,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,comparison,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,studies,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,mae,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,infinity,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,regression,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,mape,has_abstract
e866cadc660cb4ba98d03a363b99523923fb149b,machine,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Challenges,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,development,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,assay,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Zika,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoproteins,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotyping assay,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Fernando Ruiz-Jiménez,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Jose Humberto Pérez-Olais,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Chidinma Raymond,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Barnabas King,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C Mcclure,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Richard Urbanowicz,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Jonathan Ball,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Richard Urbanowicz@,has_title
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,albopictus A hensilli Yap,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primary antibodies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,serum,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,island,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,permwash,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,design,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,host,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Modifications,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,blotted,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cell,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,concentrations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,soc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manifestation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,determinant,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectious,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nave,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sarcoma,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,basal activity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nsa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,SARS-CoV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,conditions,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reporter gene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tyro,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,assay,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manufacturers,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,syngene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,labtech,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rabies virus glycoprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP ratio,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,testing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,paper,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Japanese Encephalitis virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,option,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,disease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,complexes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,footandmouth,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,modifications,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HIV p24,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ebola,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hekt,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Miniprep kit Sigma-Aldrich,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,TGX,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,potential,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Designing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,model,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,software,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CPrME genes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cytoplasm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,natural life cycle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Dr,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dapi,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,JKB,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hypothesized,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,antibodies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,membrane M protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ratios,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Truncations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,-E cyan,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,constructs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reduce,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,knockout,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotype,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,progenitor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,inhibitor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,acquisition,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,-,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,relationship,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ebov,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fernando,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,members,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoproteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptor binding,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PBSX,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular receptors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tgx,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pathogenic viruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mild febrile disease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral backbones,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ctaagagacggctgtggata,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HIV-1,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,radial glial cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,comprises,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,paraformaldehyde,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lipid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,triplasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,strain,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mutations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,saponin,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,measurement,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Fig,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protocol,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,meansd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS2NS3,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,P005 P001 P0001 P00001,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,versatile,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,methanol,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RLU,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pathogen,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,outer subventricular zone,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,shaker,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,bands,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,assays,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,effect,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fresh,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HEKT,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,non-structural viral proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,filtered,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,positive control Fige,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,aedes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ord,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hek,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lysates,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,health,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotyped,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,wild type,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,kinases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Non-Essential,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP- ZIKV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Dunnetts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Vero E6,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nonimmune,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lenti-or retro-viruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,indirect,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,version,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reading,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pCCI-SP6-ZIKV-EGFP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,antibiotics,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,matrix protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,non-reducing conditions,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reduction,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,entebbe,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,precursor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VeroE6 cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein Briefly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reporter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,way,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,EBOV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS4B,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gag protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,salt solution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,TM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectivity Figa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,phenomena,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VSV-G,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dishes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,no difference,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,genus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,significative difference,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,increases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tail,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,grown overnight,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Zika,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sequence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,saponin2,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sfb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,science,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,substrate,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Primary antibody,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,groups,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PrMM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,multiple,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vector,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,level,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,localization,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ERR,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transferred onto45,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,incapacity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,yap,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,colonies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,slides,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rau,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Chikungunya,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,murine,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,facility,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,shaker 200 rpm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,LAS,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fig,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,jkb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primary antibody,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Nigeria,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,scatter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,player,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,amino acid residues,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,overnight,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cold,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,red,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,response,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dna,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reports,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Mini-PROTEAN,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,survival,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neural retina,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,min Cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Comparing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,redundancy,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,replicon systems,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebellar hypoplasia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,producer cells Figa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,phCMV-5349,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,susceptibility,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,full-length,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,volts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Axl,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein processing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,codifies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,influence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoproteindependent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PrME,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral glycoprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Africa Malaysia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,affecting,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,images,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,expressed,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,spectrum,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,alternative,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fbs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transfected,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NPC,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,data,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mouse,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,thalamus calcifications,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infect,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dilutions,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,strategy,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cook,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,secondary,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retroviral MLV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,conjunctivitis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,alarm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,the-nucleotide region,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular compartment,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,encode,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,FBS,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pCCI-SP6-ZIKV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rubella,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,BGH,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,combination,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,host receptor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,las,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pei,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,africa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,removal,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,experiment,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,enzymatic activity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptor tyrosine kinases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,MRC grant,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Rous sarcoma virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reporter protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,correlation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebral organoids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral proteases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lysis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CHO,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,BSL3,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HRP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,congenital central neural system disorders,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,buds,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,structural flaviviral proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prme,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral protease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,indonesia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Luciferase activity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,separate,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,capsid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,middle stages,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,no effect,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,imbalance,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral backbone,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,self-cleavage,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rpm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reticulum,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,compared,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,effective,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HCV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,america,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,locations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,grant,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,families,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lysis buffer,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cOmplete Roche,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,roche,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,december,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,E,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Hepatitis C virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mothers,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sars,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,French Polynesia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,results,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,encephalitis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral accessory proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,evaluated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,JEV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ill,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,quantified,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,merits,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PrME genes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,less,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,stages,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pnllucre,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,basal ganglia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ptg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,amount,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PVDF,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figae,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,at10 cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,filter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebral volume,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,LABTECH,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,levels,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,selfcleavage,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RIPA,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Ebola virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ultracentrifugation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,models,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,corresponds,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protein structure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,coronavirus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,permeabilised,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,measured,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,envelope E protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plots,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,organoids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pvdf,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,IF,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,immunofluorescence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,proteases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ccd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neural development,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cell lines,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,none,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,signal peptidase signal peptide,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mixture,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,blot,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,radial glia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neurogenesis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HUH7,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,DENV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Primaria Corning,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,scatter plots,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,entry,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,units,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manufacturer,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,enhance,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transmembrane sequence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manufacturer ThermoFisher Briefly TOPO,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infective pseudotype,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fluorescence Figa  E protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,safety,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,interaction,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fusionentry,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,particles,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GenElute Plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,zikv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,genome,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,legends,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,form,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ORF,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,genes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Brazil,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,formation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,diluted,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CO,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primary,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,H O,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS3,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Opti-MEM media,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,value,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Pseudotypes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,frame,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,endothelial cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,incubation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Aedes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,optimize,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pluripotent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cleaving,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mean,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VSV-based,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prism,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,no signal,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,confirmed with,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pbs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Flaviviridae,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,arboviruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,biolabs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hrp,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectivity assay,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retroviruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,treated with,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PermWash solution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,significance,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ATGCTGAGAATAATCAAT-GCtagg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,at5 million cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectious particles,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Mertk,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,E protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,flaviviruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sustain,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luciferase-encoding reporter plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,clinical manifestations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Schematic,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nuclei,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,syndrome,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nanodrop,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,microscope,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,october,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,American continent Aedes Aegypti,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,chemo,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,stomatitis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gestation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figf,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,interest,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,p24 capsid protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cases,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cloning,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,supernatants,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reducing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,biorad,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cycles,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cultured,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,from8,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protease inhibitor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,strategies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,self-replicating subgenomic,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gbox,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Entebbe Uganda,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cacc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hemispheres,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ratio,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,virion,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,biosystems,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,increasing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fever,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,West African,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,SFB,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cho,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,proliferation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,insertion,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nsbns,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral vectors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,foot-andmouth disease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cotransfection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gag,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,MLV backbone plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,spread,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hcv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plasmids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,processed,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,investigate,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,imaging,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,purified protease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vsvg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,replicon,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plates,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,azure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,producer,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,factors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hepacivirus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS2B,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Flavivirus genus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nsb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Confocal microscope,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,media,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,public,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,DMEM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PBS tween1,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Easter Island,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,peptidase,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manufacturer 98 C,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Western blot,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,alterations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,june,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,immunodeficiency,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,p55,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infection Figb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,heat-shocked,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,washes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fused,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fluostar,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pNL43,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,band,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,efficient,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,seroprevalence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,safest,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Significance levels,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbone,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Zika virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lead,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mertk,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RT Cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,capsid p24,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dish,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hepatitis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,symptoms,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotype assay,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,histograms,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luminescence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,discovery,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebral-organoids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prME proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,co-transfection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,atgctgagaataatcaatgctagg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primaria,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cushion,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,matrix,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,residues,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral pNL43,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,general pseudotyping,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,virusa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,BHK-21 cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,bmg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,in-well,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,increased,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RTKs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbone Figa-e  No differences,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prmm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,forest,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,well,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reader,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,structural proteins C,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ferret,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,membrane filter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ZIKV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,packaging,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,modifying,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,correlated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Americas,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,clinical,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,concentration,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mice,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ventricle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,denv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cytoplasmic,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,harvested,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,interfere,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,long-term,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,no band,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,epidemic,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,autochthonous,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,treated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,values,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,factor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cell type,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,chikungunya,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,moderate,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infections,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,macaque,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rgp,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dissect,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,produce,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,analysis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,stored,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Yellow Fever YF Dengue DENV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,try,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Merits,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Vesicular stomatitis virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,people,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,chimeric proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,production,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,inverse,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,observation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ampicillin,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rna,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ampicillin agar,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbone plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,calcifications,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Flaviviruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Milk,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,accessory,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,producer cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,compartment,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lateral ventricle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viruses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C-PrM-E polyprotein PCR products,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,acids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,construction,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,comparison,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,arthralgia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,bgh,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primers,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tested,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Americas 7,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Ebola,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,endoplasmic reticulum retention,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pattern,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gfp,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,signal,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,range,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,replicative,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figf,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,systems,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,genelute,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pTG126,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,analysed,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,leukaemia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figb,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,obstructive hydrocephalus calcifications,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,miniprotean,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,briefly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,induced,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,children,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,polymerase,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,FLUOstar Omega BMG,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RSV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,showing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neural progenitor cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,acid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,knockout Axl,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Comparison,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,signal peptide sequence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reaction,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,zika,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,medium,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,radial glial progenitor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,positive control,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,E coli,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,osvz,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,miniprep,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mrr,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vero,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,activated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,resistant,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,positive,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,stem,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,success,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luciferase activity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dengue,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectivity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,apparent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Gibco,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular factors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,moderate value,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular receptor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,axl,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Scientific with,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,detected,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,university,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,control,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,incorporation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,polynesia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Opti-MEM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dilution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Rubella virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cleavage,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,albopictus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,genetic alterations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,West Nile WNV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,disorders,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CT sequence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,BSL4,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,development,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,impair,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cloned,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,delivery,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,degree,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,membranes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Q5 Hot Start High-Fidelity DNA Polymerase PCR New England Biolabs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,impacts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HTO,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,SARS-CoV S protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nigeria,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,scholarship,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral assembly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,graph,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tween,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lack,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retroviral,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HEK T cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein structure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP Hepatitis C HCV to test,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Substitution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,veroe,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Tyro3,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,or-nucleotide region,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,confirm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,immune response,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gibco,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,replication,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transblot,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,anova,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,life,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Bio-Rad,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,optimem,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,parameters,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS5,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,improving,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neural stem cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,zone,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,suspected,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,capsid protein C,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,secondary antibody,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rash,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Yap,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,activity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fell ill,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Luc AM Nef,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebralorganoids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,addition,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,disease-causing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,expression,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,test,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral vector,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,equivalent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,agar,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ZIKV protein sequences,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Human Immunodeficiency Virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,School of Life Science,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Nottingham,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plasma,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,UTR,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,americas,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,bsl,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lentiviral vector pNL43,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,imaging acquisition system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,chemically competent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ablation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotype A,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,packaging plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,G-complemented pseudotype virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lab,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,signal peptide,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luciferase,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,variety,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VSV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Western blots,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,species,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,envelope,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cerebellum,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotypes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,highfidelity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,particle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sigmaaldrich,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,structure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,min,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GraphPAD PRISM12,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,negative,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RGP cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,method,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,example,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hypoplasia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,polyethyleneimine,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,isolated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,incubated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,instructions,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lines,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,furin,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,npc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figa,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,SARS,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,consecutive,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,manifestations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,blocked,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cprm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luciferase assays,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,topo,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,conacyt,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,amounts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hiv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Indonesia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,non-immune cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,primary vector,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,strand,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,impact,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lipid membrane,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GBOX,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,methods,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,processing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,basal,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,passage,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,heterologous,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptor,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,attempts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,border,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,borne,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,outbreak,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP-,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vsv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,radiance,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,event,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cold PBS,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,possibility,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,endothelial,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,random,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,total,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,longterm,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dmem,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transfection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Pseudotyping,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,replicons,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fluorescence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gvsvg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,testicular,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Western blot analysis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prM protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,samples,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cellular membrane,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,OSVZ,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,graphpad,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,study,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,result,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,University RAU,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,confluence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,polyprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retention,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,microcephaly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,size,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vectors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,analyse,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,problem,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,axldeficient,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,interplay,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,axltyro,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CHIKV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,congenital Zika syndrome,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,immune cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,england,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ruiz,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,experiments,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,load,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gels,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Aedes polyniensis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C gene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tyrosine,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,blotted Figf  HEK T cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pelleted cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,assessed,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,evidence,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tri-plasmid system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plasma membrane,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reverse,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,brainstem,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,SOC,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,measurements,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,family,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,milk,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,difference,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tcs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,positivesense,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,jimenez,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,type,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Islands,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,comparing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,kit,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Amino Acids,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,changing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,products,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,susceptible,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,C-prM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tropism,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,of408016,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Radiance,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,phenomenon,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotyping,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,west,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,non-infectious,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,show,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sarscov,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Syngene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,V constant,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rlu,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,dunnetts,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transfer,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,differences,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,construct,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,supplementation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HIV Cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,positive-sense RNA,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pluripotent stem cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,candidates,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,peptide,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein incorporation,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CT,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ind,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,alternative methods,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,live virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,heterologous glycoprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HIV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PBS1,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,investigated,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,turbo,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral GP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,luciferase assay system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP proteins,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,continent,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,culture,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Trans-Blot Turbo system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,analyses,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Nanodrop,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,associated with,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,inX,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,covering,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GagPol-encoding packaging,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Axl-deficient mice,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,czs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,a22 m,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,at510 cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,leica,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,targeting,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,region,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,information,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,express,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,obstacle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mature,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,malaysia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,membrane,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectious pseudotypes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pNL,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,buffer,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,precast,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,titre,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,MLV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS2B-NS3,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,severe,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infected,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vaccine,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GTX12452,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral load,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,solution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,line,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sentinel macaque,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VSV system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mrc,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,DMEM media,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,product,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,gene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,microglia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Data,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,flaviviridae,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,volume,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,WNV,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NS4A,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,p24,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,continental America,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotype receptor binding,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Cook Islands,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,DAPI,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,internalization,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,steps,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein gene,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fulllength,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Polyethyleneimine PEI,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein-dependent entry pathway,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral proteins M,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,antibody,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral polyprotein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,controls,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Fige,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rabies,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Andres,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,compare,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pearsons,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,promega,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mammalian,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Promega,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Fernando Ruiz Jimenez,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,complexity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,No difference,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,template,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,omega,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retroviral vector,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,vermis,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,transfectioninfection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cleaved,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Pearsons correlation coefficient,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,blots,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,salt,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RGP,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,flexibility,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,err,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,RT,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,flavivirus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,virusA protease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mechanisms,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,astrocytes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,school,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mixed reports,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,layers,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CCD imaging Azure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,HUH7 cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,American,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,polarized,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,substitution,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,progression,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tools,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbone luciferase reporter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,islands,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,track,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pNL43 2 g,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,screened,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sentinel,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CZS,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,packaging system,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,assembly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,decrease,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,negative controls,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,truncations,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,TOPO,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GP Figf,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CONACYT,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Biosystems,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,one-way ANOVA,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,VSV-G protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figg,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,laboratory,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,mlv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,essential,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cortical,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cprme,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,PrMME,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,low,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Figb c,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,nile,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,room,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ability,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viral particles,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ice,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,CTAAGAGACGGCTGTGGATA,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pellets,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,retroviral backbone pNL,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,BHK-21,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,temperature,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,signs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,thalamus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rash fever arthralgia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,figure,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,amino,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,colocalization,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Graphs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,stellar cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,spreading,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,continuing,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,brazil,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protein expression,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,role,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,virus,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbones,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,increase,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,orf,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,progenitors,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ganglia,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,r053,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plate,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,NEAA,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,immune,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,optimised,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,g of protein,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,standard protocol,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,neocortex,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,function,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,member,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,contrast,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,human,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,junction,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,opportunity,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP- ZIKV construct,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pnl,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cycle,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,scope,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotypes cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,Briefly,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prmme,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,non-structural NS1 NS2A,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,T7,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,TAM,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,alter,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sites,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pelleted,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,sucrose cushion,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,graphs,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,new infection,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,different families,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,rous sarcoma virus rsv 40 hiv typically buds,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP ZIKV Figd,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP ZIKV construct,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,structural ns1 ns2a ns2b ns3 ns4a ns4b ns5 1 zikv,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,fluostar omega bmg labtech plate reader briefly hek,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,prepared seeded at5 million cells per dish primaria corning thermofisher,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,west african outbreak 13 14 15 16 17 18 19 huh7 hekt cho bhk,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ZIKV producer cells,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP ZIKV pseudotypes,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,GFP ZIKV plasmid,has_body
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tyrosine,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotype,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,plasmids,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,longterm,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lines,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,lack,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,virus,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbones,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,backbone,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,methodology,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,hypothesis,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protease,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,z,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,proteins,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,family,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,conclusion,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,producer,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,zika,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,strategies,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,production,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cells,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,continent,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ability,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,cell,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,substitution,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,appearance,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,model,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,incorporation,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,entry,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,infectivity,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,permit,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ratio,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,reports,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,health,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,impact,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tropism,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,flaviviruses,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,kinases,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,number,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,glycoprotein,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,variety,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,concerns,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,capability,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,methods,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,czs,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pathway,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,line,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,tool,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,matrix,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,viruses,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,pseudotypes,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,concern,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,development,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,syndrome,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptor,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,protein,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,ratios,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,damage,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,introduction,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,supplementation,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,zikv,has_abstract
e734e7d3b890eb4e5f5cd5f590201f3a4a45da01,receptors,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,Characteristics,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,laboratories,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,prognosis,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,COVID-19,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,Tokyo,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,area,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,case,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,series,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,severe,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,metropolitan area,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,retrospective case series,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,Shusuke Mori Id,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,Tomohiko Ai,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,Yasuhiro Otomo,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,I ,has_title
e9f4e223a840bf55a1bcfc2646946612361289eb,viral,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,MOF,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diabetes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,well,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,guardians,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Japan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,covid,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Marchth,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,antiinterleukin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,statistics,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thrombosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,procedure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tertiary medical centers,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,design,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,laboratory examination,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,prone,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,M2020,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,interstitial pneumonia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cell,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Helsinki,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,one-time,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,processes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,complication,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,social media,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,surgical intervention,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,clinical use,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,viral transmission,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Western countries,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Organ Failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,clinical,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,chi-square test,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,concentration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,inhalation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,weeks,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tables,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,infectious,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,estimated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,guideline,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,icu,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,RNA virus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,limitations,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SPSS Statistics Version IBM,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,poor prognosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tocilizumab,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cardiovascular diseases,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anticoagulants,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pandemic declaration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,computed tomography CT,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,systemic thrombosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,was5,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,background,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,long-term,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cost,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,try prone,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treatment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,drugs,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,yen,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,relaxant,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,accordance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,embolisms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,paper,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,therapy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hospitalized patient cohort,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,coagulopathic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,disease,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,moderate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gene expression levels,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,infections,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,analysis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,try,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,prone position,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,dorsal side,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thromboplastin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PaCO2,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PaCO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,effectiveness,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,older age,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rna,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,preexisting,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SpO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,institution,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,evita,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,subcutaneous emphysema,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,higher,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,marchth,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expiratory,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,admission,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,comparison,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,enteritis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,muscle,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,wards,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tested,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Table,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,deep venous thrombosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Situation report,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nasopharyngeal samples,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,deteriorated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metamorphoses,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,New York City 4,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Italy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,insurance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pandemic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,patient charges,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,loading,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,range,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,CRRT,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metropolis area,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,centers,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,myocardial infarction,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ciclesonide,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,RR,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,sample,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,internal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,COVID pneumonia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,surgical,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,januaryst,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,consistent with,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,corp,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,corona,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lipid,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ventilation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,laboratories,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,oecd,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,system,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,skeptical,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,costs,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,polymerase,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thoracoscopy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metropolitan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Sequential,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,chain,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ivermectin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,showing,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,support,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tests,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,endoflife,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treated by,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thrombomodulin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Clinical,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,calmettegurin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,principles,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,infarction,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,trocar,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,single-cell analysis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Comparison,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,world,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lung rest strategy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lopinavir,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,reaction,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,non-placebo controlled randomized study,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,exclusion,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treatments,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,disturbance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,therapies,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,conclusions,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hemorrhagic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metabolisms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Wuhan China 1,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,organ failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,D-dimer,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,coagulation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,germany,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tube,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,procedures,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,activated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,health,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,facilities,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,chaotic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,team,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,positive,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,dire,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,prevalence,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,elevation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mannwhitney,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,immune reactions,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Favipiravir,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,chloroquine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,chisquare,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,roles,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,version,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Hydroxychloroquine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,National Institute of Infectious Diseases,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,casualties,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,assessment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,care,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,activated clotting time,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Assessment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,to3,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,withdrawal criteria,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anticoagulation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,findings,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,act,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,laboratory findings,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,japan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Group M,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pao,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,examination,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,university,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,epidemiology,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,control,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,inpatients,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,board,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,intubation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ritonavir,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mass,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,existed,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,stage,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lymphopenia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,refractory,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,endotracheal intubation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gender high body mass index,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pulmonary embolisms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory distress,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treatment facilities,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,increases,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SARS-CoV-2 infection hydroxychloroquine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hyperlipidemia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,disorders,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,approximately0,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,June,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,China,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mgday,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,intensive care unit,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,information S1,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hospitals,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,charges,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mass misinformation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,survival rates,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,crude,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,misinformation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Terumo Corp,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,blood anticoagulated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Written,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,groups,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,multiple,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hospitalized,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,drger,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,fishers,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,V300 Drger,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lack,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,abnormal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gas,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tokyo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ecmo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anti-interleukin receptor monoclonal antibody,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,community,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,wuhan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Sever Acute Respiratory Coronavirus SARS-CoV-2,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gmday,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,VV-ECMO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cells,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,forced,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,life,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,advanced facilities,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,reports,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PEEP,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,total death,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,outcomes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anyearold,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,predict,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,inflammatory processes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diagnostic tests,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,prognosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,distributed,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,crrt,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,body,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,survival,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tertiary emergency medical centers,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,troubleshooting,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anticoagulation therapy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,comorbid,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treat,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,specialists,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,antithrombin III,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,center,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,survival rate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,moment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diabetes mellitus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,addition,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,extubation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,distress,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,day,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expression,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,was8,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,instability,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,test,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,aptt,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,describe,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mlkg,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lymphocytes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,periods,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expressed,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,junend,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,infection,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,deaths,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,helsinki,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,FiO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,review,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,societies,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,data,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,fio,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,strategy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,bronchodilator,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Anticoagulation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,concerns,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,management,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,adequate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,drug use,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,median,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,use,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nitric,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,p005,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Januaryst,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,randomized placebo control,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,equipment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,external hemorrhages,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cmh,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,European countries,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Complications,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,placebo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,interquartile range,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mesylate recombinant,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,least210,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mesylate andor,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,method,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,contraindicated,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mechanical ventilators,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,elso,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,bcg,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,maneuver,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,vvecmo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hemorrhages,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,fee,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,reasons,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,quite,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,manifests,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rates,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,manifestations,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medical,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Prodromal symptoms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,reactions,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,consents,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nonplacebo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,impact,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,kidney,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,OECD,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,awake,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,admitted nationwide,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,methods,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pathogens,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tomography,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Declaration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hospital,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pathophysiology,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,p001,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,sequencing,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,asymptomatic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mandatory Prone,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,oxide,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,emergency,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,institute,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,receptor,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Dental University,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Mechanical ventilation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,norway,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory disease,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,inflammation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cross,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,observed,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,efforts,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,effective,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,total,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PCR tests,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,onset,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,profiles,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,longterm,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,position,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,efficacy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,status,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,vs8 p005,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,countries,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expectoration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,shut,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Intravenous heparin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,polymerase chain reaction PCR,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,case,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,taste,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,World Health Organization WHO 2,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,residing,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tokyo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,samples,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,results,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,survived,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hydroxychloroquine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,spss,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tracheal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ill,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,table,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,study,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anticoagulant,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,facts,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,risk factors,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,week,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,recruitment,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,less,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,acute respiratory failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,immune cells,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,multiple organ failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,normal blood gas,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,york,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Extracorporeal Life Support Organization,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,complications,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,iii,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,specialized,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diagnoses,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,iqr,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,evidence,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,variables,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,smoking habits,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,phenotypes,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ELSO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mesylate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,difference,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,levels,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,type,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hours,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,indication criteria,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,extracorporeal membrane,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,combinations,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Japanese,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,coronavirus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lbeck,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,randomized,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,dose,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,inhaler,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,extubation criteria,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,introductory procedure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PaO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,index,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,kingdom,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,show,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,sarscov,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,types,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,differences,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,intervention,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,retrospective study,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,habits,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,necrotic enteritis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,CT,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mgkg,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,serviced,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ibm,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,follow,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hype,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,interim,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypercoagulable state,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory function,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,loading dose,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,remdesivir,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,singlecell,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,US,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,vaccination,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,orally,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ventilators,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,days,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cohort,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Day,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,end,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,indication,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,analyses,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,community-acquired infections,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medical expense,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,maintenance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anti-interleukin agents,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,associated with,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,side,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SP-200,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pressure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,NEO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,investigators,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,was6,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Methylprednisolone,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Evita1,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ddimer,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,financial status,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,plan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,information,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Germany,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SARS-CoV-2 5,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,membrane,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,trouble-shooting cost,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,male,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,institutional review board,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,recommendation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,city,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,from3,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tokyo population,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,prevalent,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,reduced,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,oxygenation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medical societies,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,severe,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PF,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,excessive,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hundreds,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,BMI,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expense,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,value,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory medicine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,methylprednisolone,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,lung,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,microvasculitis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,died,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Wuhan China,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rsbi,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,New York older age,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,patient,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,agents,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ethical principles,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,sex,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PCR,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,monoclonal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,death,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,clinically,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,coagulation disorders,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,respiratory rate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gene,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,guidelines,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,statistically significant,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nitric oxide,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Data,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,volume,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,withdrawal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,unit,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,damages,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,COVID-19,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,anti-influenza reagent,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,preparation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,duration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SARS-CoV-2 positive merely,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,end-of-life stage,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,case series,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,toll,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Continuous variables,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,antibody,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treated with,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Ciclesonide,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,consolidation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pneumothorax,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,recovered,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tidal volume,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ECMO procedures,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,state,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,series,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,oxygen,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,S,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,discharged,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ECMO procedure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mortality,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,oxygen concentration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ICU admission,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,social insurance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,approximately5,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,extracorporeal membrane oxygenation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hemodynamic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mellitus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Juneth,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypercoagulation disorders,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,regions,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,organ,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,heparin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,dental,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mmHg,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,comorbid lipid disorders,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,taste disturbance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,area,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,severity,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Positive end expiratory pressure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,patients,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Fishers exact test,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,terms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,decision,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,minute,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,gender,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pH,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SARS-CoV-2 RNA,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,risk,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,published,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ancestral types,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,follow up,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,RSBI,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medications,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,criteria,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,cases,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,extent,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metropolis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,confirmation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,organization,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Venovenous extracorporeal membrane oxygenation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tables,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,exclusion criteria,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Norway,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,short-term,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,favipiravir,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thend,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,million,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,In addition,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diagnosis,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medical community,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,china,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,bacillus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,emphysema,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,neo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,case reports,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ratio,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,number,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,treatment plan,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,scores,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diagnostic,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,novel,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,VT,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,shortterm,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mechanical ventilation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypercoagulation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,insertion,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,drug,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,skin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,FDP,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pneumonia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,regular wards,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,report,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rest,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,rhabdomyolysis-induced acute kidney failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,approval,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,corona virus disease,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medical costs,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ill quicker,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Extent,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,spread,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tracheal,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,smoking,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tertiary university hospital,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,vs43,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,population,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thoracostomy,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,laboratory,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,actual,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,characteristics,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,low,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,effort,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,factors,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,acute kidney failure,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,andor,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nasogastric tube,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,media,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,time,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,thrombotic disorders,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,biochemically high FDP,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,baseline,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Bacillus Calmette-Gurin BCG,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,june,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,IQR,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,transmission,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,age,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,metropolitan area,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,health insurance,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,nafamostat,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Impact,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,peep,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,blood,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Male,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,in-hospital costs,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ST,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,outlets,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,PCR-positive,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,declaration,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypertension,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,central nervous system,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,sofa,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,news,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,role,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,virus,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mmhg,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,body mass indices,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Mann-Whitney U tests,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mortality rate,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pneumomediastinum,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,government,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,diseases,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,tachypnea,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypercholesterolemia,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,symptoms,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,United Kingdom 53 vs4,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,pre-existing hypertension,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,antithrombin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,situation,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,period,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,WHO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Characteristics,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,immune,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,function,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,medicine,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,contrast,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,human,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,shorter,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,admitted,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,hypercoagulation state,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,take,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,ECMO,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,spo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,SOFA,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Patients,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,relied,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,effects,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,bronchoalveolar immune cells,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,white blood cell,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,average,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,clinical profiles,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,covid-19,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,membrane oxygenation ecmo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,2 infection hydroxychloroquine chloroquine 14 ivermectin 26 lopinavir ritonavir 27,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,Tokyo Japan Tokyo,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,expectoration 3hemodynamically stable 4 showing normal blood gas 5 respiratory rate 35 per minute 6 tidal volume 5 mlkg 7 fio 04 peep 8cmh,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,patients Table Group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,square test using spss statistics version ibm armonk new york,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,severe pneumonia group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,moderate pneumonia group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,8 rsbi rr vt 100minl venovenous extracorporeal membrane oxygenation vv,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,blood anticoagulated using antithrombin iii human recombinant thrombomodulin nafamostat mesylate andor heparin,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,mechanical ventilation Group,has_body
e9f4e223a840bf55a1bcfc2646946612361289eb,juneth,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,tests,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,iqr,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,group,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,need,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,cases,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,transaminases,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,records,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,albumin,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,ecmo,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,world,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,oxygenation,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,japan,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,countries,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,epidemiology,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,rate,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,university,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,failure,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,treatments,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,factors,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,deaths,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,days,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,range,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,mass,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,tokyo,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,cities,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,end,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,data,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,lymphopenia,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,institution,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,lactate,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,fibrinogen,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,dehydrogenase,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,impact,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,sex,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,study,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,marchth,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,organ,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,hospital,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,june,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,body,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,survival,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,pathophysiology,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,hyperlipidemia,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,admission,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,procalcitonin,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,median,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,icu,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,index,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,area,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,shortterm,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,protein,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,patients,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,ventilation,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,casualties,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,pneumonia,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,risk,has_abstract
e9f4e223a840bf55a1bcfc2646946612361289eb,groups,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,investigation,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approaches,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ray,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,image,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,COVID-19,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detection,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution approaches,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray image,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Aras Ismael,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Abdulkadir Şengür,has_title
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,output weight vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,architecture,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classification,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,bayes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,viral,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,engr Health Inf Sci Syst,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,normalized energy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,illustration,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,convolution,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Fourier transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,covid,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,formulation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,methodology,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep learning-based approach,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,statistics,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,procedure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cross-validation technique,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,design,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,threshold,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,outperformed,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,kumar,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,calculated,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Section,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,edema,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,learning activity,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,nave,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,upper respiratory viral infection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,output matrix,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature extraction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,fine-tuning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pyramidal,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pass,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multilevel disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,energy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,treatment,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,running,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,values,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,factor,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,testing,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,segmented,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,paper,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,point discontinuities,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,component,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,mentioning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machine learning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ground-truth output Equation 2,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,analysis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ellipsoid,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Neighbor k-NN technique,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sensitivity,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,specialist,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,db1 wavelet function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,inverse,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,model,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,effectiveness,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lbp,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,extracted-dimensional feature vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Bayesian optimization,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,software,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,issues,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cover,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,goes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,unit variance criteria,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,syst,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,comparison,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hot,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution techniques,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,handle,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,fact,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,works,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,No image enhancement methods,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,networks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Contourlet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approach,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decomposition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Table,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,datasets,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,fine-tuning procedure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shannon,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,energy features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung carcinomas,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sect,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,task,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,mathematical function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,texture,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,frequency,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,rajpurkar,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,signal,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transforms,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray image-dimensional feature vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,elm,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,coefficient image,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sample,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Figure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,j2      ,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,specificity,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,double filter banks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,figb,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,loss function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lungs,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Fig,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,system,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,abnormality,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Authors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,analytical calculation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature extractors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,websites,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,technique,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,labeling,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Adaboost Random,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,to01,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,descriptors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,bands,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,anisotropic,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,contours,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,precision scores,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,world,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,directional,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,neural networks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gda,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,geometric features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,conclusions,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,MATLAB software,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,An68 accuracy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,health,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,positive,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,and3,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,zero error,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature selection method,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,T,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,flipping,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,neurons,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Wavelet Shearlet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,prediction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,version,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,energy functions,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,training,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,resolutions,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Ismael,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,reduction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,nodules,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung area,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,plankis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,VGG16 models2,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ismael,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,banks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,xray,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shearlet transforms,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,disadvantages,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,interstitial lung disease pneumonia,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,regularization,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,two-stepped approach,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,zero,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decomposes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,page,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cnn,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,stage,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,forests,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung nodule,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,class,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Transfer learning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Wavelet transforms,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Laplacian pyramid,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classifier,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pnn,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pass filter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sampled,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,step,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,level,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,selection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,proposed,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,remainder,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Contourlet decomposition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,authors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,image,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,difficulties,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,fig,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,energy techniques,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,expansion,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,functions,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,output,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,individuality,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,locating,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,disease detection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pathologies,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,parameters,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,interstitial lung disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,improving,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,input,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,GIST,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,set,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hand-crafted,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,average,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,scale,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hiddenlayer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,weights,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decomposing,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,state-of-the-art performance,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,direction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,non-subsampled Contourlet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hierarchical-CNN model,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Contourlet coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,process,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,activity,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Page,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,partitioning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution approach,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,kernel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,rule,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,redundancy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,optimal,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,GDA,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,input samples,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,addition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,normal healthy chest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decade,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,evaluation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,learning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,CNN,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,nyquists,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,vgg,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,metrics,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,images,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,infection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,dong,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,respiratory,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,engr,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung cancer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,data,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Plankis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detail coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,scales,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,SqueezeNet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,strategy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Bayes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,frequency bands,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,neighbor,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,nodule,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,rows,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,part,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Table Table,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,use,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Gabor filters,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pyramid,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,structure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multilevel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,negative,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,recognition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,twolevel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machine,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,method,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,example,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shearlet coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,patterns,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,experiment,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,components,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,medical doctors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,figa,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shuffle sampling,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,quite,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,texture-based,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Quadro M4000,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,parameter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,achievements,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ram,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,misclassification,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,medical,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,details,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,schiham,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,SVM,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,column,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Huser,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,fast,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung nodules,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,and944,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,alevel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,processing,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,methods,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,a-layered,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,crossvalidation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,dimension,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep feature extraction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung abnormalities,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,signal individuality,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,three-level,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,followup,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet transformation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,interests,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,learning machines,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,measures,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shearlet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wei,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,follow-up,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,contourlet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,compared,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,moorepenrose,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,normal chest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,the-dimensional input data,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,arranged,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,thoracic diseases,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ELM,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,error,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,coeffs,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray image classification,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pkva,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,words,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,case,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,address,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Fast Finite Shearlet Transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,analytical,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,samples,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,results,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,performances,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,input weight vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,experimental works,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,diffuse,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,table,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hand-crafter features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,study,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,coefficient images,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Schiham,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Figa,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Steidl,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shearing filter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,size,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,less,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,vectors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,applications,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,problem,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,achievement,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,stages,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,probability,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decompose,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,alexnet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,training images,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Ozturk,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,non-subsampled Shearlet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,inf,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,filter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,enhancement,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,measurements,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep feature,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,employed,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,accurate,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Wavelet transform,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,levels,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,histogram,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,models,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,confusion,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,finetuning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,NVIDIA,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shows,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transfer learning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,HOG,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tool,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,entropy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,equation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,N,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Gaussian kernel function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,woniak,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,show,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,studies,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiscale,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,collected,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,data collection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transfer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,network,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sources 2,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,variance,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,CT,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,bayesian,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,kernels,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Moore-Penrose generalized,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,investigated,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Wavelet transform Contourlet transform Shearlet transform entropy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,airway,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,two-level,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decomposed chest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,matrix H and,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approaches,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,end,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cavities,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,anisotropic information,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,characterization,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,side,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Pyramidal,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pulmonary edema,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sub,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wedge-shaped frequency partitioning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,nvidia,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Gaussian,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detects,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,automatic detection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tasks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,comparisons,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,materials,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shearlet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,region,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,information,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,content,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,layer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,columns,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,studys,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung diseases,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,early diagnosis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,probabilistic,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classifications,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,epsilon,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,precision,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gui,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,squeezenet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,codes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gradient,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shannon entropy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,normalized,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,doctors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep learning approach,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,infected,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ozturk,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shuffle,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,value,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hidden layer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,knearest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,carcinomas,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,techniques,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,experimentation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,impose,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,complex coefficients,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Shearlet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ith,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lowpass,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet transforms,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,thoracic,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,order,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,filter banks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet decomposition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,evolution,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,momentum,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Data,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution decomposition Entropy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ethics,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,GPU,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,neuron,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest X-rays,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest X-ray,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,unit,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,COVID-19 disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,image processing,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,AlexNet model,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,learning-based approaches,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,GB,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,COVID-19,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detection system,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Rajpurkar,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,a-level,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,score,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,huser,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,concatenation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pulmonary edema detection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,ResNet50,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,indeterminacy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray images,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,section,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,active contour method,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,C value,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,RAM,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,discrete,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hyper,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,inputted,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,analyze,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,template,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,research,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,neural network model,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,binary classification,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,augmentation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,L,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,area,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sign,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,binary patterns,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sources,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,filters,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classification stage,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pixels,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,twostepped,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,smallsized,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,binary,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Contourlet transforms,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,output vector,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,criteria,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cases,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,computer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,resnet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,extractors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,topic,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,threelevel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,SVM classifier,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,layers,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,diagnosis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detail,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hand-crafted features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sigmoid,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,local,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tools,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,satisfactory,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,extract,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,performance,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pertinent,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,dataset,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,number,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,scores,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,quite surprising,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,experimental,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,GUI,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,modified,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,activation function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,novel,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,collection,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gabor,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pulmonary,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hierarchicalcnn,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,optimization,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,implementation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,input image,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray image,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hidden-layer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,changes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray image-based disease,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pneumonia,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,AUC,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,knn,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,accuracy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,literature,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,xrays,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,measuring,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,a6 accuracy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,characteristics,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,low,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,low-pass filter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,work,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,active,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,appearance,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,activation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,future,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,time,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Fine-tuning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,metric,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,noor,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,matching,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gist,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Liu,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tuberculosis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transformation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Sect,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,theories,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,algorithm,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machines,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,high-frequency,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,gaussian,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,figure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,A-classed chest,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shearing,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,deep learning,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cxnetm,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,resized,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,calculations,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Normalized energy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution approaches,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,matlab,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,spreading,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,analytically,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,calculation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,imagistic patterns,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,discontinuities,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,band,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,liu,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,efficient,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,auc,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,domain,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,LBP,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Wavelet Contourlet,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution image decomposition,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,pulmonary nodules,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,diseases,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,location,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,handcrafter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,bias,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,extraction,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature vectors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,row,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,handled,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,time domain,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,loss,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,function,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,randomly rotating shifting,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,weight,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,hog,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,healthy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sub bands,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approximation,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,matrix,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,quadro,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiscale geometric analysis,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,PNN,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,employ,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Down sampling,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,measure,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,effects,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,blocks,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,edges,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,non-subsampled shearing filter,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,SIFT,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,steidl,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cancer,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,controlled,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,node,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,satisfy,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,abnormalities,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,matrixes,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Ucar,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Features,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest x-ray,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,traditional feature extraction methods,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machine learning-based approaches,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray images ELM,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sigmoid respectively four performance evaluation metrics namely accuracy sensitivity specificity,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,proposed model produced auc values between704 and944 bhandary et al 15 modified,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shuffle sampling method dong et al 13 proposed cnn models,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,lung nodule detection schiham et al 4 proposed another hand,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest X-ray images,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,Chest X-ray,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,X-ray images Authors,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,study four local texture descriptors namely sift gist lbp,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest X-ray image-dimensional,has_body
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shifts,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,networks,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approach,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classification,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,day,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,contourlet,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,trend,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,accuracy,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,evaluation,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,score,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,covid,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,imaging,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,learning,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,xray,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,features,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,images,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,case,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,approaches,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transforms,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,end,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,stage,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,elm,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,transform,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,multiresolution,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,study,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,classifier,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,detection,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,specificity,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machines,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,applications,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,decompose,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,feature,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,shearlet,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,recognition,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,energy,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,machine,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,cnns,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,vector,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,support,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tests,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,paper,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,precision,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,resnet,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,virus,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,world,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wellknown,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,rate,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,determination,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,extraction,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,sensitivity,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,model,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,chest,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tools,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,performance,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,input,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,dataset,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,methods,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,death,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,tomography,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,wavelet,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,entropy,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,numbers,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,novel,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,comparison,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,works,has_abstract
e21fa0c3998bf989ec31046de9ebe3e074ec77ab,investigation,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,Hematemesis,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Exceptional,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Method,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Revealing,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Gastric,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Metastasis,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Breast,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Cancer,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,cancer,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Exceptional Method,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Gastric Metastasis,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Unknown Breast Cancer,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Rachid Jabi,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Nassira Karich,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Mouad Ouryemchi,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Amal Bennani,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,Mohammed Bouziane,has_title
e7816cb7c28f0fd8e752021d329a3c10875c9203,therapeutic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,pancreatic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,follow-up,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,immunotherapy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,consult,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,ppi,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,palpation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,covid,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,multidisciplinary discussion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,sporadic case,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,status,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,clinical presentation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast carcinoma,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,conclusion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,anemia,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,exceptional gastric,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,case,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,National Comprehensive Cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,difficulty,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,results,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,complication,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,hemorrhage,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,at1,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cancers,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,study,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,stable,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,clinical,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast level,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,notion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast metastases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,contraception,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,absence,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,extension,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,context,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,less,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gynecological,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,poor prognosis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,monitored,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,signet,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,stage IV,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,mandatory,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,pass,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nehmeh,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,treatment,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gdl,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,site,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,biological,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric process,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,tumor syndrome,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast origin,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,tnxm,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,disadvantage,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,disease,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,health practitioners,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cause,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,subjects,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,organizations,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,north-eastern part,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,CAse REport,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,financial support,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,autopsy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,hematemesis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,medical condition,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,emergency situation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,sensitivity,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,type,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,invasive,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,particularity,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,admission,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,goes,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cancer death,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,proton pump,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,evidence-based medicine,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,network,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,disclosure,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric perforation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,practitioners,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nour,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,origin,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,digestive metastases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,history,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,years,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,inhibitor,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,exceed3,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,exceptional case,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,digestive hemorrhage,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Financial relationships,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,febrile,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,condition,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,days,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,multidisciplinary management,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,right breast,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,analyses,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,standardization,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,women,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,enrich,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gynecological cancers,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,declare,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,incidence,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,side,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,screening strategies,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,consensus,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric metastases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,ring,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,validate,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,selfpalpation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,preferred,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,region,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,children,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,obstacle,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,symptomatology,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,woman,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,form,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,support,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,advanced,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,ICMJE,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,respiratory infection,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,rarity,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,GI tract,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,world,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,highlight,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,perforation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,effect,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,biopsy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,palliative,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,consults,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,country,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,histological study,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,patient,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,health,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,episodes,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nursing,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,sex,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,team,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breasts,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,colonic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,death,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,clinical examination,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,unrecognized,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,metastasis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,systematic clinical examination,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,mobile,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,biological analyses,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,comprehensive,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,screening,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,guidelines,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,problems,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,place,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,care,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,metastases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,colonic tumor,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,COVID-19,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cause of,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Hb,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,paymentservices,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,exploration,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric metastasis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,examination,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,mortality,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,commit,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,systematic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,retro,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,stage,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,hemodynamic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,neutropenia,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,consent,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,endoscopy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,tumor,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,compliance,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,discussion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,axillary adenopathy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,anatomopathological results,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,syndrome,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,influenced,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,ultrasoundmammography,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,proton,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,patients,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,adenopathy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,terms,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,decision,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,PPI,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,months,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,device,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,CARE,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,level,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,localization,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,oral contraception,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast primary,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,BIRADS,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,poor literature,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,relationships,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Conflicts,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,interest,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,female sex,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,authors,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nipple,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Nehmeh WA,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,forms,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,organization,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,radiological,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,signet ring cells,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,emergencies,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,care team,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,diagnosis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,strategies,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,GI,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cells,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,transfusion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,favor,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,pain,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,re-interviewed,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,injection,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,hope,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,pump,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,sacred,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,epigastric,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,mother,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,prognosis,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,oral,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast biopsy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nccn,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast node classified,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,metastatic forms,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,info,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,treat,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,bleeding,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,process,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,thanks,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,report,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,examinations,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,literature,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Consent,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,epigastric sensitivity,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast Human subjects,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,specimens,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,radiological extension study,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,side effect,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast pain,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,describe,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,highest,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,self-palpation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Apodaca-Rueda M,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Breast Health Global,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,infection,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,respiratory,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,work,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,stomach,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,metastatic site,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,financial relationships,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,advent,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,forgotten,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric level,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Thraux J,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,secondary,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nodule,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,evaluate,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,colonic occlusion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,clinical examinations,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,management,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,part,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,gastric region,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,occlusion,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,age,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,epigastralgia,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,figure,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,case presentation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,immunohistochemical study,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,universal right,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,palliative chemotherapy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,lobular type cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,annual,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,nursing mother,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Breast cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,activities,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,motivating,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,means,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,medical,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,thraux,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,location,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,carcinoma,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,submitted work,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,situation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,female,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,initiative,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,discovery,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,T1NxM1 A decision,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,endoscopic,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,diagnosed,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,impact,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,medicine,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,participants,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,ER,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,chemotherapy,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,birads,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,emergency,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,presentation,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,subject,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,medico-legal problems,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,Paymentservices info,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,followup,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,node,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,reminder,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,adenocarcinoma,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,new cases,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,latest national comprehensive cancer network nccn report breast cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast cancer unrecognized,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,emergency situation must never allow systematic clinical examinations,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,retro nipple without axillary adenopathy whose ultrasoundmammography,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,report breast cancer,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,signet ring cells features figure confirmed,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,several new therapeutic means including immunotherapy 3,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,NCCN report breast,has_body
e7816cb7c28f0fd8e752021d329a3c10875c9203,treatment,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,classification,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,localization,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,history,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,consult,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,disease,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,cases,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,palpation,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,majority,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,hematemesis,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,examination,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,breast,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,diagnosis,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,sensitivity,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,case,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,days,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,condition,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,women,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,patient,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,health,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,episodes,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,immunohistochemistry,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,incidence,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,nodule,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,endoscopy,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,tumor,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,admission,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,epigastralgia,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,presentation,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,patients,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,problem,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,cancer,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,impacts,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,months,has_abstract
e7816cb7c28f0fd8e752021d329a3c10875c9203,woman,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,Deep,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Learning,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Stroke,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Disease,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Prediction,has_title
e01871778fa196a0886eae089dc352c5c41d856f,System,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Time,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Bio,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Signals,has_title
e01871778fa196a0886eae089dc352c5c41d856f,disease,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Deep Learning-Based Stroke Disease,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Real-Time Bio Signals,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Yoon-A Choi,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Se-Jin Park,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Jong-Arm Jun,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Cheol-Sig Pyo,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Kang-Hee Cho,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Han-Sung Lee,has_title
e01871778fa196a0886eae089dc352c5c41d856f,Jae-Hak Yu,has_title
e01871778fa196a0886eae089dc352c5c41d856f,ischemic stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,updates,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classification,has_body
e01871778fa196a0886eae089dc352c5c41d856f,dependency,has_body
e01871778fa196a0886eae089dc352c5c41d856f,senior citizens,has_body
e01871778fa196a0886eae089dc352c5c41d856f,thighs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,power values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,basically shared,has_body
e01871778fa196a0886eae089dc352c5c41d856f,forest,has_body
e01871778fa196a0886eae089dc352c5c41d856f,well,has_body
e01871778fa196a0886eae089dc352c5c41d856f,attributes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,early,has_body
e01871778fa196a0886eae089dc352c5c41d856f,covid,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pri,has_body
e01871778fa196a0886eae089dc352c5c41d856f,medical professionals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electrical activities,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rehabilitation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,algorithms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sines,has_body
e01871778fa196a0886eae089dc352c5c41d856f,design,has_body
e01871778fa196a0886eae089dc352c5c41d856f,threshold,has_body
e01871778fa196a0886eae089dc352c5c41d856f,implementing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,redefining,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tree,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cell,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tension discomfort,has_body
e01871778fa196a0886eae089dc352c5c41d856f,AI,has_body
e01871778fa196a0886eae089dc352c5c41d856f,processes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sequences,has_body
e01871778fa196a0886eae089dc352c5c41d856f,discover,has_body
e01871778fa196a0886eae089dc352c5c41d856f,difficulty,has_body
e01871778fa196a0886eae089dc352c5c41d856f,correlated,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Section,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Gautam,has_body
e01871778fa196a0886eae089dc352c5c41d856f,raw values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,clinical,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EMR,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Tables,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnnbidirectional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,detection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rhythmic,has_body
e01871778fa196a0886eae089dc352c5c41d856f,detrended fluctuation analysis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,from1,has_body
e01871778fa196a0886eae089dc352c5c41d856f,topography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-LSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain waves,has_body
e01871778fa196a0886eae089dc352c5c41d856f,axis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,eml,has_body
e01871778fa196a0886eae089dc352c5c41d856f,limitations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,showed0,has_body
e01871778fa196a0886eae089dc352c5c41d856f,directions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,feature extraction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ischemic stroke disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,machine learning techniques,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decision tree,has_body
e01871778fa196a0886eae089dc352c5c41d856f,background,has_body
e01871778fa196a0886eae089dc352c5c41d856f,long-term,has_body
e01871778fa196a0886eae089dc352c5c41d856f,collect,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cost,has_body
e01871778fa196a0886eae089dc352c5c41d856f,treatment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,incision,has_body
e01871778fa196a0886eae089dc352c5c41d856f,calculate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,multilayer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,showed4,has_body
e01871778fa196a0886eae089dc352c5c41d856f,biological,has_body
e01871778fa196a0886eae089dc352c5c41d856f,normal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,skull thickness,has_body
e01871778fa196a0886eae089dc352c5c41d856f,values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classified,has_body
e01871778fa196a0886eae089dc352c5c41d856f,testing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,meaning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,paper,has_body
e01871778fa196a0886eae089dc352c5c41d856f,literature review,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cause,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cox,has_body
e01871778fa196a0886eae089dc352c5c41d856f,component,has_body
e01871778fa196a0886eae089dc352c5c41d856f,situations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,machine learning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stored,has_body
e01871778fa196a0886eae089dc352c5c41d856f,analysis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,services,has_body
e01871778fa196a0886eae089dc352c5c41d856f,people,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Giri,has_body
e01871778fa196a0886eae089dc352c5c41d856f,program,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sensitivity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mitigating,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lowincome,has_body
e01871778fa196a0886eae089dc352c5c41d856f,potential,has_body
e01871778fa196a0886eae089dc352c5c41d856f,model,has_body
e01871778fa196a0886eae089dc352c5c41d856f,inverse,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low-income earners,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rahma,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mean value,has_body
e01871778fa196a0886eae089dc352c5c41d856f,front,has_body
e01871778fa196a0886eae089dc352c5c41d856f,learning ability,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data points,has_body
e01871778fa196a0886eae089dc352c5c41d856f,physiological,has_body
e01871778fa196a0886eae089dc352c5c41d856f,higher,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimental accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EML,has_body
e01871778fa196a0886eae089dc352c5c41d856f,yaxis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,outside,has_body
e01871778fa196a0886eae089dc352c5c41d856f,learned,has_body
e01871778fa196a0886eae089dc352c5c41d856f,X-ray ECG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ratios,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emergency room,has_body
e01871778fa196a0886eae089dc352c5c41d856f,technology,has_body
e01871778fa196a0886eae089dc352c5c41d856f,comparison,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Stroke disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,regression,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cumbersome process,has_body
e01871778fa196a0886eae089dc352c5c41d856f,earners,has_body
e01871778fa196a0886eae089dc352c5c41d856f,comparative experiments,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deltatheta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,control data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Power ratio index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Table,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alpha,has_body
e01871778fa196a0886eae089dc352c5c41d856f,varelas,has_body
e01871778fa196a0886eae089dc352c5c41d856f,history,has_body
e01871778fa196a0886eae089dc352c5c41d856f,listed,has_body
e01871778fa196a0886eae089dc352c5c41d856f,aged,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pattern,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Intel,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reverse inference,has_body
e01871778fa196a0886eae089dc352c5c41d856f,generalizable stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,logistic regression model,has_body
e01871778fa196a0886eae089dc352c5c41d856f,standard deviation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,collects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,psd,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cortex,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fractal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gamma,has_body
e01871778fa196a0886eae089dc352c5c41d856f,adds,has_body
e01871778fa196a0886eae089dc352c5c41d856f,multiple subjects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,structures,has_body
e01871778fa196a0886eae089dc352c5c41d856f,condition,has_body
e01871778fa196a0886eae089dc352c5c41d856f,frequency,has_body
e01871778fa196a0886eae089dc352c5c41d856f,proposedlayer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,scans,has_body
e01871778fa196a0886eae089dc352c5c41d856f,range,has_body
e01871778fa196a0886eae089dc352c5c41d856f,elm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Figure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,incidence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,systems,has_body
e01871778fa196a0886eae089dc352c5c41d856f,clinical setting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,specificity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prepares,has_body
e01871778fa196a0886eae089dc352c5c41d856f,seniors,has_body
e01871778fa196a0886eae089dc352c5c41d856f,expressing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,input value,has_body
e01871778fa196a0886eae089dc352c5c41d856f,shortcomings,has_body
e01871778fa196a0886eae089dc352c5c41d856f,walking situations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,measurement,has_body
e01871778fa196a0886eae089dc352c5c41d856f,seconds,has_body
e01871778fa196a0886eae089dc352c5c41d856f,protocol,has_body
e01871778fa196a0886eae089dc352c5c41d856f,eog,has_body
e01871778fa196a0886eae089dc352c5c41d856f,system,has_body
e01871778fa196a0886eae089dc352c5c41d856f,induced,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lastminute,has_body
e01871778fa196a0886eae089dc352c5c41d856f,costs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,simultaneously,has_body
e01871778fa196a0886eae089dc352c5c41d856f,bilstm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Tables-8,has_body
e01871778fa196a0886eae089dc352c5c41d856f,support,has_body
e01871778fa196a0886eae089dc352c5c41d856f,exposure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,athens,has_body
e01871778fa196a0886eae089dc352c5c41d856f,densenet,has_body
e01871778fa196a0886eae089dc352c5c41d856f,baseline models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tests,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mild stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,machine learning methods,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neural,has_body
e01871778fa196a0886eae089dc352c5c41d856f,comfort,has_body
e01871778fa196a0886eae089dc352c5c41d856f,delivers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,false negative ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alphabeta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain blood vessels,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hyperparameters,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electroencephalography EEG electrocardiography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,learn,has_body
e01871778fa196a0886eae089dc352c5c41d856f,DAR,has_body
e01871778fa196a0886eae089dc352c5c41d856f,world,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Sensitivity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based studies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cardiovascular disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,walking protocol,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CT analysis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,degrees,has_body
e01871778fa196a0886eae089dc352c5c41d856f,radiation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,last-minute pattern,has_body
e01871778fa196a0886eae089dc352c5c41d856f,blood tests,has_body
e01871778fa196a0886eae089dc352c5c41d856f,normalization,has_body
e01871778fa196a0886eae089dc352c5c41d856f,entered,has_body
e01871778fa196a0886eae089dc352c5c41d856f,complex,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sleep states,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictive experiments,has_body
e01871778fa196a0886eae089dc352c5c41d856f,health,has_body
e01871778fa196a0886eae089dc352c5c41d856f,positive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,and3,has_body
e01871778fa196a0886eae089dc352c5c41d856f,professionals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electrooculography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain CT,has_body
e01871778fa196a0886eae089dc352c5c41d856f,consists,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neurons,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sharp,has_body
e01871778fa196a0886eae089dc352c5c41d856f,spectral density,has_body
e01871778fa196a0886eae089dc352c5c41d856f,MLP,has_body
e01871778fa196a0886eae089dc352c5c41d856f,offline processing unit,has_body
e01871778fa196a0886eae089dc352c5c41d856f,screening,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-bidirectional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prediction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reverse processing layer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,problems,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brainwave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,of0,has_body
e01871778fa196a0886eae089dc352c5c41d856f,training,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predicting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reduction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based,has_body
e01871778fa196a0886eae089dc352c5c41d856f,advantages-h EEG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,false positive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,expensive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,trend,has_body
e01871778fa196a0886eae089dc352c5c41d856f,precursor,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sum,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Fawaz,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ais,has_body
e01871778fa196a0886eae089dc352c5c41d856f,update,has_body
e01871778fa196a0886eae089dc352c5c41d856f,xray,has_body
e01871778fa196a0886eae089dc352c5c41d856f,total subjects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,natural setting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,golden,has_body
e01871778fa196a0886eae089dc352c5c41d856f,speech,has_body
e01871778fa196a0886eae089dc352c5c41d856f,preset frequency,has_body
e01871778fa196a0886eae089dc352c5c41d856f,examination,has_body
e01871778fa196a0886eae089dc352c5c41d856f,university,has_body
e01871778fa196a0886eae089dc352c5c41d856f,exploits,has_body
e01871778fa196a0886eae089dc352c5c41d856f,amplitude sizes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,control,has_body
e01871778fa196a0886eae089dc352c5c41d856f,amplitude,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neat signal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictive accuracies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnn,has_body
e01871778fa196a0886eae089dc352c5c41d856f,MRI,has_body
e01871778fa196a0886eae089dc352c5c41d856f,speech recognition,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stage,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alpha power ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pre-detection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,times,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lts,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classifier,has_body
e01871778fa196a0886eae089dc352c5c41d856f,length,has_body
e01871778fa196a0886eae089dc352c5c41d856f,increases,has_body
e01871778fa196a0886eae089dc352c5c41d856f,frequency ranges alpha wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Varelas,has_body
e01871778fa196a0886eae089dc352c5c41d856f,PRI,has_body
e01871778fa196a0886eae089dc352c5c41d856f,figures,has_body
e01871778fa196a0886eae089dc352c5c41d856f,nihss,has_body
e01871778fa196a0886eae089dc352c5c41d856f,protocols,has_body
e01871778fa196a0886eae089dc352c5c41d856f,and4,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sequence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,descriptions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,equations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low-cost method,has_body
e01871778fa196a0886eae089dc352c5c41d856f,daily life,has_body
e01871778fa196a0886eae089dc352c5c41d856f,step,has_body
e01871778fa196a0886eae089dc352c5c41d856f,inference,has_body
e01871778fa196a0886eae089dc352c5c41d856f,forgetting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cpu,has_body
e01871778fa196a0886eae089dc352c5c41d856f,roc,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alzheimers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mris,has_body
e01871778fa196a0886eae089dc352c5c41d856f,degree,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time collected data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,device,has_body
e01871778fa196a0886eae089dc352c5c41d856f,date,has_body
e01871778fa196a0886eae089dc352c5c41d856f,biological tests,has_body
e01871778fa196a0886eae089dc352c5c41d856f,multiple,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ANN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,level,has_body
e01871778fa196a0886eae089dc352c5c41d856f,vector,has_body
e01871778fa196a0886eae089dc352c5c41d856f,poststroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,illustrated,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fine-tuned models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,graph,has_body
e01871778fa196a0886eae089dc352c5c41d856f,phase,has_body
e01871778fa196a0886eae089dc352c5c41d856f,false positive rate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,multimodal studies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fatigue,has_body
e01871778fa196a0886eae089dc352c5c41d856f,right brain hemisphere,has_body
e01871778fa196a0886eae089dc352c5c41d856f,identification,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low-cost,has_body
e01871778fa196a0886eae089dc352c5c41d856f,MRI scans,has_body
e01871778fa196a0886eae089dc352c5c41d856f,head,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lack,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hier,has_body
e01871778fa196a0886eae089dc352c5c41d856f,abnormal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,degradation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,image,has_body
e01871778fa196a0886eae089dc352c5c41d856f,beta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sampling,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Bidirectional RNN BRNN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,finnigan,has_body
e01871778fa196a0886eae089dc352c5c41d856f,xie,has_body
e01871778fa196a0886eae089dc352c5c41d856f,scalp,has_body
e01871778fa196a0886eae089dc352c5c41d856f,expansion,has_body
e01871778fa196a0886eae089dc352c5c41d856f,functions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,designing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,output,has_body
e01871778fa196a0886eae089dc352c5c41d856f,perceptron,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cells,has_body
e01871778fa196a0886eae089dc352c5c41d856f,wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,clinical meaning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,historical,has_body
e01871778fa196a0886eae089dc352c5c41d856f,insomnia,has_body
e01871778fa196a0886eae089dc352c5c41d856f,adhi,has_body
e01871778fa196a0886eae089dc352c5c41d856f,life,has_body
e01871778fa196a0886eae089dc352c5c41d856f,GBD,has_body
e01871778fa196a0886eae089dc352c5c41d856f,waveforms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,parameters,has_body
e01871778fa196a0886eae089dc352c5c41d856f,help,has_body
e01871778fa196a0886eae089dc352c5c41d856f,accurately,has_body
e01871778fa196a0886eae089dc352c5c41d856f,input,has_body
e01871778fa196a0886eae089dc352c5c41d856f,koreans,has_body
e01871778fa196a0886eae089dc352c5c41d856f,proposed-layer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,genetic algorithms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predict,has_body
e01871778fa196a0886eae089dc352c5c41d856f,set,has_body
e01871778fa196a0886eae089dc352c5c41d856f,wavelet,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prognosis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,DFA,has_body
e01871778fa196a0886eae089dc352c5c41d856f,scale,has_body
e01871778fa196a0886eae089dc352c5c41d856f,body,has_body
e01871778fa196a0886eae089dc352c5c41d856f,database,has_body
e01871778fa196a0886eae089dc352c5c41d856f,direction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,imaging techniques,has_body
e01871778fa196a0886eae089dc352c5c41d856f,at2,has_body
e01871778fa196a0886eae089dc352c5c41d856f,process,has_body
e01871778fa196a0886eae089dc352c5c41d856f,behavioral,has_body
e01871778fa196a0886eae089dc352c5c41d856f,activity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,center,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fast activity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,optimal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signal sensors,has_body
e01871778fa196a0886eae089dc352c5c41d856f,addition,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neurological,has_body
e01871778fa196a0886eae089dc352c5c41d856f,checkups,has_body
e01871778fa196a0886eae089dc352c5c41d856f,relative values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Korean seniors,has_body
e01871778fa196a0886eae089dc352c5c41d856f,men,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,test,has_body
e01871778fa196a0886eae089dc352c5c41d856f,categorized,has_body
e01871778fa196a0886eae089dc352c5c41d856f,biosignals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,learning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predicted,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Li,has_body
e01871778fa196a0886eae089dc352c5c41d856f,periods,has_body
e01871778fa196a0886eae089dc352c5c41d856f,metrics,has_body
e01871778fa196a0886eae089dc352c5c41d856f,expressed,has_body
e01871778fa196a0886eae089dc352c5c41d856f,images,has_body
e01871778fa196a0886eae089dc352c5c41d856f,paramount,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emg,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Res-CNN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deaths,has_body
e01871778fa196a0886eae089dc352c5c41d856f,healthcare services,has_body
e01871778fa196a0886eae089dc352c5c41d856f,delta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,recall,has_body
e01871778fa196a0886eae089dc352c5c41d856f,review,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alpha beta theta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,spaces,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ECG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tune,has_body
e01871778fa196a0886eae089dc352c5c41d856f,validations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,analytical information,has_body
e01871778fa196a0886eae089dc352c5c41d856f,caption,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain nerve cells,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Dourado,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neighbor,has_body
e01871778fa196a0886eae089dc352c5c41d856f,concept,has_body
e01871778fa196a0886eae089dc352c5c41d856f,bio-signals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Rahma,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cgan,has_body
e01871778fa196a0886eae089dc352c5c41d856f,recurrence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,accuracies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,part,has_body
e01871778fa196a0886eae089dc352c5c41d856f,use,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Gamma Gamma power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cardiovascular index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Signal processing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hidden-state,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Alzheimers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ecg,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hidden layers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,structure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,negative,has_body
e01871778fa196a0886eae089dc352c5c41d856f,recognition,has_body
e01871778fa196a0886eae089dc352c5c41d856f,machine,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-bidirectional LSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,method,has_body
e01871778fa196a0886eae089dc352c5c41d856f,analyzed,has_body
e01871778fa196a0886eae089dc352c5c41d856f,example,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,verification,has_body
e01871778fa196a0886eae089dc352c5c41d856f,healthcare,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experiment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brainwaves,has_body
e01871778fa196a0886eae089dc352c5c41d856f,monitoring stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based stroke disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,monitoring system,has_body
e01871778fa196a0886eae089dc352c5c41d856f,chapter,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lines,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electrocardiography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,constant,has_body
e01871778fa196a0886eae089dc352c5c41d856f,correlation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sleep,has_body
e01871778fa196a0886eae089dc352c5c41d856f,exposure to,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diagnostic method,has_body
e01871778fa196a0886eae089dc352c5c41d856f,staff,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Beta Low beta power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,medical staff,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ram,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rates,has_body
e01871778fa196a0886eae089dc352c5c41d856f,conduct,has_body
e01871778fa196a0886eae089dc352c5c41d856f,side effects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,medical,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnnlstm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,SVM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reactions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,nerve,has_body
e01871778fa196a0886eae089dc352c5c41d856f,control group,has_body
e01871778fa196a0886eae089dc352c5c41d856f,calves,has_body
e01871778fa196a0886eae089dc352c5c41d856f,OS,has_body
e01871778fa196a0886eae089dc352c5c41d856f,health monitoring,has_body
e01871778fa196a0886eae089dc352c5c41d856f,impact,has_body
e01871778fa196a0886eae089dc352c5c41d856f,neurological physiological methods,has_body
e01871778fa196a0886eae089dc352c5c41d856f,raw data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,participants,has_body
e01871778fa196a0886eae089dc352c5c41d856f,methods,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ROC,has_body
e01871778fa196a0886eae089dc352c5c41d856f,processing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,method electrodes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,chungnam,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-based,has_body
e01871778fa196a0886eae089dc352c5c41d856f,biosignal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hospital,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain locations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,time periods,has_body
e01871778fa196a0886eae089dc352c5c41d856f,disease screening,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emergency,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hemisphere,has_body
e01871778fa196a0886eae089dc352c5c41d856f,points,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hiddenstate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,thetadelta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pretreatment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Beta High beta power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,followup,has_body
e01871778fa196a0886eae089dc352c5c41d856f,dar,has_body
e01871778fa196a0886eae089dc352c5c41d856f,disability,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reverse predictions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,movement,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time EEG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,admitted with,has_body
e01871778fa196a0886eae089dc352c5c41d856f,add,has_body
e01871778fa196a0886eae089dc352c5c41d856f,follow-up,has_body
e01871778fa196a0886eae089dc352c5c41d856f,bidirectional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,module,has_body
e01871778fa196a0886eae089dc352c5c41d856f,random,has_body
e01871778fa196a0886eae089dc352c5c41d856f,walking chair,has_body
e01871778fa196a0886eae089dc352c5c41d856f,longterm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,onset,has_body
e01871778fa196a0886eae089dc352c5c41d856f,beta features,has_body
e01871778fa196a0886eae089dc352c5c41d856f,locations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ELM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,thickness,has_body
e01871778fa196a0886eae089dc352c5c41d856f,figures time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,biological-signal-based,has_body
e01871778fa196a0886eae089dc352c5c41d856f,y-axis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,WT structures,has_body
e01871778fa196a0886eae089dc352c5c41d856f,countries,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sensors,has_body
e01871778fa196a0886eae089dc352c5c41d856f,theta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classify,has_body
e01871778fa196a0886eae089dc352c5c41d856f,contact,has_body
e01871778fa196a0886eae089dc352c5c41d856f,realtime predictive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluating,has_body
e01871778fa196a0886eae089dc352c5c41d856f,address,has_body
e01871778fa196a0886eae089dc352c5c41d856f,analytical,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mlp,has_body
e01871778fa196a0886eae089dc352c5c41d856f,results,has_body
e01871778fa196a0886eae089dc352c5c41d856f,transform,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluated,has_body
e01871778fa196a0886eae089dc352c5c41d856f,server,has_body
e01871778fa196a0886eae089dc352c5c41d856f,advantage,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emergency medical center,has_body
e01871778fa196a0886eae089dc352c5c41d856f,LTS,has_body
e01871778fa196a0886eae089dc352c5c41d856f,table,has_body
e01871778fa196a0886eae089dc352c5c41d856f,study,has_body
e01871778fa196a0886eae089dc352c5c41d856f,result,has_body
e01871778fa196a0886eae089dc352c5c41d856f,waves,has_body
e01871778fa196a0886eae089dc352c5c41d856f,advantages,has_body
e01871778fa196a0886eae089dc352c5c41d856f,and0,has_body
e01871778fa196a0886eae089dc352c5c41d856f,dysfunction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cell state C t,has_body
e01871778fa196a0886eae089dc352c5c41d856f,environment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,guntari,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alpha wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,slope,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fast Fourier transform FFT,has_body
e01871778fa196a0886eae089dc352c5c41d856f,dependency problem,has_body
e01871778fa196a0886eae089dc352c5c41d856f,F-Score of1,has_body
e01871778fa196a0886eae089dc352c5c41d856f,problem,has_body
e01871778fa196a0886eae089dc352c5c41d856f,inconvenient,has_body
e01871778fa196a0886eae089dc352c5c41d856f,channels,has_body
e01871778fa196a0886eae089dc352c5c41d856f,feature,has_body
e01871778fa196a0886eae089dc352c5c41d856f,environmental,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Bayesian Classifier,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictive models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experiments,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signal processing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,relative ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Bayesian,has_body
e01871778fa196a0886eae089dc352c5c41d856f,burden,has_body
e01871778fa196a0886eae089dc352c5c41d856f,beta ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Theta Theta power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emotions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alexnet,has_body
e01871778fa196a0886eae089dc352c5c41d856f,medical data False Negative,has_body
e01871778fa196a0886eae089dc352c5c41d856f,specialized,has_body
e01871778fa196a0886eae089dc352c5c41d856f,subjects scale index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,usingD,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diagnoses,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gait motion,has_body
e01871778fa196a0886eae089dc352c5c41d856f,emr,has_body
e01871778fa196a0886eae089dc352c5c41d856f,disadvantage,has_body
e01871778fa196a0886eae089dc352c5c41d856f,faster,has_body
e01871778fa196a0886eae089dc352c5c41d856f,group,has_body
e01871778fa196a0886eae089dc352c5c41d856f,xaxis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,validation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,epilepsy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,subjects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,density,has_body
e01871778fa196a0886eae089dc352c5c41d856f,computer engineering studies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,engineering,has_body
e01871778fa196a0886eae089dc352c5c41d856f,slower,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sophisticated time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,amplitude sum,has_body
e01871778fa196a0886eae089dc352c5c41d856f,input sequence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,measurements,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Section1,has_body
e01871778fa196a0886eae089dc352c5c41d856f,accurate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,consider,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mapping,has_body
e01871778fa196a0886eae089dc352c5c41d856f,skull,has_body
e01871778fa196a0886eae089dc352c5c41d856f,type,has_body
e01871778fa196a0886eae089dc352c5c41d856f,invasive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,propose,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electroencephalography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,compensate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,NVIDIA,has_body
e01871778fa196a0886eae089dc352c5c41d856f,normal people,has_body
e01871778fa196a0886eae089dc352c5c41d856f,discards,has_body
e01871778fa196a0886eae089dc352c5c41d856f,measured,has_body
e01871778fa196a0886eae089dc352c5c41d856f,PSD,has_body
e01871778fa196a0886eae089dc352c5c41d856f,global,has_body
e01871778fa196a0886eae089dc352c5c41d856f,females,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low false,has_body
e01871778fa196a0886eae089dc352c5c41d856f,entropy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,implemented,has_body
e01871778fa196a0886eae089dc352c5c41d856f,MB,has_body
e01871778fa196a0886eae089dc352c5c41d856f,equation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hyper-parameters,has_body
e01871778fa196a0886eae089dc352c5c41d856f,index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EEGs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,older,has_body
e01871778fa196a0886eae089dc352c5c41d856f,multilayer perceptron,has_body
e01871778fa196a0886eae089dc352c5c41d856f,show,has_body
e01871778fa196a0886eae089dc352c5c41d856f,methodologies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,studies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Oz,has_body
e01871778fa196a0886eae089dc352c5c41d856f,five-fold,has_body
e01871778fa196a0886eae089dc352c5c41d856f,types,has_body
e01871778fa196a0886eae089dc352c5c41d856f,collected,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data collection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,network,has_body
e01871778fa196a0886eae089dc352c5c41d856f,FNR,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Equation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,differences,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sets,has_body
e01871778fa196a0886eae089dc352c5c41d856f,variance,has_body
e01871778fa196a0886eae089dc352c5c41d856f,identified,has_body
e01871778fa196a0886eae089dc352c5c41d856f,relative value showed2,has_body
e01871778fa196a0886eae089dc352c5c41d856f,loss functions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CT,has_body
e01871778fa196a0886eae089dc352c5c41d856f,converges,has_body
e01871778fa196a0886eae089dc352c5c41d856f,feedforward,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sleeping,has_body
e01871778fa196a0886eae089dc352c5c41d856f,giri,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tension,has_body
e01871778fa196a0886eae089dc352c5c41d856f,years,has_body
e01871778fa196a0886eae089dc352c5c41d856f,bayesian,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EMG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decreased,has_body
e01871778fa196a0886eae089dc352c5c41d856f,indicator,has_body
e01871778fa196a0886eae089dc352c5c41d856f,GA,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,die,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deltaalpha,has_body
e01871778fa196a0886eae089dc352c5c41d856f,short time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data learning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Equations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Studies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cell state,has_body
e01871778fa196a0886eae089dc352c5c41d856f,moving objects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,New,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deltaalpha IDAR,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Hier,has_body
e01871778fa196a0886eae089dc352c5c41d856f,llearning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,units,has_body
e01871778fa196a0886eae089dc352c5c41d856f,screening method,has_body
e01871778fa196a0886eae089dc352c5c41d856f,structural limitations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hidden neurons,has_body
e01871778fa196a0886eae089dc352c5c41d856f,image caption,has_body
e01871778fa196a0886eae089dc352c5c41d856f,T7 C1 C2 T8,has_body
e01871778fa196a0886eae089dc352c5c41d856f,kummer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,contrast agents,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decreasing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,side,has_body
e01871778fa196a0886eae089dc352c5c41d856f,receiver,has_body
e01871778fa196a0886eae089dc352c5c41d856f,power ratio index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,support vector machines,has_body
e01871778fa196a0886eae089dc352c5c41d856f,entire region,has_body
e01871778fa196a0886eae089dc352c5c41d856f,nvidia,has_body
e01871778fa196a0886eae089dc352c5c41d856f,acute ischemic stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,frequency mapping phase,has_body
e01871778fa196a0886eae089dc352c5c41d856f,shorttime,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classifiers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,aspects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,automatically classifies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,intel,has_body
e01871778fa196a0886eae089dc352c5c41d856f,automatic detection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,residual unit,has_body
e01871778fa196a0886eae089dc352c5c41d856f,determines,has_body
e01871778fa196a0886eae089dc352c5c41d856f,C t vector,has_body
e01871778fa196a0886eae089dc352c5c41d856f,of1,has_body
e01871778fa196a0886eae089dc352c5c41d856f,elderly Koreans,has_body
e01871778fa196a0886eae089dc352c5c41d856f,disaggregate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electronic medical recording,has_body
e01871778fa196a0886eae089dc352c5c41d856f,plan,has_body
e01871778fa196a0886eae089dc352c5c41d856f,information,has_body
e01871778fa196a0886eae089dc352c5c41d856f,region,has_body
e01871778fa196a0886eae089dc352c5c41d856f,layer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,conditional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnns,has_body
e01871778fa196a0886eae089dc352c5c41d856f,eegs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,kim,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classifications,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stroke disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pre-symptoms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electromyography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,undergoes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,precision,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimentally,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Section2,has_body
e01871778fa196a0886eae089dc352c5c41d856f,kurtosis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,kalchbrenner,has_body
e01871778fa196a0886eae089dc352c5c41d856f,home,has_body
e01871778fa196a0886eae089dc352c5c41d856f,attribute,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reduced,has_body
e01871778fa196a0886eae089dc352c5c41d856f,verification accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,wavelets,has_body
e01871778fa196a0886eae089dc352c5c41d856f,kind,has_body
e01871778fa196a0886eae089dc352c5c41d856f,NIHSS,has_body
e01871778fa196a0886eae089dc352c5c41d856f,month,has_body
e01871778fa196a0886eae089dc352c5c41d856f,severe,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Llearning machine,has_body
e01871778fa196a0886eae089dc352c5c41d856f,leg muscles,has_body
e01871778fa196a0886eae089dc352c5c41d856f,converge,has_body
e01871778fa196a0886eae089dc352c5c41d856f,value,has_body
e01871778fa196a0886eae089dc352c5c41d856f,leads,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cerebral cortex,has_body
e01871778fa196a0886eae089dc352c5c41d856f,raw,has_body
e01871778fa196a0886eae089dc352c5c41d856f,wijaya,has_body
e01871778fa196a0886eae089dc352c5c41d856f,time information,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hidden layer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,x-axis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,techniques,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Cox regression Aside,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimentation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,patient,has_body
e01871778fa196a0886eae089dc352c5c41d856f,agents,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Global Burden Disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,FFT,has_body
e01871778fa196a0886eae089dc352c5c41d856f,idar,has_body
e01871778fa196a0886eae089dc352c5c41d856f,frequency domain,has_body
e01871778fa196a0886eae089dc352c5c41d856f,optimize,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electrode,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluation indicators,has_body
e01871778fa196a0886eae089dc352c5c41d856f,death,has_body
e01871778fa196a0886eae089dc352c5c41d856f,properties,has_body
e01871778fa196a0886eae089dc352c5c41d856f,solution,has_body
e01871778fa196a0886eae089dc352c5c41d856f,clinically,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mri,has_body
e01871778fa196a0886eae089dc352c5c41d856f,activity protocols,has_body
e01871778fa196a0886eae089dc352c5c41d856f,time series,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CPU,has_body
e01871778fa196a0886eae089dc352c5c41d856f,high,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Bidirectional LSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNNs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,LSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,GPU,has_body
e01871778fa196a0886eae089dc352c5c41d856f,theta extracting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,volume,has_body
e01871778fa196a0886eae089dc352c5c41d856f,torical information,has_body
e01871778fa196a0886eae089dc352c5c41d856f,generation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gbd,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Athens Insomnia Scale,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EEG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,wearable electrodes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,unit,has_body
e01871778fa196a0886eae089dc352c5c41d856f,schneider,has_body
e01871778fa196a0886eae089dc352c5c41d856f,standing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,COVID-19,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based learning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,steps,has_body
e01871778fa196a0886eae089dc352c5c41d856f,risks,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pain-free,has_body
e01871778fa196a0886eae089dc352c5c41d856f,performance index,has_body
e01871778fa196a0886eae089dc352c5c41d856f,observations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,discomfort,has_body
e01871778fa196a0886eae089dc352c5c41d856f,digital signal processing,has_body
e01871778fa196a0886eae089dc352c5c41d856f,advantagesh,has_body
e01871778fa196a0886eae089dc352c5c41d856f,correlation aspects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,vessels,has_body
e01871778fa196a0886eae089dc352c5c41d856f,toll,has_body
e01871778fa196a0886eae089dc352c5c41d856f,daily,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signal process,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ResNET50,has_body
e01871778fa196a0886eae089dc352c5c41d856f,controls,has_body
e01871778fa196a0886eae089dc352c5c41d856f,vertical axis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Brain signals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,overall,has_body
e01871778fa196a0886eae089dc352c5c41d856f,score,has_body
e01871778fa196a0886eae089dc352c5c41d856f,patch,has_body
e01871778fa196a0886eae089dc352c5c41d856f,AIS,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CGAN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fnr,has_body
e01871778fa196a0886eae089dc352c5c41d856f,state,has_body
e01871778fa196a0886eae089dc352c5c41d856f,interpretations,has_body
e01871778fa196a0886eae089dc352c5c41d856f,series,has_body
e01871778fa196a0886eae089dc352c5c41d856f,frequency component,has_body
e01871778fa196a0886eae089dc352c5c41d856f,candidate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ischemic,has_body
e01871778fa196a0886eae089dc352c5c41d856f,compare,has_body
e01871778fa196a0886eae089dc352c5c41d856f,section,has_body
e01871778fa196a0886eae089dc352c5c41d856f,specified,has_body
e01871778fa196a0886eae089dc352c5c41d856f,allergic,has_body
e01871778fa196a0886eae089dc352c5c41d856f,anomalies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,automatic,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ECG electromyography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fpr,has_body
e01871778fa196a0886eae089dc352c5c41d856f,mortality,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time brainwave data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,MRIs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,RAM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,occurrence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,citizens,has_body
e01871778fa196a0886eae089dc352c5c41d856f,thetadelta values,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain wave topography,has_body
e01871778fa196a0886eae089dc352c5c41d856f,health examination,has_body
e01871778fa196a0886eae089dc352c5c41d856f,research,has_body
e01871778fa196a0886eae089dc352c5c41d856f,analyze,has_body
e01871778fa196a0886eae089dc352c5c41d856f,regions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,binary classification,has_body
e01871778fa196a0886eae089dc352c5c41d856f,augmentation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,patch images,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Inverse ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prediction systems,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Beta Beta power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,rnn,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Alpha Alpha power,has_body
e01871778fa196a0886eae089dc352c5c41d856f,non-invasive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real-time stroke disease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,BiLSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,usefulness,has_body
e01871778fa196a0886eae089dc352c5c41d856f,walking data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,raw value,has_body
e01871778fa196a0886eae089dc352c5c41d856f,severity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,inserted,has_body
e01871778fa196a0886eae089dc352c5c41d856f,patients,has_body
e01871778fa196a0886eae089dc352c5c41d856f,separating,has_body
e01871778fa196a0886eae089dc352c5c41d856f,brain imaging,has_body
e01871778fa196a0886eae089dc352c5c41d856f,terms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decision,has_body
e01871778fa196a0886eae089dc352c5c41d856f,trols,has_body
e01871778fa196a0886eae089dc352c5c41d856f,detecting,has_body
e01871778fa196a0886eae089dc352c5c41d856f,risk,has_body
e01871778fa196a0886eae089dc352c5c41d856f,states,has_body
e01871778fa196a0886eae089dc352c5c41d856f,computation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,delta wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,list,has_body
e01871778fa196a0886eae089dc352c5c41d856f,detect,has_body
e01871778fa196a0886eae089dc352c5c41d856f,eeg,has_body
e01871778fa196a0886eae089dc352c5c41d856f,manages,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cases,has_body
e01871778fa196a0886eae089dc352c5c41d856f,extent,has_body
e01871778fa196a0886eae089dc352c5c41d856f,resnet,has_body
e01871778fa196a0886eae089dc352c5c41d856f,computer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,males,has_body
e01871778fa196a0886eae089dc352c5c41d856f,judgment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Guntari,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prediction analysis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,World Health Organization,has_body
e01871778fa196a0886eae089dc352c5c41d856f,improvement,has_body
e01871778fa196a0886eae089dc352c5c41d856f,chair,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tables,has_body
e01871778fa196a0886eae089dc352c5c41d856f,older adults,has_body
e01871778fa196a0886eae089dc352c5c41d856f,organization,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sizes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,feed,has_body
e01871778fa196a0886eae089dc352c5c41d856f,layers,has_body
e01871778fa196a0886eae089dc352c5c41d856f,bio-signal data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diagnosis,has_body
e01871778fa196a0886eae089dc352c5c41d856f,formula,has_body
e01871778fa196a0886eae089dc352c5c41d856f,references,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Chungnam National University Hospital,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sigmoid,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tools,has_body
e01871778fa196a0886eae089dc352c5c41d856f,remembering,has_body
e01871778fa196a0886eae089dc352c5c41d856f,access,has_body
e01871778fa196a0886eae089dc352c5c41d856f,extract,has_body
e01871778fa196a0886eae089dc352c5c41d856f,motion,has_body
e01871778fa196a0886eae089dc352c5c41d856f,spectral mean entropy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,performance,has_body
e01871778fa196a0886eae089dc352c5c41d856f,contaminated,has_body
e01871778fa196a0886eae089dc352c5c41d856f,causes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,real time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prediction module,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Equations 2,has_body
e01871778fa196a0886eae089dc352c5c41d856f,noises,has_body
e01871778fa196a0886eae089dc352c5c41d856f,objects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,encoding,has_body
e01871778fa196a0886eae089dc352c5c41d856f,recording,has_body
e01871778fa196a0886eae089dc352c5c41d856f,number,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-Bidirectional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,explores,has_body
e01871778fa196a0886eae089dc352c5c41d856f,scores,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decision tree techniques,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimental,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diagnostic,has_body
e01871778fa196a0886eae089dc352c5c41d856f,health checkups,has_body
e01871778fa196a0886eae089dc352c5c41d856f,activation function,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gautam,has_body
e01871778fa196a0886eae089dc352c5c41d856f,backwards states,has_body
e01871778fa196a0886eae089dc352c5c41d856f,tanh,has_body
e01871778fa196a0886eae089dc352c5c41d856f,novel,has_body
e01871778fa196a0886eae089dc352c5c41d856f,collection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,translation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,individual,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictive accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,false negative,has_body
e01871778fa196a0886eae089dc352c5c41d856f,skin,has_body
e01871778fa196a0886eae089dc352c5c41d856f,adults,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signal-based,has_body
e01871778fa196a0886eae089dc352c5c41d856f,changes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Chinese stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,electrodes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,indicators,has_body
e01871778fa196a0886eae089dc352c5c41d856f,pneumonia,has_body
e01871778fa196a0886eae089dc352c5c41d856f,informs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,learning process,has_body
e01871778fa196a0886eae089dc352c5c41d856f,decrease,has_body
e01871778fa196a0886eae089dc352c5c41d856f,training accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,criterion,has_body
e01871778fa196a0886eae089dc352c5c41d856f,finding,has_body
e01871778fa196a0886eae089dc352c5c41d856f,sequential,has_body
e01871778fa196a0886eae089dc352c5c41d856f,report,has_body
e01871778fa196a0886eae089dc352c5c41d856f,RNN,has_body
e01871778fa196a0886eae089dc352c5c41d856f,to6,has_body
e01871778fa196a0886eae089dc352c5c41d856f,developing countries,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,extracts,has_body
e01871778fa196a0886eae089dc352c5c41d856f,lstm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,seizure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,literature,has_body
e01871778fa196a0886eae089dc352c5c41d856f,accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,medical costs,has_body
e01871778fa196a0886eae089dc352c5c41d856f,core,has_body
e01871778fa196a0886eae089dc352c5c41d856f,relative value,has_body
e01871778fa196a0886eae089dc352c5c41d856f,measuring,has_body
e01871778fa196a0886eae089dc352c5c41d856f,create,has_body
e01871778fa196a0886eae089dc352c5c41d856f,link,has_body
e01871778fa196a0886eae089dc352c5c41d856f,minimum,has_body
e01871778fa196a0886eae089dc352c5c41d856f,highest,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cell-state,has_body
e01871778fa196a0886eae089dc352c5c41d856f,features,has_body
e01871778fa196a0886eae089dc352c5c41d856f,horizontal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning model,has_body
e01871778fa196a0886eae089dc352c5c41d856f,characteristics,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low,has_body
e01871778fa196a0886eae089dc352c5c41d856f,contact with,has_body
e01871778fa196a0886eae089dc352c5c41d856f,zhang,has_body
e01871778fa196a0886eae089dc352c5c41d856f,room,has_body
e01871778fa196a0886eae089dc352c5c41d856f,work,has_body
e01871778fa196a0886eae089dc352c5c41d856f,allergic reactions,has_body
e01871778fa196a0886eae089dc352c5c41d856f,normal controls,has_body
e01871778fa196a0886eae089dc352c5c41d856f,activation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ability,has_body
e01871778fa196a0886eae089dc352c5c41d856f,determine,has_body
e01871778fa196a0886eae089dc352c5c41d856f,future,has_body
e01871778fa196a0886eae089dc352c5c41d856f,time,has_body
e01871778fa196a0886eae089dc352c5c41d856f,convolutional,has_body
e01871778fa196a0886eae089dc352c5c41d856f,goal,has_body
e01871778fa196a0886eae089dc352c5c41d856f,distinguish,has_body
e01871778fa196a0886eae089dc352c5c41d856f,chin,has_body
e01871778fa196a0886eae089dc352c5c41d856f,judgments,has_body
e01871778fa196a0886eae089dc352c5c41d856f,examples,has_body
e01871778fa196a0886eae089dc352c5c41d856f,labels,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Liu,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alphadelta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,evaluate,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cell state First Equation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,theta wave,has_body
e01871778fa196a0886eae089dc352c5c41d856f,baseline,has_body
e01871778fa196a0886eae089dc352c5c41d856f,to77,has_body
e01871778fa196a0886eae089dc352c5c41d856f,algorithm,has_body
e01871778fa196a0886eae089dc352c5c41d856f,grows,has_body
e01871778fa196a0886eae089dc352c5c41d856f,curve,has_body
e01871778fa196a0886eae089dc352c5c41d856f,age,has_body
e01871778fa196a0886eae089dc352c5c41d856f,prediction method,has_body
e01871778fa196a0886eae089dc352c5c41d856f,monitoring,has_body
e01871778fa196a0886eae089dc352c5c41d856f,machines,has_body
e01871778fa196a0886eae089dc352c5c41d856f,figure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Zhang,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning,has_body
e01871778fa196a0886eae089dc352c5c41d856f,confidence,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stores,has_body
e01871778fa196a0886eae089dc352c5c41d856f,blood,has_body
e01871778fa196a0886eae089dc352c5c41d856f,daily activities,has_body
e01871778fa196a0886eae089dc352c5c41d856f,poor accuracy,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based stroke diseases,has_body
e01871778fa196a0886eae089dc352c5c41d856f,transmits,has_body
e01871778fa196a0886eae089dc352c5c41d856f,batch,has_body
e01871778fa196a0886eae089dc352c5c41d856f,distance,has_body
e01871778fa196a0886eae089dc352c5c41d856f,ROC curve,has_body
e01871778fa196a0886eae089dc352c5c41d856f,liu,has_body
e01871778fa196a0886eae089dc352c5c41d856f,elderly,has_body
e01871778fa196a0886eae089dc352c5c41d856f,walking,has_body
e01871778fa196a0886eae089dc352c5c41d856f,data set,has_body
e01871778fa196a0886eae089dc352c5c41d856f,vital-signal collection sensors,has_body
e01871778fa196a0886eae089dc352c5c41d856f,increase,has_body
e01871778fa196a0886eae089dc352c5c41d856f,activities,has_body
e01871778fa196a0886eae089dc352c5c41d856f,hemorrhagic stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,presymptoms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,of5,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deviation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Korean,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EOG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,interpretating,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fluctuation,has_body
e01871778fa196a0886eae089dc352c5c41d856f,domain,has_body
e01871778fa196a0886eae089dc352c5c41d856f,minutes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,output layer,has_body
e01871778fa196a0886eae089dc352c5c41d856f,realtime,has_body
e01871778fa196a0886eae089dc352c5c41d856f,dourado,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diseases,has_body
e01871778fa196a0886eae089dc352c5c41d856f,online processing unit,has_body
e01871778fa196a0886eae089dc352c5c41d856f,extraction,has_body
e01871778fa196a0886eae089dc352c5c41d856f,symptoms,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low-income,has_body
e01871778fa196a0886eae089dc352c5c41d856f,reliable,has_body
e01871778fa196a0886eae089dc352c5c41d856f,next stage,has_body
e01871778fa196a0886eae089dc352c5c41d856f,statistical metrics,has_body
e01871778fa196a0886eae089dc352c5c41d856f,period,has_body
e01871778fa196a0886eae089dc352c5c41d856f,everyday,has_body
e01871778fa196a0886eae089dc352c5c41d856f,WHO,has_body
e01871778fa196a0886eae089dc352c5c41d856f,doubled,has_body
e01871778fa196a0886eae089dc352c5c41d856f,stroke diseases,has_body
e01871778fa196a0886eae089dc352c5c41d856f,loss,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimental environment,has_body
e01871778fa196a0886eae089dc352c5c41d856f,diagnosed,has_body
e01871778fa196a0886eae089dc352c5c41d856f,gpu,has_body
e01871778fa196a0886eae089dc352c5c41d856f,signals,has_body
e01871778fa196a0886eae089dc352c5c41d856f,function,has_body
e01871778fa196a0886eae089dc352c5c41d856f,deep learning-based real-time EEG,has_body
e01871778fa196a0886eae089dc352c5c41d856f,framework,has_body
e01871778fa196a0886eae089dc352c5c41d856f,acquire,has_body
e01871778fa196a0886eae089dc352c5c41d856f,contrast,has_body
e01871778fa196a0886eae089dc352c5c41d856f,institutes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,experimental results,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Delta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classifying,has_body
e01871778fa196a0886eae089dc352c5c41d856f,opportunity,has_body
e01871778fa196a0886eae089dc352c5c41d856f,quadro,has_body
e01871778fa196a0886eae089dc352c5c41d856f,Chapter concludes,has_body
e01871778fa196a0886eae089dc352c5c41d856f,false positive ratio,has_body
e01871778fa196a0886eae089dc352c5c41d856f,leg,has_body
e01871778fa196a0886eae089dc352c5c41d856f,National Institutes of Health Stroke Scale,has_body
e01871778fa196a0886eae089dc352c5c41d856f,measure,has_body
e01871778fa196a0886eae089dc352c5c41d856f,proportion,has_body
e01871778fa196a0886eae089dc352c5c41d856f,with5,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predetection,has_body
e01871778fa196a0886eae089dc352c5c41d856f,effects,has_body
e01871778fa196a0886eae089dc352c5c41d856f,fft,has_body
e01871778fa196a0886eae089dc352c5c41d856f,incurring,has_body
e01871778fa196a0886eae089dc352c5c41d856f,FPR,has_body
e01871778fa196a0886eae089dc352c5c41d856f,alpha beta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,body falling,has_body
e01871778fa196a0886eae089dc352c5c41d856f,domains,has_body
e01871778fa196a0886eae089dc352c5c41d856f,average,has_body
e01871778fa196a0886eae089dc352c5c41d856f,abnormalities,has_body
e01871778fa196a0886eae089dc352c5c41d856f,predictive,has_body
e01871778fa196a0886eae089dc352c5c41d856f,increased,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnn-bidirectional lstm models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,cnn-lstm models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,three frequency ranges alpha wave 813 hz theta wave 48 hz,has_body
e01871778fa196a0886eae089dc352c5c41d856f,time series data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,health stroke scale nihss li et al 18 et al introduced various machine learning methodologies,has_body
e01871778fa196a0886eae089dc352c5c41d856f,low beta low beta power 1225 hz high beta high beta power 2530 hz theta,has_body
e01871778fa196a0886eae089dc352c5c41d856f,raw EEG data,has_body
e01871778fa196a0886eae089dc352c5c41d856f,extracted eeg attributes delta delta power 14 hz theta theta power 48 hz alpha alpha power 813 hz beta beta power 1430 hz gamma gamma power 30 hz,has_body
e01871778fa196a0886eae089dc352c5c41d856f,EEG data stroke,has_body
e01871778fa196a0886eae089dc352c5c41d856f,LSTM bidirectional LSTM,has_body
e01871778fa196a0886eae089dc352c5c41d856f,CNN-bidirectional LSTM models,has_body
e01871778fa196a0886eae089dc352c5c41d856f,delta wave 14 hz schneider et al 21 analyzed brain wave frequency,has_body
e01871778fa196a0886eae089dc352c5c41d856f,classification,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,feasibility,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,approach,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,needs,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,trend,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,discomfort,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,necessitating,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,stroke,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,lstm,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,accuracy,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,project,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,acquisition,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,attributes,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,findings,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,population,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,covid,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,learning,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,methodology,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,algorithms,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,series,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,fnr,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,sensors,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,images,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,fpr,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,mortality,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,emergence,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,frequency,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,time,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,results,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,data,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,application,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,research,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,increases,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,waves,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,detection,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,recurrence,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,monitoring,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,equipment,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,shortcomings,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,jhy,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,expectancy,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,confidence,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,system,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,brain,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,csp,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,cost,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,date,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,eegs,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,healthcare,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,administration,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,eeg,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,paper,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,interest,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,improvements,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,authors,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,disease,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,society,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,funding,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,services,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,rate,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,realtime,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,diseases,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,cnnlstm,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,birth,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,model,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,life,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,observation,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,z e,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,techniques,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,models,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,supervision,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,monitor,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,technologies,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,procedures,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,health,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,number,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,deeplearning,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,predict,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,processing,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,methods,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,properties,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,mri,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,prediction,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,version,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,studies,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,manuscript,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,changes,has_abstract
e01871778fa196a0886eae089dc352c5c41d856f,nonfacetoface,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibition,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ensembles,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,states,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allosteric,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational ensembles,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sampling,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Jung Ah Byun,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Bryan Vanschouwen,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Madoka Akimoto,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Giuseppe Melacini,has_title
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,architecture,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding site,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitory,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein-protein interfaces,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multistate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,diabetes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-state equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,locks,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,design,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,boltzmann,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rpbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,implement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,thermodynamic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,concentrations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric signalling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,calculated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,silences,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric antagonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modulations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric systems,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-dependent activation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD-A domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,determinant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,release,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hydrogens,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resolution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,capping,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-terminal helices,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,distances,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sulfur,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cassette,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conditions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R528K,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric models,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bridges,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,phosphorothioate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drugs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,adjacent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hinge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric response,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resemblance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,paper,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,anticipated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complexes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMRbased analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,asnbdcgmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ubiquitous mechanism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modifications,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,wedge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bsubdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,propensity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allos-teric pluripotency,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,potential,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,model,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CE3F4RRp-cAMPS,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,aromatic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rotates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding mechanism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ratios,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit-bound structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbdb,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,clashes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,elucidating,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ribose-phosphate moieties,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intervening,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cyclic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-domain system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MD simulations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,financial interests,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,high-affinity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activelike,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediate state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-terminal hinge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbds,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lid,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sample,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fractions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hybrid,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulatory,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lowaffinity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,phosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,predicts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mutations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mechanism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,communication,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,measurement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Fig,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,diverse,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric pluripotency model,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,topology,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric sites,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bindingnbdcgmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,K C values,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric inhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,two-state onoff,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modulator,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,accessibility,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,onon,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effect,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,assays,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,define,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,treatments,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,therapies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,degrees,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,triad,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conclusions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,half,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,subunits,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complex,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active-state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,state-specific association constants,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,EPAC2,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,consists,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,screening,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,insight,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,roles,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzymatic function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,parasite,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cnmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,disruption,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,picture,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,side chain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active structures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD-B,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,shift,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,autoinhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PKA C,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,experimental analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,slow exchange,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,campaigns,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interacting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conceptualized,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ribose-phosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,setting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,breast,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,free energies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,reverse agonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,excited,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,functional response,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,phenomena,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,DG B,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interacts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric responses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,base,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,observable,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,antagonism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,balance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosterically regulated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conjunction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sampled,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PKG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,B,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,B values,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,subdomains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,substrate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analogue,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,higherresolution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,non-continuous a-subdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic region,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,motif,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multiple,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,level,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dealing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,competitive,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,administered,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR-based analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational transition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resemble,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hypothesis,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,knf,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fig,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CMs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,functions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CE3F4R,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmpversuscamp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,centersofmass,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,red,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,response,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,input,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pka,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein dynamics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R484D533 lid,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,set,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-analog,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complement experimental methods,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,weights,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,distribution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic subunit C,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,anda,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,adopts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R484A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ploop,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase substrate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,limitation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structure-based statistical mechanical model,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP binding pocket,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,plasmodium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,maximizes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,imatinib,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PfPKG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,continuous,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,relative population,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,influence,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,predicted,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Molecular Dynamics MD simulations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBDs A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,review,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,data,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rap substrate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effector,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inactive state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activation FigA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,driving,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,subdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonistically,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding sites,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,synergy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mgatp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,partial,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active-inactive equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric modeling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,part,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nucleotides,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chemical shifts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulator,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,opposite,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,prototype,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,RC complex,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combination,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR spectroscopy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,implications,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,helices,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformers,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,predictions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,viral infections,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding affinities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dictated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,parameter,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBDs FigA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,switch,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multidrug,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,explore,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational equilibria,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic domains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD-ACBD-B interaction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fully-inactive,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigA B,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,campdependent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,averages,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pocket,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intra-R-subunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamicsfunction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,elements,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-terminal helix,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,flexible,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nuclear magnetic resonance NMR,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,centers-of-mass,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,thenbd,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analogue-NBD-cGMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzymes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,observed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigH-J,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,endogenous,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,glutamine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mwc,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,weakens,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effective,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,efficacy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proteinligand complex,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibition-incompetent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,wild-type PfPKG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,diverging,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,case,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,address,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic site,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sars,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,grafting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,results,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fige,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pkg,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,latter,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stable,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dictates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ad hoc NMR,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,apo,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exploiting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,started,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,less,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,instance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,feature,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,boundnbdcgmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzyme inhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonismto-antagonism switch,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,simplify,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,engagement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,molecule,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allosteric modelling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,scaling factor c,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sbsmma,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,state-specific association constant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,macromolecules,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigC E H I,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,trends,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,W260A mutant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,EAMs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,parameterized,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,levels,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBDs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase activity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inter-domain interaction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,models,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cluster,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinetics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,open topology,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,koshlandnemethyfilmers,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,measured,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,guanine Exchange Protein,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,equation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,change,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,atomic resolution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,P-loop,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,studies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-versus-cAMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ground state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,identified,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proteases,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,non-additivity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,state populations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,differential,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,focus,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allosteric Modeling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR chemical shift analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-terminal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric phenomena,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structural tendencies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,block,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,projection,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,postulates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-binding domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,end,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed intermediates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric pluripotency,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lowresolution assays,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,relaxation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,declare,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enhance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analoguenbdcgmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric partial,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domain inhibition-competent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,apo CBD-A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hand,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interaction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,DG B free energies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resembles,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,RMSDs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,comparisons,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp-bound state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonism mechanisms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stabilization,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,form,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp Rp FigA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interface,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,experimentally,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,formation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,crossactivation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigB,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chespa,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,primary,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR chemical shift time scale,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figj,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,simulations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamical information,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,vide,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,value,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,open states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,turn,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-dependent protein kinase,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,adjuvant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Elucidating,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,properties,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigE,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,target,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP FigA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,high,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multidomain system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,discuss,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,highlighting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,unit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,EPAC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediate states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,disrupted,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,displays,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,feasibility,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exhibits,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domain FigD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combinatorial,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamical changes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,functional,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric drugs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,perturbation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric modulators,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intensity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,N-terminal a-helices b-subdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigD-I,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp-bound structures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,preferentially bind,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmpand,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric regulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MWC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ensemble,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rsubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,transition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,functional activity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Quantitative models,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,phosphate binding cassette,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric domains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,posttranslational,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibits,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figg,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit Reference,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Abl kinase,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,computational method,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed intermediate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric cancer,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediate structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,association constant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,free energy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,microstates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cNMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figf,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,turns,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,signalling pathways,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cases,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,abl,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,strategies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nucleotide,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bridging,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,molecular details,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,therapeutics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,wildtype,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,gap,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,association,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ratio,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,falciparum,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,increasing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic binding pocket,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modified,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effectors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,novel,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,next section,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modeling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmpbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proliferation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,partner,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mutants,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,antagonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,libraries,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pose,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,changes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resource,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,assess,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sequential,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cNMP-phosphate binding cassette,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ideal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Sampling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,as-NBD-cGMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,compute,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric effector,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,investigate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,population,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figd,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,crrp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,off state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,transitions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resistance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit binding forming,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,factors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,work,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,time,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,goal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,examples,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,alters,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,guanine base,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,monitoring,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,association constants,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,residue,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,moiety,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,translate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fractional activations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analogbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conversion,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agreement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,map,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MgATP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,responses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,low-resolution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,polypeptide chains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analog-bound system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,distance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,efficient,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,overlaid,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,minimal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,eam,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,topologies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ribosephosphate moiety,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drug target,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,means,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lead,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,deviation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp binding FigE,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,coordination,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Plasmodium falciparum,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,serves,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mers,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,diseases,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,constants,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,field,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Covariance Analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,plethora,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Koshland-Nemethy-Filmers KNF,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,instrumental,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closed topologies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Nterminal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,breast cancer,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,translational,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Knowledge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,illustrative,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,residues,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,highaffinity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric inhibitors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp FigE,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,can-not,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,excess,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fully-active conformation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,viral,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pancreatic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,freeenergy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Activated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Partial,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quantifies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,well,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,reader,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,explanation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,formulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,importance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,coordination propensity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric enzymes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,simulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Ensemble,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,correlated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulatory region,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR-based,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase activities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pbc,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,concentration,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbdd,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cross-peak,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonismtoantagonism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,potency,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rpcamps,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,absence,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzyme function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,estimated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,limitations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MDEAM,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,molecular chaperone-client interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase inhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multidrug combinations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,energy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hpkg,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,treatment,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figc,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,site,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pfPKG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,base favors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,values,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,factor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibition-competent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,comparative analysis,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closer,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Boltzmann statistical weights,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,infections,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analysis,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dissect,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,perturbations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-domain protein,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,I942,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,synergistic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,failure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effectiveness,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modulators,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,within-NBD-cGMP-bound PfPKG CBD-D FigD F,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,glutamate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inter-subdomain interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,parts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,moieties,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,landscape,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,KNF,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,q A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ensembles,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,construction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rise,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,two-state model,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,signaling pathways,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit FigC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exhibit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein sections,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational ensemble Starting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,outcome,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,filtering,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allosteric stimuli,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tested,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,networks,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,approach,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,statistical,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rsubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pattern,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,affinity losses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,EPAC1,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,campbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PKARp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tapping,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,orientation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lysine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,reviews,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Representative structures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,relevant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,range,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,symmetry,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CHESPA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational shifts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hybrid structures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,systems,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric communication,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,blind,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,clash,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hybrid structures FigJ,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allostery,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbda,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzyme,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,symmetric,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,base-binding region,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,affinity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figb,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chesca,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cNMP-binding domains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational switches,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lowresolution,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protection,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein molecule,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,therapeutic strategies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,guanine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cyclic nucleotide,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,camp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,amide hydrogens,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,building block,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,determining,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,B conformational changes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,external stimuli,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stimuli,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,purpose,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PKARp system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,aC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allosteric sites,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,derivations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,relation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pfpkg,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitionincompetent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,HD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,base moiety,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,off states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,linker,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,insights,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inactive,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modelling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigA-C,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,prediction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD-A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,DG A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,assessment,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drivers,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,DG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drug-pairs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,concentration ratios,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigB C,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding intermediate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,trend,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,understanding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP-dependent protein kinase,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intercbd,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP-bound CBD-B,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,macroscopic averaged observables,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,findings,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inter-CBD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pluripotency,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,act,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cNMP-bound forms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,in-NBD-cGMP-bound wild-type PfPKG CBD-D,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,detected,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP analog,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binds,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inactive structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,respect,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figad,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,explains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cross-check,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active site,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,perturbing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bulky sulfur atom,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,subsets,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed inhibition-competent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-terminal lid,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,knowledge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,equations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational change,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CRRp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,step,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,formulate hypotheses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,subunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,date,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,statistical weights,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,central controlling unit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,authors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,constituent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sampling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mechanistic studies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP-bound state FigD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,designing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,confirm,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quantitative modeling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pathways,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,parameters,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,scenarios,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multimeric proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,N3A,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Boltzmann factors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closedtoopen,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,average,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,contributions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,facilitates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,scale,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,EAM,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,description,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Y480R528,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,orthosteric sites,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,higher-resolution picture,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,observables,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,addition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analog,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigF,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PFs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inter-CBD interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,trajectories,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,key,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intrarsubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hPKG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,screening I942,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Chemical Shift Projection,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp-saturated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,box,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,populations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,use,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,generic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ahelices,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pkarp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,highlights,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding elements,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bind,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,off conformation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,guide,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigD G,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,moved,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,method,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analyzed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,example,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exhaustive,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,visible perturbations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding events,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,asubdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,isolated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tandem,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activationinhibition,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,articles,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,docks,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proteinpartial-agonist complex,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figa,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quite,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,SARS,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PKA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,side effects,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,details,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quadratic equation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,isoform,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,correction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active-like arrangement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complex system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,non-uniform,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quantitative,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,methods,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pathogens,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,promote,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fighj,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,refine hypotheses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,points,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cefr,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,environmental conditions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,functional responses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structural andor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP analogue,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,affinities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interests,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,macroscopic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,apo Rsubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,compromises,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-state equilibria,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,prototypical,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stabilized,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,efforts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,therapeutic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nature,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inter-domain interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulatory conformational equilibria,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,catalytic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ligand,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,realization,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figdi,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,examine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rmsds,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,native,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,arrangement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ground,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exchange protein,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drugpairs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cNMP base moiety,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modified base moiety,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,activations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,samples,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R values,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational ensemble,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamics-function relationships,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric modulation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,monophosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quantitatively,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,switches,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,personal relationships,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,study,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric model,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ligands,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conventional,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Targeting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structural,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,noncnmp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformational state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,threestate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,experiments,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,microstate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domain FigE,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tyrosine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intracellular,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric drug,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,group,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nmr,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric effectors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,low c,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conservation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,measurements,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,difference,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conformations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,type,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,reference,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,propose,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,electrophysiology,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R528,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,comparing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combinations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,distant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,evolutionary pressure 1,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regulate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bridge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric switch,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CHESCA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,understand,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,lock,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,salt bridge,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ligand binding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,action,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tendencies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,aloop,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,shows,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,energies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,FigC D,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP binding site,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Csubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,tool,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,partial agonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,SBSMMA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,capping triad,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,phenomenon,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,estimate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,show,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,types,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combat,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fraction,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,spectroscopy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,camps,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,quantitively relate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,N-terminal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,fractional change,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,opportunities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,andA,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,a-helix,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drug design,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Monod-Wyman-Changeuxs MWC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,investigated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cnmpbinding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,events,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,state-specific affinities,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,approaches,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analyses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,building,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric signaling systems,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closed-to-open transitions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding pocket,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,associated with,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ternary complex,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,side,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,basis,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP-bound mixed intermediate state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pressure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,open,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,K m,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,translated,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR chemical shifts FigB,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,targeting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,absent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit Fig,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,region,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,information,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nonadditivity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,PBC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,conditional,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,partner proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-domain complexity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,induced-fit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sections,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,retaining,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,synergies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,equilibria,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cyclic nucleotide monophosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,equatorial oxygen,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combination therapies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit binding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bound states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Mixed states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,active conformation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,differential relaxation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,csubunitbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,malaria,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,clinically,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cyclic nucleotides,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,infra,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,interpreting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,comprehensive,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cnmpbound,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,andE,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric modulator,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cancer-driver function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,guanine nucleotide exchange factors,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,summarize,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pre-lid region,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,explanations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,epac,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R484D533 interactions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,csubunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,losses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,statistical weight,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,links,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,covariance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,idea,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,series,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,compare,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp-cAMPS,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,section,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,oxygen,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,suppressed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,chemical,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intrinsic,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,WT,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complexity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,contributor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,with-NBD-cGMP docked,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analyze,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,regions,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cluster analysis,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,unmodified,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,computing,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,crit-ical,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,A-loop,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding-NBD-cGMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,terms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,internal dynamics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,simplest system,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,salt,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,AB,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Allostery,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complex systems,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,flexibility,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzymatic assays,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rrp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,R-subunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mechanisms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,relationships,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed intermediate state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp turns,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,previously-reported inter-domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,forms,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ribosephosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,CBD-D,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,wellknown,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,twostate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exchange,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multidomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric inhibitor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stabilizes,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp binding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,eams,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,targeted hypotheses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mdeam,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,macromolecule,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,red box,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mutant,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,build,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,driver,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,substrates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,free-energy,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,RRp,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzyme assays,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,essential elements,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed conformations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,RC,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cAMP binding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intersubdomain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,drug,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbd,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixtures,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bottleneck,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,shifts,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,grafted,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bound-NBD-cGMP,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rp-bound R-subunit,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitioncompetent,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resonance,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,measuring,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinks,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,essential,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,rap,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,features,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,presence,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bulkier,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,low,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Rpbound states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cancerdriver,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,andor,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ability,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,determine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonists,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,bsubdomain FigB,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,signaling proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,figac,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,N relaxation,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmpanalog,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,helix,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,choice,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,similarity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,computational,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,C-subunit R,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hybrid structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,MERS,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,unconventional partial agonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,calculations,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,refine,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,three-state equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,poor potency,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Boltzmann equilibrium,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,coupling,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,role,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,energetics,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,hypotheses,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cyclic phosphate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,selectivity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dfg,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domain,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,DFG,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Cterminal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,stabilize,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,share,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,motifs,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multi-domain proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosterically regulated proteins,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Mixed intermediate,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,molecular dynamics MD,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,computed,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,loss,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,function,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cgmpbinding,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,disengagement,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,human,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cGMP-bound active structure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,weight,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibiting,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,maximal,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,opportunity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cooperativity,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,Synergies,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,predictive tool,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,take,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,measure,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,proteinpartialagonist,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,closed topology,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,preserve,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,effects,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intensity measurements,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mechanical description,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cancer,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domains,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,onoff,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,sites,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,account,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,disengaged,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,propagates,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,novel mixed states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbd-a,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,cbd-b,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,structural information,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinases 10 11 12 guanine nucleotide exchange factors 13 tyrosine kinases 15,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,networks 3 4 5 allosteric drug design 6 7 8 9,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mixed conformational states,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,NMR chemical shift,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,field 3 33 34 35 36 37 38 39 40 2 partial agonism,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric model EAM,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,intermediate mixed state,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,camp epac 10 11 12 13 14 28 29 30 31 32,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,binding domains cbds 10 11 12 13 14 cbds share,has_body
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,addition,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,camp,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,avenue,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,freeenergy,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,mechanisms,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,epac,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nmr,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,role,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,losses,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,resonance,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pluripotency,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibition,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,eam,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inform,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,analysis,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modulation,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domain,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,inhibitors,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,design,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,exchange,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,allosteric,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,simulations,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,multidrug,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,case,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,eams,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonists,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,advances,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,theme,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,dynamics,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,combinations,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,generations,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,response,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,pkg,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,function,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,campdependent,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,kinase,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,complement,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzyme,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nmrand,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,agonism,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,potency,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,landscape,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,nucleotides,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,protein,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,modeling,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,ensembles,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,studies,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,map,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,domains,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,enzymes,has_abstract
e0d703d0c8f9ccc535f6d7f6c6114f63cd6411d4,states,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Effect,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restriction,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policy,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quality,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,system,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamics,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,model,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-restriction policy,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,improving,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air quality,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,non-homogeneous discrete grey model,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Zhen Chen,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Zhe Zan,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,· Shuwei Jia,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Z Chen,has_title
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public-transport,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,needs,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,smaller,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health benefits,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamic simulation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cognitive,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,COHCNO X,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,jain,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Ma,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,options,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,well,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,covid,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,tang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,arrows,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,importance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,yearbooks,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,statistics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-congestion pricing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,varying,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,license,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implementing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,zhong,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,water ecological system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trafficcongestion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implement,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,targets,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sequence correlation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by63,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,meteorological,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cities,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,calculated,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,scrap,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,down,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figc,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,errors,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,concentration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulated values,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by1363 and63,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,definition,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Su,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,assumptions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicle restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Vensim,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,inflection,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figb,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stricter curves-4,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,limitations,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ridesharing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,migration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,conditions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Traffic governance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ways,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,background,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,long-term,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,grey,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stock flow,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,energy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ndgm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cost,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,epidemic,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,governance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,System,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,behavior,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulation analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,loops,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,values,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,factor,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction paradox effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,testing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,TI,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Positive,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,paper,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,acceptance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,option,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,s10098,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop2,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cause,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,HC,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,external environment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,thes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,timeliness,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,situations,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental issues,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,services,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,society economy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,people,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cleaner vehicles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sensitivity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,affects,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pti,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effectiveness,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pvar,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,system modeling,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,agglomeration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,software,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,electric,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,issues,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PTI,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,physiological,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,alleviate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,higher,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,long term,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,appendix,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,monoxide,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,braking,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by46,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fulfillment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,gasolinebased,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Private car,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fuel combustion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,numbers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Urban economy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,panel,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,System dynamics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,root,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,endanger,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental subsystem,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,technology,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,growth rate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,rise,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,aqhi,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Appendix A,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,yang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,regression,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public transport,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,handle,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fitting,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,approach,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonlinear function,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reduce,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Table,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,resident,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,datasets,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,China Statistical Yearbooks,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,jay,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,car,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,HCNO X,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,relationship,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Changes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,brissaud,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loops-8,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,weakening effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,buying,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamic simulation analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adjustment factor,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Grey system theory,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,physiological indicators,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,publictransport,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,relevant,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,alleviating,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,range,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,EEA,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cars,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Beijing Shanghai,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,green,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,green technology,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,systems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,language,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,energy vehicles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,exogenous,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,consistent with,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figb-d,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,figb,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,loop,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health Tang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,multicollinearity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulation software,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Fig,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reach9793,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,protection,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,buy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,costs,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,medellin,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mexico,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,decline,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,single-tail number restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,chain,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,turning,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,real-time data,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,supply,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,support,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,exposure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,improved,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,literature dissipation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,showing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,tests,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,circula,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economic development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ecological,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,net migration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reasonable,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Public,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,purpose,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,indicative pollutants,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,departments,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,subsystems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Appendix B,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,point N,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Air pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,paradox,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,degrees,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,conclusions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reach3624,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor vehicle,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,milan,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fire,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving-restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,wang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Beijings Fifth Ring Road,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,odd,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,complex,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,purchaserestriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,positive,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,insights,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,COHCNO,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,United States Dedoussi,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,platerestriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PM,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,plugin,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,carbon,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,indirect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,model testing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,version,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,prediction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sun,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,feedback control theory,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,econometrics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,assessment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,place,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ideas,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,predicting,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reduction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dissipation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,investigation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,come,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Xiao,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Public transport,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health Liu,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trend,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,deal,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fundamentally solve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economic problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,way,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Table B1,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,findings,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,original sequence,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,weight value,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dap,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,energy consumption,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,infrastructure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,control,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,unchanged,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,makers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,xiao,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,linear nonthreshold,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,road-traffic capacity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stage,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental fee,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,matter,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,road,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,control congestion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,material,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,increases,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,solutions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,weekdays,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,conjunction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,tail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,China,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hoy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,subsystem,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Attraction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sequence,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,completeness,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,descriptions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,charges,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,science,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fuel taxes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,equations,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop5,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,degree,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,gdp,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,requirements,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,First focusing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Government,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,level,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban population,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,source Zhang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by27,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adjustments,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emissionreduction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hcno,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Appendix C,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicle pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,time NO X,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nitrogen,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health Sun,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Urban population,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,harm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,readers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop6,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fig,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,rate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,decision-making,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Driving restrictions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,AQHI,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Fulfillment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,life,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,parameters,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,help,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,regression analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,improving,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,grade,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic indicators,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Fig  Appendix C,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban traffic-restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,short term,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,contributions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,respiratory-related,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stocks,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,countermeasures,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shortdistance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,drivingrestriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,process,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,singletail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bus,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Official website statistics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,real-time ride-sharing framework,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,contribution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,synergistic effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,addition,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,residents,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,private car,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Transport investment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,declines,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fees,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,day,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Jain,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fuel,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,perspective,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emitted,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,obtain,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,evaluation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,test,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,diagrams,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Adnan,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,run,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,chart,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effects of,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ride-sharing problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Jia,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Mortality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,scholars,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Air quality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Government governance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,upward,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,chen,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,points E,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,data,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,point,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policymakers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,SD-NDGM,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,saavedra,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,partial,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trafficrestriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,management,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,phased,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,downward,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,lot,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,subsidies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,see,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,capacity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,highorder,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,assumption,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,MEE,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,non-homogeneous exponential growth,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,structure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pricing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,negative,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,theoretical model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,combination,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,method,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,analyzed,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economic costs,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loops,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,example,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,naderi,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,https,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,verification,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,transport,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,conclude,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,lagging effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollutant,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by4806,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Kuai,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by52,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,zhu,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,correlation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,solving,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,figa,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by26,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fee,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reasons,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,congestion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,parameter,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,conduct,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mandatory restrictions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,switch,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,explore,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop1,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,lacks,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air quality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,RTC,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ramos,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,kuai,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,greener,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public transport system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,https doi,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,aggravates,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,impact,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,data series,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,jia,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Assume,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bonilla,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quantitative,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,math,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,elements,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,flexible,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,single-tail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shanghai,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,taxis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,points,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,speaking,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,games,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,outbreak,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,circular,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health indexes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,improve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hybrid vehicles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,measures,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,credibility,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction Jay,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,flowchart,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,efforts,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,endogenous,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,SPSS,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,gradual,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban road,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,compared,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health effects,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,millardball,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,no restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effective,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,consideration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,longterm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,social,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor vehicles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,scientific,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,error,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Santiago Yang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,smog,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sao,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamic,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,words,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,non-homogeneous discrete grey model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,decreases,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,forrester,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,case,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,address,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,attraction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,results,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fige,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,evaluated,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,orderly growth,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,spss,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Reducing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,table,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,buses,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,convenience,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stable,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quantified,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,feedback loops,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figurea,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,study,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,result,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,computer simulation technology,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,positively,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,correlations,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vensim,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,advantages,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figa,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,single-tail numbers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,water,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,less,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban air pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,evening,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,private,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,problem,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,temporary,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stages,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shared bicycles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figb -d,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environmental,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,experiments,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicle,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shenzhen,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reach6896,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,manner,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,burden,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,double-tail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quotas,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,socioeconomic development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figd,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,NDGM,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,today,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,feedback,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,amount,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Degree,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,validation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,travelling,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,variables,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Positive effects,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by05,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic congestion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ambulances,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trends,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,benefit,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,rebound,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,RI,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,consider,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Millard-Ball,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hours,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Assumption,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-restriction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulated,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,models,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,grey model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,modeling approach,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,highorder complex system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,scenario,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,transportation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hydrocarbons,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,original,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,systematic policy system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by59,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,marginal,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Mexico,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shows,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implemented,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,and91,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonthreshold,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,index,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,phenomenon,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,change,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,show,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,studies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mitigation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,types,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission rate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,areas,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,panel data-based policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,intervention,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,differences,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,price,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,energy supply chain management,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,identified,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Forrester established system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,peak,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quantify,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,term,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop7,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,researchers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,years,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,overview,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,HC CO,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,police,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,private cars,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,consumption,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,SD,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,investigated,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,demand,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Environmental,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,real-time traffic,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonlinear,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Urban economic development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,benefits,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stock,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Positive feedback loops,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,days,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,approaches,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,end,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,analyses,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,DID,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,enhance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,associated with,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,of59,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,basis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Compared,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,purchase-restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ring,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Chinese cities,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamics model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PM5,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,information,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,evaluation method,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop4,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,taxes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,studys,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restricted,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,real-world,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,loop chain,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,peak morning,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,city,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,prioritizing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,social subsystem,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,GAM,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Beijing Municipal,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,lin,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,CO,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,society,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reduced,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,excessive,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,system science,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Sao Paulo Zhang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,license plate tail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Car restriction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,value,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving-restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,morning,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,M,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Beijing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,practicability,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,integrates,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollutants,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-related,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PM pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,turn,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,computers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cohcno,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Traffic congestion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,interrelationships,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,death,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,solution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PVAR,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,order,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figa -d,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,comprehensive,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,governance effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Data,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,General additive models,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,figurea,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Beijing residents,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health level,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,exhaust,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,indexes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Brissaud,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,HC NO X,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,of15,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,odd-even license plate-restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,points E F,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,hinder,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bicycles,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,COVID-19,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,steps,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,particulate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air quality health index,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,DTC,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,econometric model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,daily,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mere change,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Residents,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop3,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,anticipation-based migration,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,carbon monoxide,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,buenos,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction management,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trigger,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Sun,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,residual,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Fige,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicle-restriction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,market-based measures,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,guo,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,theory,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,intensity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,series,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,beijing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economic model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction management model,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,internal relationships,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traveling,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fuel economy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mortality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,keeping,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,engines,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,intention,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,NO X,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,citizens,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Wang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonhomogeneous,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,consumers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,beijings,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,analyze,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,agglomeration effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,research,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,multiple pollutants,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,regions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,time effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,supplementary material,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,circumvent,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ECC,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adnan,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollution problems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mediumand,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,area,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,solves,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,novelty,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sources,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulation sequence,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,doubletail,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,economy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,GDP,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,solve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,states,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic-related air pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Health implication,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,by020719,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,complex systems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,allocate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implemented curves,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,auxiliary variables,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bogota,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,early stage,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,research flow chart,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,relationships,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mechanisms,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,guerra,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health index,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adverse conditions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,extent,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,computer,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reducing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implemented curve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,prediction analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Milan Sun,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,improvement,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,realworld,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonmarket,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,You,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,carstrucksbuses,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,short-term,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bbrand,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,In addition,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,HC nitrogen oxides,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,million,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,manage,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,china,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,rtc,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,references,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adverse effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public-transport services,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,enforcement,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pan,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,tools,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,gap,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Bonilla Medellin,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implication,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,adjustment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,causes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ratio,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,permanent,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,math tests,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Air quality health index,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,number,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emissions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,carrying,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonlinearity,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,recommendations,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,increasing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,RTC is2906,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Shenzhen,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,aim,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving-restriction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,subsidy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,shortterm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,paulo,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,planning,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,modeling,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,parking,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,implementation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,law,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,changes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,boundary,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,indicators,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,resource,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nox,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,double-tail number restriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,decrease,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,B-brand taxis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,studying,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,DAP,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restrictions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,accuracy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,literature,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,NOx,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Per vehicle,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,investigate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,medium-and longterm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,population,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reviewed,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,create,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,levers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Olympic Games Beijing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,premise,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,combustion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,actual,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,F,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,stock-flow diagram,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,bus trips,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,characteristics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,delayed,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,low,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,factors,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,zhang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,social impact,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,work,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,external factors,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,aires,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,ability,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,combine,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,determine,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,lottery,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,time,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,public-transport development,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,premature mortality,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sdndgm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,roads,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulating,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,efficiency,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,travel,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,driving restrictions,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Liu,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,poor information Liu,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,evaluate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,growth,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Hoy No Circula restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamic system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Definition,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,algorithm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,multiple elements,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,curve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,external costs,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,plate-restriction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sensitivity analysis,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,figure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Zhang,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,incomplete,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,org,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,flow,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emission-reduction policies,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,insufficient,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,qualitative,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Zhong,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehiclerestriction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Road,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,nonhomogeneous exponential growth,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,calculation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,logic function,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,smog pollution,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,tactics,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Severe,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,annual,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Figa -d curve,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,efficient,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,private carstrucksbuses,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,liu,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,role,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban traffic-environmental system,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,increase,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,website,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,uncertain systems,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,curves,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,a13,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,short-distance,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,paradox effect,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,plate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,realtime,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,government,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,investment,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Price levers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mortality rate,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dtc,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,constants,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,online version,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,period,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trips,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,purposes,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,situation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,affected,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Researchers,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,initiative,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Buenos Aires,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,function,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Saavedra,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,check,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,research areas,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,framework,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,variable,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,test results,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,official,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,human,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,weight,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,assessing,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,take,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,standards,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollution reduction,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,measure,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Guerra,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,proportion,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,timeframe,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effects,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,fundamentally controlled,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,operation,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,graphical function,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,average,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,SD-NDGM-based algorithm,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,Loop8 PVAR,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,increased,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,diagram,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policy option,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urban traffic,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor vehicle trips pm emissions loop7 dtc government governance ti road investment ri road area,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor vehicle trips pvar rtc dtc loop6 pm emissions dap ecc government governance ti pti number,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,PVAR RTC DTC,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cities including santiago yang et al bogota bonilla medellin ramos et al milan sun,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic congestion air,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,number restriction policy,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,energy consumption liu et al water resource management naderi et al renewable energy supply chain management saavedra et al green economics kuai et al,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,car trips Number,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor vehicle trips pm emissions dap loop5 dtc government governance transport investment ti public transport investment pti number,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,private car trips,has_body
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,approach,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,accuracy,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,emissionreduction,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restrictions,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,term,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,quality,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,acceleration,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,longterm,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,findings,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,society,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,congestion,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effect,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,rate,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,simulations,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,benefits,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,paradox,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,degrees,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,publictransport,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,midand,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,model,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,sdndgm,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,dynamics,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,policy,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,time,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,trips,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,agglomeration,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,cars,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,purchaserestriction,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,integrates,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,air,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,function,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,health,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,study,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,number,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,carrying,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,increases,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,management,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,restriction,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,environment,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,capacity,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,development,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,traffic,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,effects,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,drivingrestriction,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,problems,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,problem,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,mitigation,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,motor,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,terms,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,exhaust,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,types,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,indexes,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,system,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,vehicle,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,pollution,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,reduction,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,combination,has_abstract
ded8b23d86de8a12fe5f5ddbc0e50c780d97f8d8,urbanization,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Viral,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Host,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Transcriptomes,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CoV-2,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Infected,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Human,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Lung,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Cells,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2-Infected,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Lung Cells,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Xuefeng Wang,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Yudong Zhao,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Feihu Yan,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Tiecheng Wang,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Weiyang Sun,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Na Feng,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Wenqi Wang,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Hongmei Wang,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Hongbin He,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Songtao Yang,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Xianzhu Xia,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Yuwei Gao,has_title
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,antibody responses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,manually,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,percentage,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,derivatives,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,serum,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,in vivo,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,early,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,noncanonical sgmRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,the-nt reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cfx,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sirtuin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,electron transporter,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,design,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,B2M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,concentrations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tens,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,calculated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,normal medium,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,magnetic viral DNARNA kit Tiangen China,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol-and valine-treated cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,orfab,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S4C,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Tables,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral infection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,primary receptor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Transcriptional dysregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infectious,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bckdhb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rcpf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,energy metabolism,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,extension,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,BCAA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 infection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,manufacturers,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Thermo USA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Mock-treated cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,phosphorylation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,adjacent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,High,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hsdb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,postinfection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,total RNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,T cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S4A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,prime,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,peaks,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,disease,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,started with,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,situations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pathogenic respiratory virus,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tissue,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stress,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,library,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,repeated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,model,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,glyceraldehyde-3-phosphate dehydrogenase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,phusion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,read depths,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,software,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytoplasm,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NDUFS6,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral RNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,higher,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,returned,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coding upstream,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,numbers,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,equilibrate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,qPCR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,antibodies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigG,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S6B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,log fold,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S sgmRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SIRTs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S4B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amplicons,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Overnourished medium,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fact,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nuclear enzymes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,counted,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell number,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lvaline,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,generate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tumor necrosis factor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,clusterprofiler,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,knockout,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,late infection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,return reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibitor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,covs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,relationship,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GAPDH,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,calu,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,keto,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ifnb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,utr,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,crosses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,manual,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Illumina NEB USA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptional regulators,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S3A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coordinate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DNA fragments NEBNext adaptors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lengths,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,specificity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokine-related transcriptional regulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NFKBIABCDE,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,consistent with,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RT-PCR fluorescence probe,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,loop,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Table S4,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lipid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,square,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mechanism,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,start sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exonucleasepolymerase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discontinuous,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rectangles,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rnasimple,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACAT2 phosphomevalonate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigD,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,portion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mevalonate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,degs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fragmentation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bronchoalveolar cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,subunits,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF10,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORFs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ending site,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACE2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Nanopore technology,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,complex,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,subgenomic,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF7b,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,trss,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lysine deacetylases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,consists,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,phosphomevalonate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,largescale,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,divergent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,screening,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GAACttt sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nfkbia,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ABCA1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,insight,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,supermix,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proteomic methods,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,red dashed-solid lines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,index X primer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,denaturation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time point,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNF-alpha,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,betamicroglobulin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,precursor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mutation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,way,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,body TRSs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol synthesis pathway,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,receptorassociated factor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,naprtase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upregulated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,examination,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular functions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,supernatant,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,querying,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,phenomena,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,IFNL,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular phenomena,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,E membrane M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gapdh,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coterminus,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,index-coded,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tumor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell detachment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signaling components,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tail,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,regulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signaling pathway,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DNA polymerase I,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,blocking,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nucleic acid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,thent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,peripheral blood mononuclear cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptome analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,colors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,divergence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,alzheimers,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lymphotoxin-alpha LTA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,clearer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,level,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,universal,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,illustrated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Cholesterol,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,identification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,kegg,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genomic results,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sterol-demethylase Significant,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MEM,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sodium,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,enlarged,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,probable,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hijacked,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mock-treated cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fig,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,spike S envelope,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF7,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tiangen,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,functions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pairs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,answer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rnase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cold,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,red,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,response,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mock-treated samples,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,set,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nfkb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hour,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acetylcoa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene expression programs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,body,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CDS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,translocation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,kilobase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mock-infected cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exonucleasepolymerase activities,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,process,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,IPA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acyl-CoA dehydrogenase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,alignment-based strategy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,copy numbers,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Host,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short specific,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Universal SYBR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,KEGG,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,polyA tail,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,after-TRS read,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Viral RNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lymphotoxin FC 2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mrnas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytochrome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNF-induced,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuous,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,false discovery rate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,High-titer stocks,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,PBS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,influence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,angiotensin II type I receptor 21,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,predicted,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hexamer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Infrastructure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,intensify,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,expressed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF3 genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fatty acid oxidation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ended,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fbs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sense primer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,data,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,point,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,adaptors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mg100,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amino acid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,strategy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,leader sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibited,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,thermo,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,part,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,interleukinA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FBS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S3A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coleader sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ingenuity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GAACttt sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,heterochromatin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,deg,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Oxidative,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,components,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,neurodegenerative diseases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene functions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host calibrators,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,HSD17B4,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,constant,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,histone,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mmulv,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NM0040484,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CoA-related,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,negative-strand intermediates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,energy usage,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical transcription,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,usage,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,platform,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sirts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequencing depth,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bcaa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,flexible,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,false,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,highthroughput,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Z-score,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,enzymes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,organisms,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,observed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pyruvate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,twice,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pink,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,query,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,annotation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA-Seq,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discrepancies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,variable sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Qubit0,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF3 M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,E,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,integrity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,case,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,grch,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genomic UTR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NCBI Sequence Read Archive,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,results,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dot,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,phosphoribosyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,evaluated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,advantage,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,andbp,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,taaacgaac,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cardiovascular cholesterol,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stable,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ATG101,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,quantified,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,double references,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,first-strand cDNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequencing errors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,started,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,XP beads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 genome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,less,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amplification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,normal cell,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,zerotimepoint,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,monitored,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activators,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,aftertrs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amplicon,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discontinuous region,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Supplemental material,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acetyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TRAF2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2-infected cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuous process,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genome transcription,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 transcriptional,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,prepare,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,angiotensin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,trends,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mild,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accurate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,levels,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mapping,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NOS3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptional dysregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,preliminary studies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CRISPR-based screening study,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cluster,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,peak levels,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,to8,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lung cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,atppf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pathway,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,poly A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 gene,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,AMPure XP beads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,index,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,change,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,T25 flasks,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Coronaviruses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,msrs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mapped,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcript,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,studies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discontinuous regions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,programs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2-infected,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Puruikang China,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,identified,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,peak,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dnarna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,near,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,read counts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell lines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,alignment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Mammalian,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,structural proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,histone modification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lleucine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,calibrate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N1 read counts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Maxima H Minus,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,entry,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,end,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,efflux,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Bio-Rad CFX96 system,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,application,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNF-alpha-induced protein,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,impede,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,surrounded,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tnf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,penicillinstreptomycin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Compared,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,oxidative,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TRS sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exacerbate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nidovirales,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inoculated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inset,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mem,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fused sites,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genomic,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol biosynthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,start site,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,formation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CO,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,diluted,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Institute,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,beta-2microglobulin B2M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,origins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,modulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral RNA synthetase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,value,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA-Seq study,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical sgmRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DEG,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,random hexamer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,firststrand,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,after-TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,high-throughput RNA sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,IL-1A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,frame,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular process,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptional process,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S7,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TRS-related sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigE,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,target,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,order,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,maintained,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,autophagy-related genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,high,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Parkinsons disease,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,branchedchain,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coronaviridae,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ATG14,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,UTR-TRS-ORF structure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Cell Line Resource,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,grna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,frameshifts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cdna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,COVID-19,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,unintended,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,USA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exhibits,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,foxo,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time point Functional analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,treated with,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,protease,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Similar,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,state,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TAA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral replication,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Cytokine storms,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,timescaled transcriptomes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Alzheimers disease,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,extended,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,noncanonical TNF receptor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,revealed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acgaac,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cds,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical N,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,at39,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,utrtrsorf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,figg,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Table S5,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fusion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,patients,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cbot,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RCPF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,detecting,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Illumina NovaSeq platform,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,receptors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,noncanonical sgmRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,published,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,necrosis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,deviant,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,calibration,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,figf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RSEM,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,criteria,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,logP,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,extent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SUPPLEMENTAL,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,angiotensin I,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hightiter,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,biorad,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downregulated genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time-scaled read count,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tables,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cycles,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,flasks,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cultured,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SOD2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuous sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,strategies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,china,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,references,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lymphotoxin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FPKM,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tenfold,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,qubit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,histones nicotinate phosphoribosyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,square B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,beads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,number,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACAT1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral transcription,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,increasing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,novel,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,libraries,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene ORF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,changes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time factor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pneumonia,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,resource,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CoV,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,widespread,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV 7,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Downregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hairpin loop,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequential,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular RNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lisoleucine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reviewed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,figd,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lowest,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S3B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,highest,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SSR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Vero E6 cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,body TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,M-MuLV reverse transcriptase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,plates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,factors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,induce,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNFR2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,diphosphomevalonate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,catalyzes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription discontinuous RNA synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,usa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,integral,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NAD-dependent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inferred,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,polyproteinab,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Military Veterinary Medicine RNA extraction,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,deletion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ssr,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hadh,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuous-nt,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,theories,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rare,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,algorithm,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MBTPS2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,curve,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genome sites,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,to7,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,monitoring,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,qRT-PCR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time points,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,conversion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hybridization,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N ORFs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,agreement,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,differentially,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acetyl-CoA acetyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SIRT6,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,blood,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,question,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fused,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,responses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,beginning,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,overnourished medium,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,untreated cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Differential,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,glyceraldehydephosphate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,branched-chain amino acid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activities,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,minimal,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,curves,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream ORF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription strategy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,diseases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,extraction,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coenzymes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,theddct,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S region,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nuclear translocation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discovery,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,file,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,The-nt,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,medicine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,variable,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,orfb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,metabolism,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,truncated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,trs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,aligning,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proportion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,PTX3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,increased,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,vivo,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reason,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,modification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,publications,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical sgmRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral RNA percentage,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Hisat2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Nidovirales,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SSR mapping,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,melting curve,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,well,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sodium pyruvate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,read,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,depth,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,procedure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,targets,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral genome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,processes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,difficulty,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,high-fidelity DNA polymerase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,errors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inset figures,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,noncanonical sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,clinical,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,concentration,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,treating,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downstream genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,detection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,absence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription-regulating sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TCID,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MSRs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,polyproteina,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene expression,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,limitations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bcaas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,the000 position,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular processes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,CoVs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,energy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downstream sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Transcriptome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA genome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,treatment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downstream body,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,atC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,site,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accordance,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,factor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,values,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,absolute,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream genomic region,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rfam,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,component,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNFR2-related immunological studies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibitors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,parkinsons,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Situations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF7p1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,production,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig  N,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,No shading,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,positivestrand,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,biochemical,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,significantly thereafter,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACE,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acyl-CoA derivatives,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,more-consolidated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,physiological,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accessory,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,quantification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,deficit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viruses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACGAAC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,study Cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription factors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acids,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,technology,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signaling pathways,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cold phosphate-buffered,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,primers,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,elongated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,AGTRAP,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,junctions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,penicillin-streptomycin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,A C G A A C,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coleaders,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,antisense,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,paired-end reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lysine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bronchial epithelial cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signal,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,washed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Table S3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cDNA synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,E structural genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,interfering,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rsem,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Double references,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,H2B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,enzyme,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,classical,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,abundances,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,First-strand cDNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sitebysite,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dulbeccos,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,figb,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuous read count,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,system,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,as2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sense,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,induced,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,molecular,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,polymerase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,zscore,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nucleocapsid N structural proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,enrichment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,branched-chain keto acid dehydrogenase complex,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,leader UTR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Table S6,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,showing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MSR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-2-CoV,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lta,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibition,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nonspecific,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NOS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,grnas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reaction,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,true TRSs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sod,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,primer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sirt,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,medium,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,secondstrand,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infectious pneumonia,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,abundance,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,vero,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream stop codon E,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,publication,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SsoAdvanced,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stem,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hydroxysteroidbeta,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ace,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inactive,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ends,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,in-TRS read,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pools,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,count,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 genome study,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptional response,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acute inflammation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,calibrators,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sirtuins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,generating,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Primer pairs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stop codon,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mitochondrial energy deficit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,findings,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral genomic RNA gRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amino acid degradation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,deacetylases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,interactor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,copy number,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coterminal,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MORF3E,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infrastructure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hydroxyacylcoa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mapped reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tnfalpha,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,homology,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,existed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,expression curves,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NEBNext Ultra II directional RNA library prep,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fragments,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,circles,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,overlap,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,times,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,material,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,length,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Agilent system,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,figures,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,illumina,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,replicates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmrnas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,China,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,saline,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,protein-comparable antibodies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short query,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,white,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,perturbed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,step,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gaacttt,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sra,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,subunit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Coronaviridae,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ATG4,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genomic sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S2A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,energy utilization,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,melting,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tnfaip,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,library insert size,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pauses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lack,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,counts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,MT291831,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,degradation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Dulbeccos Modified Eagle Medium DMEM,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,synthesis sites,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,beta,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hpi,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reninangiotensin,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Read pools,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S2B,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cells,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,immune response,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,replication,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pathways,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,flanking,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Bio-Rad,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,valine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical N sgmRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accession number,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,archive,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,renin-angiotensin system,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,database,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,priming,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Beckman USA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,virus-infected,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stocks,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,kinase diphosphomevalonate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA-Seq results,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accession,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Table S1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,partial sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,addition,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptionregulating,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular level,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream query,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pairedend,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,expression,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,conserved-to-nucleotide,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SIRT1-mediated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GRCh38,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proinflammatory,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,oligonucleotide,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S4A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA-Seq analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,copy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SIRT1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell types,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,atc,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical ORFs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,core sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,UTR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,large-scale,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cDNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tnfr,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral RNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,respiratory,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fatty acid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SSRs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,early infection,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcripts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,envelope,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hisat,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,see,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,highfidelity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fetal bovine serum,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,material metabolism,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,structure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,immunogenicity,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DEGs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S6A,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,zero-timepoint,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,antisense primer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,beta subunit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,guide,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S ORF3 M,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,method,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,analyzed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,example,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,conservedtonucleotide,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,L-isoleucine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,verification,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exhaustive,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,core gene,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,instructions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,in-well plates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NR1H2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,quite,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,medicines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,consecutive,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,manifestations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nucleocapsid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reactions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hyclone,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical sgmRNA sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,clusterProfiler,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downregulated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol efflux,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reflect,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,methods,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene transcriptomic,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,agtrap,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,time-scaled expression,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,promote,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACAT2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,matches,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptomes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,institute,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,receptor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,intermediates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,points,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DHCR24,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pair,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV produces,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,read count,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,overhangs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,storms,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sharply,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,credibility,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inflammation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infection time,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,homologous coleaders,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,untranslated region,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,adenylation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,clustering,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNFR1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bidirectional,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,consideration,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,total,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dmem,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,examine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,position,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fluorescence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accessory proteins,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cotermini,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,samples,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,biosynthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,suppose,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Rfam database,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,table,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,switches,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,study,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,result,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cov,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,L-leucine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,length whose-nt sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SRA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,conventional,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,DOT1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TMPRSS2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,size,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNAsimple extraction kit Tiangen China,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,protein,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,problem,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,probe,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,body TRSs FigA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cellular metabolic state,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,experiments,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,orfs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,synthetase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,timepoints,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ampure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 RNA synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokine storms,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ifnl,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ATGs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,negative-strand synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gadd,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,detachment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,novaseq,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,assessed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tcid,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Calu-3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,PDF file3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,evidence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,group,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NEBNext first-strand synthesis reaction buffer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reverse,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,read pools,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,guiding,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,majority,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,viral entry,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,family,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,difference,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,employed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmRNA sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cell death,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,copies,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,reference,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,type,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hours,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FigA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ending sites,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Nanopore sequencing study,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,catabolic pathways,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,comparing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,prolongation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,confusion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,kit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,regulate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,products,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,purchased,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,identical,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,regulators,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,machinery,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dose,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,global,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exist,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA-Seq IFNB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,methyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sarscov,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,types,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,differences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sets,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cDNA library,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,primes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,note,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,candidates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nrh,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signaling,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,PCR products,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,quarter,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TAAACGAAC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Viral genome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,synthesized,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fpkm,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rnas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inconsistent,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SIRT7,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NFKBIA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,days,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,culture,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA synthetase complex,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NFKB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S downstream,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,analyses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,magnetic beads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hydroxysteroid-beta dehydrogenase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,associated with,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,basis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proteome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF7p3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream ORFs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,translated,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rrna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,BCKDHB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gaps,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Ingenuity Pathway Analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,oxidative stress,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,elicited,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,region,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,information,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,express,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bidirectional regulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,membrane,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,issue,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,buffer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fused body,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmrna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acylcoa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,puruikang,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cBot cluster generation system,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downstream,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,severe,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infected,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,return,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Phusion,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N gene,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sgmrnasgrnas,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bckdh,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,codon,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ATP5PF,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lung,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bioanalyzer,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Sanger sequencing analyses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S protein,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,continuousnt,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,electron,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,PCR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mutant RNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pool,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sanger,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,death,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,line,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short extension time,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,portions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,product,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,abca,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Data,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF1ab,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,histone lysine methyltransferase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,generation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Downstream genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hydroxyacyl-CoA dehydrogenase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fragmentation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,histones,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,black,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ncbi,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,BCAAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,steps,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fulllength,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,blunt ends,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,eagle,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,antibody,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N sgmRNAs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accession number SRP324059,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fatty,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,in-TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcribed,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rnaseq,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,series,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,compare,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mammalian,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,red dotted lines,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF8,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,qRT-PCR-based methods,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mortality,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV ACGAAC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,upstream ORFs FigB,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Expression,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Mutual,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene sets,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,biophysical activities,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,template,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ssrs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,regions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,analyze,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,N peaked,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,aerobic,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,templates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,questions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,isopentenyl-diphosphate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,IL-6,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNF-related,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gRNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,oxidative phosphorylation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,biosafety,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,execute,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,a-nCoV,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coronaviruses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,leader,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,disomerase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Sanger sequencing-based analysis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,utilization,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,prep,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,IFNL2,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,former,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amino acids,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Lower expression,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,BCKDH,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,view,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,promotes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Manual,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,black frame,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,decarboxylase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,E gene,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Nanopore sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,containment,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibit,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,depths,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,HADH,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mutant,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transporter,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV The,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,recommendations,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amplify,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,atgs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stems,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rectangle,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mrna,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,exceptions,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,availability,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,bovine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genomes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,S ORF3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Site-by-site sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TRSs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,intrs,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,accuracy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transaminases,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,core,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,measuring,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 Minimal,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,laboratory,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,involvement,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mock-treated replicates,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,low,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short reads,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,NM0020467,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,andor,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,determine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Fig S5,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA viruses,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,short read query,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Mild cytopathy,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dysregulation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coding sequence,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transformation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,evaluate,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical transcripts,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,kinase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dysregulated pathways,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pdf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FOXO1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,functioning,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,amino,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,stop,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TNFAIP3,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,canonical,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,homologous coleader,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,GADD45,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,hypertension,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,oxidation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,induction,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Cellular RNA,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coleader,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,virus,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,increase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fragments per kilobase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Agilent Bioanalyzer Agilent USA sequencing libraries,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,orf,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,valine degradation pathway,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,realtime,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,FC 1,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,log,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tissue culture,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,proinflammatory activities,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,site-by-site,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sirtuin pathway,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dehydrogenase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNase,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,immune,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,affected,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,TheDDCT,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ribosome-related oxidative phosphorylation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,signals,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,function,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,virus pool,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,contrast,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,human,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ORF6,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,inhibiting,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lglutamine,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,standard protein,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lower sequencing errors,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,employ,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Briefly,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,SARS-CoV-2 transcriptome,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,AMPure,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,effects,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,subject,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RT-PCR,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,RNA degradation,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,account,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sites,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,valine metabolism,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,Illumina sequencing,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,expression level changes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sars-cov-2 genes,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,2 genome mt291831 using hisat2 generating read pools containing viral sequences read pools,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,ACGAAC core TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,core TRS ACGAAC,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,illustrated using read count per fragments per kilobase per million mapped reads rcpf values,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discontinuous RNA sequences,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,fragments per kilobase per million mapped reads fpkm values,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,discontinuous RNA synthesis,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,glutamine thermo usa mm sodium pyruvate thermo usa nonessential amino acids thermo usa,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,tnfr2 fragments per kilobase per million mapped reads fpkm 3 calu,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,downstream body TRS,has_body
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,treatment,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcriptionregulating,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,level,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,perspectives,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,support,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genes,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coronaviruses,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,perspective,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,expression,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mrnas,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,transcription,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,lack,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,principles,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokine,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activities,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,attention,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,importance,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cholesterol,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,functions,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,infection,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,host,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,details,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,strategies,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,levels,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,nucleocapsid,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,replication,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,pathways,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,activation,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sequences,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,rna,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,obstacles,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,valine,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,strategy,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,synthesis,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,coronavirus,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,dysregulation,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,cytokines,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,health,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,acgaac,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,research,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,metabolism,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,trss,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,methods,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,largescale,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,gene,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,imbalance,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,storm,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,novel,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,emergency,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,development,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,syndrome,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,sarscov,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,mrna,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,information,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,genome,has_abstract
e88b7d8fd78e306625316fd8ef4d6b328d637c6a,responses,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Community,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,methicillin,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Staphylococcus,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,aureus,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pneumonia,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,rhabdomyolysis,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,case,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,report,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,methicillin-resistant,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Staphylococcus aureus,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,case report,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Poorani Goundan,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Anurag Mehrotra,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Deepa Mani,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Indumathy Varadarajan,has_title
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CT computerized tomography,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hospital policy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,predominance,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,compared,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,systolic,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,serum,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Cockroft,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diabetes,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Ul,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,well,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Legionella Influenza virus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,status,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,prick,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,rehabilitation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,capneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,expectoration,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,case,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intravenous piperacillin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,aureus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,lung fields,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,serum creatinine of7,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,table,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Editor-in-Chief of,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,leukocidin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,study,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,clinical,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,weeks,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,definition,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,infectious,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Staphylococcus aureus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,absence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,initiation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,etiologies,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,icu,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,monitored,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,problem,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,conditions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Echo echocardiogram,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,creatine phosphokinase,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,complications,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,site,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,non alcoholic He,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,factor,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,assessed,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,therapy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,evidence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diastolic functions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cause,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,infections,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,PO2FIO2,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,analysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,suspicion,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tissue,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,South Indian,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,local pattern,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,failure,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hypoxemia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,creatine,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,consider,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sensitivity,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,clinical course,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,physiotherapy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hours,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,invasive,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,chest,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,comparing,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,chlamydia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,monitor,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,striated muscle,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hospitalization,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,scenario,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tazobactum,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,higher,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,disintegration,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CA-pneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sensitive,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,admission,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cover,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cardiac functions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,thenar,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Written informed consent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,index,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,estimate,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hemodialysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,respiratory rehabilitation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,studies,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Chlamydia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,piperacillin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,muscle,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intervention,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,normal cardiac functions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Staphylococcus aureus ARDS,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,arterial blood gas analysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,renal vasoconstriction,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,vancomycin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,history,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,dialysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Acute renal failure,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,years,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,begin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,relatives,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,decreased,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,denied,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pattern,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acute presentation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,endocarditis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mandates,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,HIV,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,filtration,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,febrile,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,emphysemacopd,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,nephrotoxic effect,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,no history,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acidbase,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,immunosuppressive,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,days,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,centers,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,incidence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,associated with,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cellsmm3,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,basis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cough,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,opacities,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hand,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,methicillin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cast,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,prognostic,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,exotoxin genes,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,thorn prick,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Vancomycin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pofio,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,induced,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Hemodialysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,impairment,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,male,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,improved,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,form,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,genes,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,thorn,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tests,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,saturations,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,labs,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,formation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Staphylococcus aureus infection,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,grade fever,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,creatinine,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,infecting,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,respiratory infections,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,effect,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Panton Velentine leukocidin gene,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,infective endocarditis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,severe,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cpk,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pneumoniae,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,disturbance,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,lung,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tracheostomy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,country,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,copy of,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,leukocyte counts,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,bilateral bronchopneunomia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acute,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,initiate,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,illicit intravenous drug use,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,long list,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,patient,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,aciduria,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,publication,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,health,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,BUN,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,resistant,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,positive,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mgdl,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,written consent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,nonsmoker,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sterile,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,rhabdomyolysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,prevalence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,order,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,gene,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,drowsiness,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,course,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,oxygen saturations,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,ards,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Rhabdomyolysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Mycoplasma,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,antibiotics,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,suffering,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,care,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,unit,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,meropenam,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,influenza,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,HbsAg,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,year,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,fields,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,drowsy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,gram,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,stains,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,per glomerular,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Gault formula,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,case report,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,state,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,meropenem,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Methicillin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,examination,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,oxygen,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Meropenem,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intubation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,discharged,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mortality,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,legionella,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,echo,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,thorax,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,persistent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,surfaceD,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,occurrence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,contributor,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,renal impairment,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,prognostic factor irrespective,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Systemic examination,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,times,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,precautions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,balance,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,consent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diabetes hypertension,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,advice,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,blood cultures,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,department,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,panton,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intensive care unit,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,non-smoker,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,syndrome,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,severity,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,MRSA,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,patients,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,electrolyte,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,polymorphic,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hbsag,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,echocardiogram,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,urea,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,heme-protein,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,groups,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,list,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,drug resistant bacteria,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hospitalized,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hypovolemia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,HA hospital acquired-MRSA 4,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,bilateral,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,nitrogen,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,counts,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,oligouric renal failure,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,gas,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,immunosuppressive therapy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,dissolution,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,phosphokinase,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,soft tissue infections,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,community,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,functions,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,rate,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diagnosis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,output,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,formula,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,right hand,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,view,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,non-homogenous,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,policy,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,not hospital,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,prevent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,editorinchief,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,exotoxin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,injection,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,grade,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,causes,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acute respiratory distress syndrome,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,echos,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,fever,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,journal,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,treat,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Linezolide,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,abscess,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,empirical antibiotics,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,skin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,drug,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,blood urea,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,bronchoalveolar lavage,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,community-acquired pneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,ABG,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mgdl serum creatinine,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,addition,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,transesophageal,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,report,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,distress,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,day,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,surgery,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,urine,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,xrays,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,smoking,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CPK,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,confines,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intraluminal,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,eminence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cast formation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,vasoconstriction,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mrsa,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,presence,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,images,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,staphylococcus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,infection,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,ICU,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Streptococcus pneumoniae,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,respiratory,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,review,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,time,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CT thorax,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CA,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,UL,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,trauma,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,decho,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sometimes,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tuberculosis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,myoglobin,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mucoid expectoration,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,necrotizing pneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,part,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,definition hospital,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,use,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Respiratory infection,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,immunodeficiency,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,streptococcus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,figure,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,abg,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,empirical gram negative,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,elevated,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,psttaci,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,negative,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,blood,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cultures,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acid-base status,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,threat,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,crackles,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,camrsa,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,gault,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,calculation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,leukocyte,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hemeprotein,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Indian scenario Studies,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hypertension,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mycoplasma,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,virus,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acquiredmrsa,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,linezolide,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Arterial Blood Gas analysis,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,drowsy state,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,CA-MRSA,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,health care,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hiv,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,period,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diastolic,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,emergency department,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,diagnosed,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,outpatient,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,ARDS,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,admitted,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tomography,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,lavage,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hospital,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pH disturbance,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,bronchopneunomia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,emergency,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,Patients,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,presentation,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,india,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,India,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,bacteria,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sites,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,measures,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,toxicity,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,organisms,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,patients clinical course,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,severe community acquired,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,community acquired MRSA,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,community acquired pneumonia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,methicillin resistant staphylococcus aureus ards acute respiratory distress syndrome abg arterial blood gas analysis echo echocardiogram hiv human immunodeficiency virus ct computerized tomography bun blood urea nitrogen cpk creatine phosphokinase written informed consent,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,community acquired infections,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acquired MRSA infection,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acute respiratory distress syndrome ards,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,acute potentially fatal clinical syndrome acute renal failure occurs,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,tracheostomy care methicillin resistant staphylococcus aureus mrsa,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,arterial blood gas analysis abg showed hypoxemia,has_body
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,camrsa,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,male,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,report,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,distress,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,fluid,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,year,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,dialysis,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,authors,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,entity,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pattern,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,laboratory,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,morphology,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,mrsa,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,cpk,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,staphylococcus,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,failure,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,levels,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,intubation,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,sensitivity,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,case,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,work,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,aureus,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,culture,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,thorax,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,patient,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,organism,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,nations,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,rhabdomyolysis,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,lavage,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,hospital,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,methicillin,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,guidance,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,india,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,necrotizing,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,patients,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,problem,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,reporting,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,antibiotics,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,blood,has_abstract
ea0ae02d57835b862e82faacc5b8e9ed9a92bebb,pneumonia,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,Breast,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Reconstruction,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,COVID-19,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Systematic,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Review,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Breast Reconstruction,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Pandemic,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Systematic Review,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Kshipra Hemal,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Carter Boyd,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Jonathan Bekisz,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Ara Salibian,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Mihye Choi,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,Nolan Karp,has_title
e4bf8b793bcd248417acceeeb459134f2c6a633b,provision,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,full-text review,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,needs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,publications,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,divert,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,recommending mastectomy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,patient demographic factors,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,video,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,South America,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,well,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,options,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,secondary to,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,covid,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Multidisciplinary teams,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,early,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,assembles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,importance,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,methodology,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Proponents,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adversity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,design,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,andin,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstructed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,office visits,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,representatives,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reassignment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,complication,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,positioning,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prophylactic mastectomies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,infectious,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,institutions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,absence,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,injury,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,scan,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,limitations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,satisfaction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ERAS,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ways,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,long-term,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Reviewing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,imperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cost,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,treatment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Women,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,testing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,halting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,therapy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,disease,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,impaired,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,aid,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,services,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,tissue,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delay,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pandemic published,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,practice,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,goals,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,potential,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,meta-analysis,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Cochrane Database,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,observation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Evidence,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Implant-based breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,multidisciplinary collaboration,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,institution,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,timing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,thromboembolism,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pressures,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,age breast cancer,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast-conserving surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,testing protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,higher,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,parts,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,costanalysis,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Meta-Analyses,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,innovative protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,landscape,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,admission,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,numbers,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,comparison,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,wards,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,superiority,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reduce,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Table,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,manuscripts,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,abr,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,policies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,france,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,infectious risk,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,circumstances,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Italy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pandemic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reviews,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,embase,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,personal protective equipment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,canada,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,felt,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,primary outcomes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,symmetry,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,women,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,sample sizes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,sample,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,shortages,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Figure,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,video laryngoscope,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,strove,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pandemic citing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,regional anesthesia,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,discharge,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prophylactic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mechanism,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Fig,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,protocol,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,system,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,costs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,swabs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cessation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,duplicates,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,English,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,popularity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,exposure,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,tests,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,article,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,targeted pain control,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,RT-PCR tests,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,principles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,operative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,telehealth,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,purpose,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Spain,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,world,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,exclusion,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,necessity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,population setting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,crisis,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,country,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperative course,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,procedures,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,health,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare setting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,team,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,insights,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,autologous reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,backlog,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,observe,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperative pathways,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,screening,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,course,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Goals,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,assessment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,virtual postoperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,place,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,topics,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reduction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,enhanced,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,apparent,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,face,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,perform,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,trend,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,settings,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,way,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,patient education,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surgeons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,infrastructure,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,examination,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,setting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,control,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstructive surgeons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,collaboration,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,intubation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implant-based reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,stage,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,health services,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pandemics,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,vulnerable,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,times,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,length,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,conjunction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,coronavirus disease,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,visits,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,globe,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cjb,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,development,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospitals,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,resource-constrained healthcare system,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,intraoperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mastectomies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prolonged,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delivery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,degree,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,outlined,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mitigate,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,groups,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,office,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,selection,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,phase,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pre-pandemic breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,crises,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Canada France,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,post-pandemic queue,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prioritized,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,authors,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,challenges,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,specifics,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,community,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,fig,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,expansion,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,rate,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pathways,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pathologies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,favor,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,regional blocks,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,impacted,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prevent,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,improving,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,response,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,countrys,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,plastic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,outcomes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,gains,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,psychological,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,creation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,metaanalysis,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,january,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,compromise,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,wound healing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,database,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,discussions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,value care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,resuming,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,addition,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pandemic screening programs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,susceptibility,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,day,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,psychosocial,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,same-day discharge,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,expanders-need,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital stay,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,test,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surveyed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,title,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pre-pandemic rates,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,direct-to-implant procedures,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,workup,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cosmetic augmentation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,periods,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,affecting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,infection,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare system,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,contracting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,respiratory,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,review,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,data,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Systematic Reviews,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,queue,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,same-day,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pulmonary disease,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,variety,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,concerns,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,categories,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,management,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,immediate,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,part,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,use,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adequate,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,median,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,equipment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,guidance,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,comment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Follow-up,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,providers,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Complications,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,negative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Content,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,example,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast conservation surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,search,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,tomographic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,considerations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,articles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,exposure to,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,optimum,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reasons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,low-dose computed tomographic scan,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,staff,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,uncertainty,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reoperation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,lieu,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nasopharyngeal swabs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare providers,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,rates,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,themes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,revision,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,creativity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nerve,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Key themes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,outpatient,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,impact,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,spain,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,conserved,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,direct-to-implant reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nutrition,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,points,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surgery pathway,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,items,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,followup,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ABR,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,serial,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,efforts,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,trying,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nature,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,follow-up,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,profile,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implant,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,compared,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,consideration,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,effective,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,longterm,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,america,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implant-based breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,profiles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,status,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,efficacy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cost-analysis,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,intra-,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,countries,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,unifying,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,conserve,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,contact,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,thromboembolism respiratory compromise,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,provider,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,case,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ample discussion,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pressure injury,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Simultaneously,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,theme,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,results,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,regional,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare resources,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,plastic surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Reducing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,table,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,convenience,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,study,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,plastic surgeons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,merits,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,waves,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,general protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,standards of care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,voiced,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Surgeons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,httplinkslwwcomprsgob,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,environment,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,concern,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,accelerated,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,less,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstructions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,specialized techniques,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,post-pandemic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,abstract,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,stages,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,manner,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Review,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,complications,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,strive,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Countries,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,autologous,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,specialized,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,assessed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,decisions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,proponents,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,diagnoses,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ranging,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,evidence,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,organizations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,variables,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,limiting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,majority,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,scheduling,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare settings,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,conservation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,length of hospital stay,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,difference,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,employed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,levels,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,type,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,individuals,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hours,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,anesthesia,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Intervention type,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Peer-reviewed articles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast surgeons,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,coronavirus,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,general anesthesia,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,screening protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,same-day mastectomy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,original,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,global,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pre-pandemic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pathway,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implemented,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,quality care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Preferred Reporting Items,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,kingdom,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstructive surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,KH,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,studies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,programs,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,heterogenous,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cochrane,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surges,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,length of stay,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,intervention,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,physical examination,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,identified,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,peak,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,administrators,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,restarting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,quality,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,years,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,readmission,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prone positioning,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,decreased,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Techniques,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Studies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,benefits,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,vaccination,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,preservation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,days,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,approaches,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mastectomy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,counsel,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,sameday,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,institutional protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nurse,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Timing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,north,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,safety,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,operative time,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pressure,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,preoperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,others,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,content,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Periods,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,male,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,improvements,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Brazil,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prospective studies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delay procedures,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,education,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reduced,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Asia,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,grouped,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,professional organizations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,value,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implants,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,legal teams,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,techniques,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,purported,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adjuvant therapy,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,patient,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,forgo surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breasts,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,MEDLINE,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adaptation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,comprehensive,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,guidelines,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Data,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Ten studies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,volume,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reporting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,discuss,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Observation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,wound,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breastconserving,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,COVID-19,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,displays,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,comorbidities,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,risks,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,discharge protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,author,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction613,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,meta-analytical techniques,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,duration,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,abates,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,oncologic diagnoses,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,case series,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,disruptive nature,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,overall,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,United States 5,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,theoretical risk,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,multiple countries,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,state,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,series,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delays,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,appointments,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital utilization,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,los,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,local anesthesia,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,clinic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,institutional policies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,overlooking,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,regions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,balancing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Population,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,augmentation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,heightened,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Delayed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,dangers,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstructions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,discussion,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,severity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,novelty,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,patients,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,questions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,terms,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,CJB,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,United Kingdom 7,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,months,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,risk,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,states,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adverse psychosocial,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstructive outcomes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,world agreed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delaying,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,challenge,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,experiences,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Key changes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mechanisms,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,interest,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,height,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,criteria,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Articles,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cases,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,retrospective studies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reducing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,standardized,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,recovery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,utilization,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,improvement,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,written,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,sizes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adoption,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,topic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,patient satisfaction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,adaptations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,detail,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,See appendix,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,strategies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,references,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperatively,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,access,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pain,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pertinent,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital administrators,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surveys,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,operating room,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,practices,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,recommendations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,halted,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,modified,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,resourcefulness,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,length of hospital,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstructive options,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,nurses,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,collection,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,devising,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implementation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,deferring,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,changes,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,perioperative,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,resource,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,implant reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,assess,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,allocation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,EMBASE,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,report,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,eras,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,restrictions,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,literature,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,spread,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,DBR,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,population,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,reviewed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,lowest,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,involvement,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,highest,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,armamentarium,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,features,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,characteristics,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,delayed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,effort,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,factors,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,preoperatively,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,resources,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,room,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,autologous breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,time,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,peripheral nerve blocks,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,healthcare team,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,ABR25,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,efficiency,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,North America,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,re-introducing,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,alterations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surgery protocols,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,mobilization,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,transmission,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,age,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,standardized patient selection protocol,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,operating,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,monitoring,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,figure,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,pre-pandemic reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,contralateral symmetry,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,remains,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Multidisciplinary collaboration,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,intent,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,apt,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,fulltext,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,brazil,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,type of surgery,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,workforce,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,halt,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,role,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,systematic review,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,oncologic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,safest,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,increase,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,bodies,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperative setting,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,synthesize,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,limited,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,location,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,prone positioning3132,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,seromas,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,period,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,postoperative care,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,operations,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,permit,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,diagnosed,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,streamlining,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,legal representatives,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,debate,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast cancer,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,anesthesiologists,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,teams,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,twentysix,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Factors,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,heterogeneity,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Secondarily,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,standards,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,aligning,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,laryngoscope,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,blocks,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,presentation,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,effects,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,limit,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,January,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,cancer,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,commentaries,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Recommending,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,LOS,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,increased,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,coronavirus disease covid-19 pandemic,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital stay following breast reconstruction 16 17 18 several studies reported,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction 29 30 31 32 33 many studies reported,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction ABR,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,personal protective equipment shortages subsided several authors argued,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,retrospective studies n surveys 5 prospective studies 4 case series 3,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,Delayed breast reconstruction,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast reconstruction patients,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,subsequent reconstruction multidisciplinary teams involving breast surgeons plastic surgeons anesthesiologists nurses hospital administrators,has_body
e4bf8b793bcd248417acceeeb459134f2c6a633b,surg,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,complications,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,selection,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,restrictions,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstruction,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,crises,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,evidence,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,challenges,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,organizations,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,findings,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,covid,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,utilization,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,opene,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,efficacy,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,surgeons,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,expansion,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,tissue,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,rates,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,breast,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,glob,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,conclusions,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,resources,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,reviews,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,plast,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,embase,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,type,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,review,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,results,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,stage,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,complication,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,directtoimplant,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,patient,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,mastectomy,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,sameday,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,times,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,study,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,length,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,methods,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,protocols,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,hospital,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,landscape,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,database,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,transmission,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,provide,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,guidance,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,preserve,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,discharge,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,questions,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,studies,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,collaborations,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,optimization,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,reconstr,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,delivery,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,care,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,cochrane,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,measures,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,resource,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,risk,has_abstract
e4bf8b793bcd248417acceeeb459134f2c6a633b,cost,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,Observer,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,descriptor,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,constraint,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,class,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,systems,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,applications,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,system,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,incremental,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic systems,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor chaotic system,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,Muhammad Sabir,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,Muhammad Marwan,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,Salman Ahmad,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,Muhammad Fiaz,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,Farhan Khan,has_title
e03cb5771dabd9210d33dd243f190aa52e398253,contraction transformation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Arnold dynamical system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,finite-time echo state,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic behavior,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mission,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,well,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,slave,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,descriptor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,explanation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,importance,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,decades,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,depth,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,simulation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,procedure,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,design,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,hyperchaotic systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,food,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,implement,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,active backstepping,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,targets,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sequences,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,calculated,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Section,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robotics,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,definition,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Putting,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Volos,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,increment,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,estimated,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,power,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,integrators,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Transform,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,octahedron,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,full-order observer 1,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,conditions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Carrol,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robust,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,energy,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mofid,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,epidemic,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Corollary7,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,behavior,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,calculate,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,oscillatory dynamics,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,values,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,factor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,paper,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equality,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,disease,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,aid,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Aghababa,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,unpredictable systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,analysis,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Linear outputs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,try,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robotic,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,external noise,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,people,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Muoz-Vzquez,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,maps,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Double convection Rucklidge 1,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,model,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,software,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,numerical simulations,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,proof,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,active control,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,numbers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,thing,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,root,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,linear output,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,ltspice,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,technology,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,comparison,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaption observer law,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,yang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,ANIC control strategy,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,approach,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nonlinear function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,theorems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,forcing,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,pattern,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,L  L,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Suppose,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Peng,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,velocity,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,condition,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,rectangular bounded area,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,signal,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Chaotic circuits,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,state observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,parameter Z,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,pulses,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Concluding remarks,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observer system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,discrete-time systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,brushless,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,exponential reduced,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,communication,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,seconds,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Fig,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Section8,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nodes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,long row,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Rucklidge chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lorenz,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,technique,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaptive controller,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,subsection,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,control procedure,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lipschitz,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,purpose,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,text,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,attention,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lyapunov stability theory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,disturbance,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,namics,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,complex,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fullorder,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,positive,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,and3,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Figs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observe,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,network models,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,volos,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,remark,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,modelling,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dimensions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Quadrotor chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,version,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,huang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,block diagram,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,icq,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,time derivative,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,minimized,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,wen,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,upto,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fields,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Third trajectory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,convection,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,way,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Algorithm,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scaling,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,system quadrotor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,disadvantages,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,exploration,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,external disturbance,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,LTspice,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,whole,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,control,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,discrete-time chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sending,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,bad hands,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,amplitude,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fuzzy modelling approach,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,class,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,books,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,time approaches,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,cubic function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,multipliers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Optimization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,figures,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,existence,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,rewriting,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sequence,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,generalized monotone,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,knowledge,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fast path,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,carrol,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,step,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,infinity,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,microcontroller,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,engineers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,papers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,synchronized,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,aerial robots,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,MATLAB,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,non-negative,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,synchronization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,receivers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,energy type function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,RBG,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,image,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Observer system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,OP,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fig,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,functions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,runzi,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,tracking,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,output,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,designing,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lemma7,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transient,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Algorithm Algorithm,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,life,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,parameters,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,help,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,input,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,V,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,linear matrix,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,set,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nd nodes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,radius,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robot,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,receiving,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Gupta,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,description,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mention,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,process,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,ICQ,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,proofs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quarantine,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,optimal,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,limitation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,moment,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,era,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,addition,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Definition1,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaos,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadratic constraint 3,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Ramirez,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Z equals,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observer17,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,preliminaries,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lorenz,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equivalent,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lemma8,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fractional order chaotic systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,channel,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,trajectories,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Li,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equilibrium,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Nasar,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lipschitz nonlinearity,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,images,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,corollary,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,gain,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chen,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,uncertainties,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lemmas,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,data,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,definitions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,point,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lemma,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,strategy,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,concept,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,control theory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,yields,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,part,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lot,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,use,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,First trajectory x,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,assumption,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Negative,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,convergence,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,hyper-chaotic systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,min,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equals,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,constraint,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,research papers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,synchronizes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,negative,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,contraction,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,hands,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,magnet,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,method,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transmitted,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,example,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,image file,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,living,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,trajectory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lines,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,solving,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transmission lines,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,parameter,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,ramirez,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic solution,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,medical,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,start,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,derivative,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matrices,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,tsunamis,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lmis,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,leaderfollower,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sides,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,amp,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dimension,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,one-sided Lipschitz,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,satisfying,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Omid,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,finitetime,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,figs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,voltage,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,movement,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,upper bound,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nature,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,consideration,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,coverage,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robots,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,arranged,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,encryption,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lorenz chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,subregion,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,error,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,blows-up,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,inject,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,flowing,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,concepts,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sensors,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,ground,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Luo,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,derive system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,unequal,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,integer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,corollaries,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dynamic,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,satisfies,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,case,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,digital,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,symmetric matrix,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,secure communication,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,clarifies,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,results,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transform,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,aerial robot,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,convenience,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,multiplied,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,result,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,stable,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,worked,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,electromechanical system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,trajectory e,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,advantages,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,continuous time chaotic systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,researcher,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaptive observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,applications,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mobile robots,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,problem,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,electric circuit,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,time Synchronization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,manner,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,floods,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dynamical behavior,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,aerial quadrotor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,norm,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,luo,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,multiplying,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chanel,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,inequalities,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,variables,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,engineering,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,robotics engineering,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,theorem,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Runzi,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,difference,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,consider,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,anonymous,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,type,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Huang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Assumption,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,things,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,compensate,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,models,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scheme,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,capacitors,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,outputs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,coronavirus,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scenario,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sudden change,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,identical,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,anonymous parameter,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,original system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,original,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,corollaries6,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nasar,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,humans,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scalar function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,wireless,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lipschitz,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,phenomenon,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,noise free,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,change,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,electric system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,show,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,motor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,types,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,bit,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,master system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,network,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,equipments,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transfer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,whole process,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,assure,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadratic restrictions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,recover,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matrix 3,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,milestone,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,bounded rectangular region,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,term,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,secure,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,begin,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,follow,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,full-order observer descriptor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,none,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaptive observers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,investigated,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,consist,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,lyapunov,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,multiple sensors,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nonlinear,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,differential equation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Shurs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,block,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,moving objects,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dynamics,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,end,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,incremental,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,medical equipments,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,application,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,hyperchaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,multi-weighted complex,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,side,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,basis,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,consensus,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,safety,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,parameter values,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,R i,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,region,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,information,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,messages,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,kaviarasan,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mode,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,form,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,issue,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,reviewing,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,controller,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Corollaries6,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transmitter,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,synchronous motor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,infected,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,simulations,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,stability,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,pecora,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,state trajectories,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,value,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,epidemic disease,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,techniques,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,notice,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,muozvzquez,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Kaviarasan,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,AD,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,minimization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,satisfied,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,properties,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,solution,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaptation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,target,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,order,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mobile,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadratic,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,eigenvalues,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sensor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,definiteness,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Chaos,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,circuit,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,bounded,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,linear velocity A V,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Generalized full-order state observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,steps,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,connectors,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,author,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nonidentical synchronization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lyapunov function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adobe,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,faces,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,zhao,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,controllers,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Similar,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,full-order observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,energy type,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scaling factor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,state,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,theory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,section,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,gupta,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Control theory,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,wireless robots,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,angular velocity A M,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,maximum,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,left side,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,echo,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,max,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,shurs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,research,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,gives,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,L,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,fractional-order chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,area,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,discretetime,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,path,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sign,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,terms,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,oscillator,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dynamical systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,JT,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,U U,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,inequality,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,specifying path,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Multiplying e T T,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,unmatched observer,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sphere,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Calculate,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,recovery,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,written,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,rbg,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,view,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic systems,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,J adaptation law,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,technologies,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,objects,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaption,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,number,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,adaptive sliding technique,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Pecora,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,estimation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,luenberger,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,nonlinearity,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,LTspice software,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,planning,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,heterogeneous,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,optimization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,implementation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,law,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,CoV,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,smooth manner,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,finding,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sequential,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,rest,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,appropriate,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,digital signals,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,public Chanel,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,restrictions,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,literature,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,compute,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,sliding,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,standard,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,floods earthquakes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Graphical explanation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,real life,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,energy function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Lemmas,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,resistors,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,minimum,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,research paper Theorem1,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,characteristics,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,inertias,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,zhang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,noise,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,work,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,active,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matrix J,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,media,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,time,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dongmo,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transformation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matrix equation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,algorithm,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,transmission,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,figure,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Zhang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,LMIs,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,linear,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,backstepping,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matlab,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,unpredictable behavior,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,amendment,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,electrical circuits,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,calculation,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,error term,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,real,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,liu,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,remarks,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,I x,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,role,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,constraints,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,controlling,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,earthquakes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,blowsup,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,generalization,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,tragedies,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,minutes,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,bounded region,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,D,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,row,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,field,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,food supplements,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,file,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,leader-follower,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Theorems1,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,function,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,signals,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,variable,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,variable Y,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,non-identical,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,peng,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,master,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,matrix,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,finance,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,dynamical system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Yang,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,U,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,scope,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,aghababa,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,circuits,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,integrator,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,controlled,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,node,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Gray scaled,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,Z e,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,supplements,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,diagram,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,various fields especially engineering technologies 6 7 8 9 10,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,observer system approaches,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,mentioned chaotic system,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor using consensus static controller zhao et al 34 worked,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic system Algorithm,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,complex power transmission lines 51 collecting media information 52 providing medical equipments,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,many new chaotic systems including double convection rucklidge 1 chen 2 liu 3 finance 4 quadrotor 5,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,chaotic system Quadrotor,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,heterogeneous nonlinear systems zhang et al considered exponential reduced order observer 40,has_body
e03cb5771dabd9210d33dd243f190aa52e398253,rotors,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,paper,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,sphere,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,descriptors,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,image,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,inequalities,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,state,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,parameter,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,designing,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,dynamics,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,observers,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,vertices,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,file,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,drone,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,concept,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,research,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,solution,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,receiver,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,matrix,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,increment,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,robot,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,observe,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,tangent,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,description,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,octahedron,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,ltspice,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,optimization,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,constraint,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,system,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,circuit,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,region,has_abstract
e03cb5771dabd9210d33dd243f190aa52e398253,quadrotor,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,Virology,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,Journal,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,Neutrophil,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,elastase,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,acid,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,serine,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,protease,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,uncoating,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,infection,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,U937,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,promonocyte,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,cells,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,virology,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,Neutrophil elastase,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independent serine protease,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 promonocyte cells,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,Joseph Golden,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,Leslie Schiff,has_title
dff6195f5e24ebfa2fb4060142611b48021f673c,vivo,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,derivatives,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,peroxidase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pH L929,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,well,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,in vivo,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,macrophagelike,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,host,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,secretion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chymotrypsin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64-resistant reovirus growth,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,calculated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tris,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,elastase inhibitor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pre-treated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,isvps,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nibert,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,productive reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pre-treat cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,antins,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,resultant particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Endocytosis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treating,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infectious,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,release,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ECL,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,detection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mice,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,weak,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,absence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infectious NE-SVPs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,exposing,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infections cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,extracellular proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,determinants,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,atpase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Purified,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,harvested,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,conditions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infection Cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,self-limiting,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pi,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,block cysteine protease activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,grey,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteolysis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treatment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,figc,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,gel,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,atC,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Fig A  NE,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,1C,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independent protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,papainlike,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,adsorption,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,values,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,factor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Calif,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell type,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,down-regulated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,segmented,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,calbiochem,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,disease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fluidphase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,isvp,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral protein 1,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infections,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,stored,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibitors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,analysis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteins,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,post,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ebola,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,replicated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tissue,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,try,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA-differentiated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,graph B L929,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,efficiently,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,model,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,observation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,purified,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64 Figure,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64 Baf,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,hrlog,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,electrophoresis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pro-vide,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,resultant,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,irreversible,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,compartment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sensitive,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,activator,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,hosts,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral yields,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,macrophage-like cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,formula log PFUml t,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,untreated U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,prototypic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,serine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fact,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,FigC,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMAinduced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,differentiate reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,approach,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA-differentiated cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Table,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus non-structural protein NS,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibitor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L929 cell monolayers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rochester,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cytokine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,maximal activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Elastase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell-specific host factor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,enzyme activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Effects of,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,promonocytic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,syncytial,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,members,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,signal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,range,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,washed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Lysates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ester,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,film,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-dependent endosomal proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular receptors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,surface,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,biotechnology,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sample,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,phorbol,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,enzyme,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,specificity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,aspect,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Baf NH,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nacl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ISVPs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,dry milk,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,consistent with,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat B-specific,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,figb,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Speed Blue,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reached9 and7,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,requirement,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,macrophages,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,laboratories,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,strain,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Fig,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Eastman Kodak Rochester NY,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,endocytosis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,induced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,conformational status,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,TBST,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,support,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Infectious virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,centrifugation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,methanol,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell lysates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,orbiviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L929,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,intact,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral spread,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,bands,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus-induced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,recapitulate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory infections,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutral protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,effect,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reaction,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fresh,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-dependent hydrolases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64-resistant infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,medium,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Reactions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,serine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lysates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,activated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,stimulation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sdspage,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat S 3,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cathepsin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monolayers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,insight,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,small effect,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,dengue,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rabbit,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ards,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,enteric,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ISVP-like particle,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,phorbol ester derivatives,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,grey bars,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,vitro-generated intermediate subvirion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,time point,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory tract,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NS,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,enhanced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infectivity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mediates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,productive infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine protease activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nitrocellulose membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Arlington Heights Ill,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L929 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteinase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,findings,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,and05,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,xray,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,detected,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,vacuolar,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,interacting,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infection Virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA-treated U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-specific inhibitor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,binds,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mechanisms Cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,broad-spectrum cysteine protease inhibitor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,baf,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fragments,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Viral yield,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,colorimetric,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,base,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,times,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophil elastase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,increases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fibroblasts,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sds,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,blocking,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,resuspended,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,azurophilic granules,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,step,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,substrate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat S,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 culture,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,requirements,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cysteine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell culture,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,graph,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chemiluminescence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treated cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tbst,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pancreatic serine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,binding virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tween,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lack,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA Figure,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-dependent protease activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,degradation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,murine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,macrophage-like cell line,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat LB,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lysosomal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-SVPs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,multiplicity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,hypothesis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,assayed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophils,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fig,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,in vitro,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,functions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,repair,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,confirm,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,intestinal tract,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,replication,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,life,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,overnight,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,slow,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monlayers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Amersham,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,SDS-PAGE,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pfuml,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pump,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,samples Virion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protease inhibitor cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Lysate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,LAMP-1,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,stained with,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory tract Analysis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,instances,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,anti-NS polyclonal antiserum,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,P388D,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rotaviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,addition,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,thermolysin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,expression,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,eresistant,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,papain,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PBS,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,equivalent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NaCl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell entry,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,consequence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell types,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,atc,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory syndrome,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA-induced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64treated U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,expressed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,extracellular medium,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nitrocellulose,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cathepsin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,data,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,point,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infect,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fluorogenic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,glycoprotein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,variety,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibited,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,yields,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protecting,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory syncytial,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pathogenesis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,capacity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,particle,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-generated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMAdifferentiated cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat LB-mediated 3 removal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus strains,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mixture0,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,melville,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,prototypic members,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cultures,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,left,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,combination,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NM001972,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,analyzed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infectious reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,example,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chemiluminescent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,bafilomycin A1,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,eastman,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,removal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,experiment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,incubated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lines,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,interactions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,raise pH,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,attachment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat B,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,microbial,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rinsed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular determinants,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chemilumescence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,blocked,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tissues,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Virion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mediate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Acidic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reactions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,untreated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,debris,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,impact,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ARDS,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nonfat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,processing,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular host,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Nitrocellulose membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cytotoxic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cystatin F,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,elements,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,promote,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Sigma,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Analysis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,junctional adhesion molecule,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,intermediates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,points,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,calif,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Reoviridae,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,plaque,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Tris,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inflammation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,removed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Protein samples,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,possibility,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,receptor-mediated endocytosis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,trypsin lack 3,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,extracellular,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nature,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independent serine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,degranulation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,experimental conditions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,CD68 62,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,aspartyl protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pH0,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,examine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 U grey bars cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,virion infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-dependent cysteine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,status,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,efficacy,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independent lysosomal cysteine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pmsf,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,svps,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,seadornaviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,decreases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sample buffer,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,samples,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteolytic processing,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,results,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,trypsin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,TLB,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ill,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,table,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,aspartyl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,quantified,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,notion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,regulating reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pro-region,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,kodak,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Baf M monensin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,less,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,raise vesicular,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,receptors sialic acid,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,experiments,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proregion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,manner,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,penetration protein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,gels,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-mediated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,animals,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,intracellular,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,assessed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tract,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,promonocytic U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Purified Lang virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 cell cultures,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,evidence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,molecule,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-dependent proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular stimulation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral yield,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,vdb,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,transferred,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,virions viral protein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,prepared,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral life cycle,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,filter,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,markers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mild,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,family,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,milk,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,difference,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,levels,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nesvps,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,type,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,hours,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,FigA,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,non-enveloped,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Ebola virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64-sensitive papain-like cysteine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,models,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,regulate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,relative difference,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,percent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine protease inhibitor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tropism,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,MeOSuc-Ala-Ala-Pro-Val-NA,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,measured,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,P388D macrophages,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,humans,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMSF,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus cell entry,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,disassembly,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,influx,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L929 cell monlayers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,arlington,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,electrophoretically,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,studies,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,endosomal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reoviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,types,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat L 30,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,requisite,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lesser,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,MOI,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,replication cycle,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pathogenic rotaviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,goat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,moi,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,polyclonal antibody,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,aciddependent proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ISVP,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Yields,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-mediates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,subvirion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,heights,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,decreased,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,B activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,metalloproteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,investigated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,SD,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mixture,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Blue staining,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nemediates,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Mammalian,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lysc,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,non-cysteine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat S-expressing cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophil proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,endoproteinase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Studies,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,block,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acidindependent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,days,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,culture,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,promonocytic pre-differentiated U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,entry,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,facilitate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,units,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,santa,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,removal infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,IL-8,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inflammatory serine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,glycine-20,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Viral infectivity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tlb,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,associated with,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,serine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Lang virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,activating,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chemoattractant,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,plasminogen,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,legend,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,exacerbate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,collagenase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,express,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,genome,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Baf,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nitrocellulose filter,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,form,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,urokinase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,post-adsorption culture medium,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,resolved,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,differentiation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,buffer,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,antirabbit,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,isvplike,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pre-treatment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cathepsin G Inhibitor I,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acid-independence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,FigB,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reduced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,capsid protein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat G-specific inhibitors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cysteine protease activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Bio-Rad Laboratories,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infected,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,behave,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NH,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cruz Biotechnology,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sigma,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lung,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,M,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,coltiviruses,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lang,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acidindependence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,agents,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protease inhibitors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA-treated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,broadspectrum,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Viral,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Serine proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mean,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,line,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral protein,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,order,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,surrounds,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,gene,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,high,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,immunogloblin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,milieu,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64-treated U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,generation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,temperature virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pbs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treated virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,postadsorption,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat L,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat S activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,NE-generated subviral particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,capsid protein 3 2,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,bronchiolitis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,bars,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,wound,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,a-well plate-24,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,black,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteinase K thermolysin endoproteinase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,steps,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,yield,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,antibody,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protease activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,horseradish,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,treated with,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L929 cells Cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Coomassie Brilliant,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,terminated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophilic invasion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mammalian,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,SDS-12,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral replication,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,post infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monensin,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,distant tissue,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,well-described effects,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,infectious particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat B mediate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutral,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,differentiated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,analyze,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pma,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,immunocompromised hosts,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,analyzing infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proteins from0,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,phenotypic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,elastase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,syndrome,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reagents,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nitrocellulose Membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cleaved,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,filters,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,polyacrylamide,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pH,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,penetration,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,receptors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,toxic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,SVPs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,U937 cell,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,mechanisms,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,extent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,supernatants,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Raw values,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Lang particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,biorad,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,chilled,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Treatment,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,henry,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,formula,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cell surface,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,participation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Nibert,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,aciddependent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,promotes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,maintains,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,emphysema,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Consistent with,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,influences,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monocyte-like cell line U937,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Protein bands,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,hydrolases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibit,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,number,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,virion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,collagenase activity,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral bronchiolitis,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,glycine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,structural features,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,for5,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,VDB,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lamp,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,granules,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat D,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,L939 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,immunoblotting,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,changes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,decrease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,finding,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,report,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ketone,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,proenzyme,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,spread,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,intracellularly,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,standard,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,urokinase plasminogen activator receptors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,polyclonal goat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,wound repair,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ISVP-like particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reviewed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMA,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,deletions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,dsRNA,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,features,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,PMAtreated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Bound antibody,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,presence,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,low,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,factors,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,induce,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Samples,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Cat G,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,antiserum,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,andor,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,uncoating,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,work,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,activation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,determine,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,undifferentiated,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,active,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,viral particles,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,time,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neonatal,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular debris samples,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,In vitro,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,recombinant,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Z-Phe-Arg-MCA,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,growth,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,temperature,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,lysosomal cysteine protease,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,horseradish peroxidase 15000,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Coomassie Brilliant Blue,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,figure,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64-treated U937,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,time points,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,B U937 cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,LAMP-3,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,nmethoxysuccinylalaalaprovalchloromethyl,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,upregulation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,arbitrary units,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reoviridae,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,question,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophilic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,frozen,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,purified virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,visualized,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monocytelike,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,representative,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cruz,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,invasion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,smokeinduced,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,untreated cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,logs,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,pre-treatment cells,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,acidic,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,adhesion,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,expression cell,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,role,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,replicate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,increase,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,zpheargmca,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,controlling,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,titer,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,source,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,deviation,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,E64 A,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,plate,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,share,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,rodent,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,log,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,Experiments,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cellular proteases,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,respiratory syncytial virus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,discovery,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,function,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,meosucalaalaprovalna,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,contrast,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,human,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,LAMP-2,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,In vivo,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,fluid-phase markers,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cycle,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,effects,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,sites,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,speed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,assay,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,monocyte-like cell line u937,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,uncoating reovirus infection,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tbst 10 mm tris ph0 mm nacl and05 tween containing nonfat dry milk rinsed,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,tbst santa cruz biotechnology inc santa cruz ca membranes,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,generated intermediate subvirion particles isvps 10 11 12 13 14,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,serine protease Cat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,cysteine proteases Cat,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,ray film eastman kodak rochester ny purified virions 14,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,junctional adhesion molecule 6 7 8 following binding virions,has_body
dff6195f5e24ebfa2fb4060142611b48021f673c,addition,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,agent,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,distress,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,proteases,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,expression,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibitor,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,infiltration,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,findings,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,virions,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,protease,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,mammalian,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,presence,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,infection,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,cell,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,acidindependent,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,aberrant,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,facilitate,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,results,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,transepoxysuccinyllleucylamidoguanidinobutane,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,chloromethylketone,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,pma,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,growth,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,yields,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,virology,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,capacity,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,elastase,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,syndrome,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,protein,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,requirement,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,lungs,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,particles,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,conditions,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,background,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,system,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,cultures,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,proteolysis,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,combination,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,cat,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,nalaalaproval,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,treatment,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,differentiation,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,promonocyte,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,role,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,infections,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibitors,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,pathology,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,neutrophils,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,rodent,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,tissues,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,cells,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,symptoms,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,amounts,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,replication,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,model,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,lung,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,z e,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,agents,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,reovirus,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,inhibit,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,broadspectrum,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,incubation,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,tracts,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,virion,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,line,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,hosts,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,journal,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,serine,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,activity,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,generation,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,defense,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,fact,has_abstract
dff6195f5e24ebfa2fb4060142611b48021f673c,subviron,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Role,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Perirectal,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Fat,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Carcinogenesis,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Development,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Early,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Onset,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Rectal,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Cancer,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancer,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Perirectal Fat,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Early-Onset Rectal Cancer,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,An Pan,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Nan Zheng,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Jin Wang,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Jean Luc,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Tshibangu Kabemba,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Kuo Zheng,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Fu Shen,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Wei Zhang,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Xian Gao,has_title
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reason,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,overweight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,serum,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,target therapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diabetes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,early,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,decades,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,depth,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,threshold,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,anbit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,food,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Group,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor development-related,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resection margin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,for-12,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,modifying,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ZW,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,aberrant,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,weight gain,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,difficulty,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,correlated,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,calculated,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,familial adenomatous polyposis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,clinical,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,no fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,preneoplastic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,waist circumference,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Figureg,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adenomatous polyp,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,massive,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,gut microbiota,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,scan,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,limitations,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,microbiota,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic MR images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colonoscopy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,treatment,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,behavior,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,inclusion criterion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,to1 per000,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,biological,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,TME,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,XHG,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,comparative analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,therapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cause,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cox,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Postoperative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,thes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ImageJ software Figurea,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tissue,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,people,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adiponectin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sensitivity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pathological,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,multivariate analyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diets,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,chest,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tnm,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,xhg,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,software,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mean value,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,regulating,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,clinicopathological,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rectum,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,higher,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Multiple,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,oncological outcomes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,local excision,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,KZ,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sensitive,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contributed,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,global westernization,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rise,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,allium vegetables,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PFA tumor deposit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,muscle,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,jin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adverse,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Table,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reduce,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,statistical,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,radiation chemotherapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,oncological,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,malnutrition,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,acquisition,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tfat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PACS,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,aged,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ruler,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,relationship,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,draft,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,standard deviation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,radical resection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pathological reports,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,viscerally obese,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,signal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,multivariate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,scans,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,range,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,general population,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,every-3,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Diet,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obscure,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,women,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sample,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor types,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Figure,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,incidence,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,alteration,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metachronous multiple,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,early-onset rectal cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surgical,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lymph nodes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,consistent with,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Korean population-based cohort study,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pfa,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,measurement,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,communication,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,NXZ,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prognostic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,JLTK,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,system,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lymph node metastasis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,children,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,only4,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,MRF,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,impairment,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fat series images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,supply,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,support,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,article,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obesity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,oncology,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Colorectal cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Vascular Invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,effect,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,biopsy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,exclusion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Comparisons,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,conclusions,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,radiation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,jltk,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,per000,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,wang,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Overweight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,procedures,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,secreting,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,immunity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colonic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,incidence carcinogenesis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,positive,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diabetes tumor deposit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,late-onset,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,young,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prevalence,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metastasis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lifestyle,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mannwhitney,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic MRI scans,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,screening,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reduces,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,margins,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mesorectal fascia MRF,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,antibiotics,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PFAs,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adipose tissues,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Oncology,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adipokines,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,changhai,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,predicting,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,investigation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,subcutaneous adipose tissue,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lorc,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,picture,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,X-ray,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,trend,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,probiotics,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colon carcinomas,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Changhai Hospital,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,margin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,xray,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lymph,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sample t-test,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metaanalyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,body Journal of Oncology weight BMI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,examination,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,university,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obesity body weight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metabolic diseases,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,digital rectal examination chest,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Age,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mass,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,MRI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,DIXON-Fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,visceral fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,T2weighted,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,conceptualization,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,included959605,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lumbar spine vertebra,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,China,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,and4,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,crypt,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,development,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,knowledge,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,date,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,groups,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,multiple,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,level,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,intersphincteric resection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fishers,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,selection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Jin Wang,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,DFS,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,authors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,N1,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,image,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surgical procedures,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,hypothesis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,demographic variables,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,stage I-III rectal cancers,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,younger age,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,nxz,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cells,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,parameters,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prevent,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,red,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reports,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,outcomes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,set,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,january,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Statistical Analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,shorter survival,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,scale,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,body,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,database,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,survival,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Clarifying,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mrf,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Lower,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,inevitable,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,body weight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pacs,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,center,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Table S1,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contradictory results,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,addition,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colorectal cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,examinations,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,American people,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surgery,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,abdominal fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,N stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,evaluation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,perineural invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,test,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,EORC,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,influence,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,N0 stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,VAT,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,inclusion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,likelihood,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Multivariate Cox analyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,gain,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lynch,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,nutritional,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,data,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,leptin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colonic cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,clinical significance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,strategy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Kaplan-Meier survival analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,accumulation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colon tumors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,part,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,median,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interests FS,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pathogenesis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,capacity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,One-way analysis of variance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,independent,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Chinese Han population,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,referral,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interquartile range,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,negative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,method,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,analyzed,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,TNM stage tumor deposit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,associations,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tertiary referral center,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,EOCRC,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,TNM Stage Tumor Deposit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,annually,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,correlation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,synthetic food dyes,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,perirectal fat area,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reasons,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,dfs,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,age-standardized,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,parameter,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,eorc,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,medical,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,explore,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tissues,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,hand  Figured,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,First Affiliated Hospital Naval Medical University,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,revision,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,dysbiosis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,menu,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,dixonfat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,supervision,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,OS,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,outpatient,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cytokines,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,impact,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interquartile,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,circumference,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,quantitative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,participants,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,nonfat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tomography,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Accumulation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pathologically,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,senior radiologist,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,People,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,hospital,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,iiii,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prognostic marker,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic MRI scan,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,flexible,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,poor,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fat area,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,T stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,red meats stress,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Weight BMI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,First Affiliated Hospital Naval Medical University Criteria,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,statistical analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,followup,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interests,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,chemoradiotherapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,December,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,chronic inflammation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,LORC,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,inflammation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adenocarcinoma,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obesity-related parameters,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,follow-up,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,wall,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,compared,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adipose tissue,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,supervision AFP,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,discrepancies,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,JW,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,anal margin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,december,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,immune therapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,conclusion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contact,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,results,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,earlyonset,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancers,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,table,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,study,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,result,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,risk factors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,positively,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,eocrc,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumorigenesis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,liver ultrasound,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,scientists,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Mann-Whitney U test,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,probability,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,intestine,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Perineural Invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obesity-induced insulin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,polyposis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prognostic factors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,specialized,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Multiple studies,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sedentary behavior,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,evidence,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,group,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prospective study,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,variables,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,synchronous,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surveillance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,MRICT,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Obesity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,figureb,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,measurements,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,benefit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,difference,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,westernization,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,accurate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,levels,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,predictor,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,specific,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,individuals,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tme,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,regulate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic contrast MRI scans,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,measured,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vegetables,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Measurement,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tool,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,excision,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PFA,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,index,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,older,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic CTMR,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Fu Pan Nan Xin Zheng,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,funding acquisition,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,neighboring,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,studies,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ischial,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Rectal Cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,types,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,areas,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,supplementation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,data collection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Chisquare test,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surrounding,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,variance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,retrospective study,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,recover,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,waist,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,LAVA-Flex-Fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,CT,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,critical,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,insulin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,original draft AFP,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,deposit,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,researchers,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,years,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,decreased,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,indicator,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,consumption,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Complete,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,liver,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,investigated,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,gut,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cohort,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Multivariate analyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,analyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,secrete,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,declare,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,associated with,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rectal adenocarcinoma,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rectal carcinomas,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Compared,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,hand,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,preoperative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ultrasound,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,particles,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,comparisons,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,T3 stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,region,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,inpatient,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,male,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,TNM stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Relationship,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resolved,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,xin,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,prospective studies,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vascular invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,SPSS0,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,formation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,abdominal adipose tissue,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,funding,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,published literature,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,BMI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,modify,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor cells,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,from6,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,kgm,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,value,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,preventing,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colon,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,carcinomas,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,investigating,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,univariate analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,patient,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic MR,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,physicians,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,image Figurec,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pfas,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mean,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mri,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,target,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interpreting,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Figureb,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,statistically significant,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Data,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Figure S1,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ethics,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,N2 stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,figurea,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,LOCRC,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contrast-enhanced,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,positive resection margins,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,year,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,USA,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,obese,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,foci,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,FS,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,overall,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,adipose,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,afp,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Colorectal Surgery Department,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pericolon fat area,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vascular,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,series,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,significance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,compare,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pearsons,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,carcinogenesis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,automatic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mortality,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Diagnosis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Multivariate analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Tripathi,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,intestinal microbiota,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,circumferential resection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,CT scan,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,analyze,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fat series,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,research,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,one-way analysis of variance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,malignancy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,transverse,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,organ,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,department,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,dysregulation diagnosis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,postoperative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,discussion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,area,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,syndrome,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,abdominal obesity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Fishers exact test,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,patients,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,body weight BMI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,perirectal fat,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,economy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Pearsons correlation coefficient,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,committee,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,crc,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,survival analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,months,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,risk,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,abdominal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rectal MR images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Traditionally body mass index,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,administration,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Parameters,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,relationships,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mechanisms,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,interest,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,height,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,criteria,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cases,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,MR images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reducing,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,younger,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,AFP,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,stage I-III rectal cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diet,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,figureg,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,clinicopathological data,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diagnosis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mesorectal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,china,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,progression,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,local,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,postoperatively,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic wall muscle,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,association,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,ratio,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PFA body weight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,growth factors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,screened,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,increasing,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tripathi,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,journal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,collection,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metabolic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,marker,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,rectal cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,polyp,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,visceral,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,surgical difficulty,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,carbohydrate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Lynch syndrome,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,decrease,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,criterion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vascular invasion invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,literature,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,predictors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Univariate,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,endocrine,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,population,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resonance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,measuring,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reviewed,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resistance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,allium,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,deposits,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,presence,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,statistical significance,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,stage IV cancers,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contact with,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,low,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,factors,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fascia,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,colorectal lesions,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,radical excision,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resources,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,electronic magnetic resonance MR images,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,work,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PACS PFA,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,active,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,determine,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,T stage N stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,goal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Abdominal obesity,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,red region,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,dysregulation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Exclusion criteria,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mrict,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,growth,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,age,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,distant metastasis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,antigen,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,figure,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor deposits,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,magnetic resonance imagingcomputed tomography,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,and197,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,CRC,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,radiologist,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pericolon,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,exclusion criterion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,by76,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,qualitative,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lesions,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lateonset,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Perirectal,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,role,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,height body weight BMI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,oncologic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,no pelvic,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,increase,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,deviation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,meta-analyses,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vertebra,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,meats,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diseases,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,bias,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,reliable,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,period,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,immune,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diagnosed,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,contrast,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,human,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,multivariate Cox analysis,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,shorter,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,weight,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,healthy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,chemotherapy,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,bmi,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,locrc,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,measure,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,T1 stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,Patients,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,molecular mechanisms,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pelvic MRI,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,operation,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,January,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancer,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,account,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,node,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,sites,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,predictive,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,increased,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,patients older,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancer mortality,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,related parameters including pathological tnm stage tumor deposit vascular invasion,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,significantly higher PFA,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,PFA TNM Stage,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lower PFA Patients,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,similar effect 14 another large study with511 participants and173 cases,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,higher PFA Group,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pfa were4 1 kg3 9 kgm and4 9 cm respectively,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,chinese han population measured using pelvic mr images was0 9 cm 23,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lower PFA Group,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,red meats stress antibiotics synthetic food dyes sedentary behavior,has_body
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,level,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lorc,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,invasion,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,decade,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lateonset,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,deposit,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,group,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cause,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,purpose,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,relationship,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,resonance,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,imaging,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,fat,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,depth,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,lymph,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,series,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,december,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,deposits,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,eorc,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,images,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,diseasefree,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,vascular,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,carcinogenesis,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,conclusions,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,predictor,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,scans,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,mass,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tnm,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,results,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,stage,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,software,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,earlyonset,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancers,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,incidence,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,study,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,methods,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,weight,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,tumor,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,january,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,hospital,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,excision,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,body,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,metastasis,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,iiii,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,survival,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,pfa,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,index,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,area,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,development,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,patients,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,cancer,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,node,has_abstract
e55da8e424d770d37b4dc2065ff9abb3e5aeb16c,groups,has_abstract
